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SUMMARY
My early clinical experience had demonstrated that abnormalities of 
endocrine testing particularly with regards to thyroid function are 
common in ill patients.
Interest in endocrine effects of illness was further stimulated by 
my study of hormone levels of uraemic patients undergoing differing 
forms of dialysis therapy. Chronic renal failure resulted in abnormal 
hypothalamic-pituitary-testicular and hypothalamic-pituitary-thyroid 
function irrespective of the nature of dialysis. Evidence for low levels 
of adrenal androgen in serum of uraemic patients was also found. As it 
was well known that abnormalities of thyroid function occurred in a 
variety of illnesses so it appeared possible that abnormalities of 
adrenal androgen status and hypothalamic-pituitary-testicular function 
might also be non-specific consequences of illness.
To investigate this hypothesis these endocrine parameters were 
measured in several groups of patients:- those ill in a general medical 
ward, in diabetic men with ketoacidosis, during recovery from burns 
injury and before and after surgery.
Serum levels of the most abundant adrenal androgen 
dehydroepiandrosterone sulphate (DHAS) were low in patients with a 
variety of non-endocrine medical illnesses only if they had been unwell 
for more than two weeks while serum androstenedione concentrations were 
higher than in controls irrespective of the duration of illness. 
Testosterone levels were also low but this was not related to the 
duration or severity of illness nor could it be accounted for by changes 
in binding proteins, hyperprolactinaemia nor on the basis of classical 
primary or secondary testicular failure.
A study of men during an episode of diabetic ketoacidosis revealed 
that this complication of diabetes mellitus is also accompanied by
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depression of serum testosterone concentrations. However serum 
testosterone concentrations of non-ketotic diabetic men at routine review 
were not found to be related to diabetic control as assessed by 
glycosylated haemoglobin estimation. There was some limited evidence in 
the literature to suggest that adrenal androgen levels in diabetic men 
might be low and that this might have a deleterious effect on islet cell 
function but no abnormality of these hormones could be demonstrated in 
this group of patients.
19 burned men were followed sequentially for several weeks. Profound 
depression of serum testosterone concentrations for several weeks was 
found with levels falling into the range found in healthy females in the 
majority of patients studied. This could not be explained on the basis of 
binding protein changes nor by alterations in the concentrations of 
prolactin or gonadotrophins. DHAS levels although normal within 24 hours 
of admission fell to subnormal levels and remained low for several weeks. 
Serum androstenedione levels were high following admission and tended to 
remain so for several weeks. These changes in adrenal androgen 
concentrations were reminiscent of my observations during medical 
illness.
Serum gonadotrophin levels of post-menopausal females were studied 
following cholecystectomy. Unlike the situation in medically ill men this 
operation led to a marked reduction in gonadotrophin levels sometimes 
down to the pre-menopausal range. Serum DHAS levels fell to below control 
values four days after surgery while serum androstenedione concentrations 
rose transiently post-operatively. The situation was however complicated 
by the administration of several drugs in particular parenteral opioids 
which might have affected gonadotrophin levels.
As such profound endocrine changes had been observed with illness, 
it was of interest to discover whether these were specific to illness or 
whether other forms of stress such as the physical stress associated
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with exercise or the psychological stress accompanying academic 
examinations might result in similar changes.
Following marathon running there was a small fall in serum 
testosterone concentrations. The situation differed from that following 
illness in that there was a massive elevation of serum cortisol as well 
as a fall in luteinising hormone (LH) levels. On the other hand veteran
athletes who had run at least 25 miles a week for many years and who are
therefore exposed to recurring and chronic physical stress had normal 
serum testosterone levels. Neither veteran athletes nor marathon runners 
showed evidence of a reduction in serum concentrations of adrenal
androgens. The stress of physical exercise has a short-lived adverse
effect on testicular function but unlike illness there are no changes in 
adrenal androgen levels.
Review of the literature suggested that psychological stress can 
adversely affect gonadal function. As illness in general can be 
psychologically stressful it seemed possible that the endocrine changes 
found could be a consequence of associated psychological stress. To 
further elicit the role of psychological stress endocrine function was 
examined in students several months before and immediately after a series 
of Degree examinations having excluded other factors which might have 
affected hormone levels. Increased psychological stress, as assessed by 
two anxiety rating scales, was reflected in increased excretion of urinary 
metadrenalines. However, there were no accompanying changes in testicular 
or adrenocortical hormone levels. The hormonal changes occurring with 
illness therefore are unlikely to be caused by the associated 
psychological stress.
Did the low levels of total testosterone found in ill men reflect a 
reduced availability of this hormone at the cellular level? Free 
testosterone levels^ often considered the physiologically active component 
of total testosterone were depressed in burned men to an extent similar
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to total testosterone levels suggesting that there is a diminished, supply 
of this hormone to cells. Our burned patients had been found to have low 
sex hormone binding globulin (SHBG) capacity within 24 hours of 
admission. This assay depends on the ability of the patients' serum to 
bind dihydrotestosterone and thus a fall in SHBG capacity might be due to 
reduced affinity of this binding protein for testosterone. The fall in 
SHBG capacity was closely mirrored by the change in SHBG measured by an 
immunoradiometric assay, suggesting that burns injury is followed by a 
fall in the absolute concentration of SHBG rather than by a reduction in 
its affinity for testosterone.
Normal hypothalamic-pituitary-testicular function is associated with 
intermittent rather than constant release of LH. Uraemic men showed 
impaired LH pulsatility when compared with healthy controls. This might 
be due to a hypothalamic-pituitary abnormality but altered metabolism of 
LH occurs in renal failure and might account for this deficit. 
Nevertheless absence of LH pulsatility might contribute to the low 
testosterone levels found in uraemic men and encouraged me to search for 
a similar disturbance in burned men.
Burned men seemed suitable for further investigations of the 
mechanisms leading to low testosterone levels as these patients have 
normal renal and liver function and have a prolonged and profound 
depression of levels of this hormone. Most burned men showed a normal 
testicular response to stimulation with human chorionic gonadotrophin 
suggesting that the major defect was at the level of the hypothalamus or 
pituitary. LH but not follicle stimulating hormone (FSH) levels responded 
normally to stimulation with luteinising hormone releasing hormone (LHRH) 
in most men. Multiple blood sampling of burned men revealed evidence of 
reduced LH pulsatility but the results were very heterogeneous with some 
individuals having absent pulsatility whilst others pulsed normally. The
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biological activity of LH when testosterone levels were suppressed was 
low and increased following recovery.
The final study described in this thesis examined LH pulse frequency 
of burned men using a shorter sampling interval and a more refined 
method of pulse analysis. In addition LH was measured by 
radioimmunoassay and bioassay through the whole pulse profile for each 
patient. In this study there was no significant difference in frequency of 
LH pulses between the burned patients and the control group although the 
former once again showed a heterogeneous response with most patients 
pulsing normally but one patient having no detectable pulses. In normal 
subjects an LH peak was followed by an increase in serum testosterone 
concentrations but this was not the case following most LH peaks in 
burned patients. LH pulses in burned men also differed from those in 
controls in that the biological activity of LH during a peak was less 
than that during a nadir whilst in normal men the biological activity of 
LH within a peak was greater than that during a nadir. Thus during 
illness LH may be secreted in a less pulsatile manner than normal and 
may be qualitatively abnormal thus being unable to promote testosterone 
secretion.
Possible mechanisms leading to these changes in serum androgen 
levels and their consequences to the ill patient are discussed.
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IITRODUCTION
Following appointment to the staff of the Endocrine Unit at Glasgow 
Royal Infirmary in 1980, I encountered a fascinating case which drew my 
attention to the effect of serious illness on endocrine function.
Mistaken.diagnosis of secondary hypothyroidism
A 76 year old man was admitted with effort dyspnoea and physical 
signs of right heart failure. Biochemical screening revealed impaired 
renal function with creatinine clearance only 13 ml/minute as well as 
thyroid function tests which when repeated over the ensuing few weeks 
were as follows :-
Admission 
Week 1 
Week 2
I4L
4
20
34
13.
0.7
0.8
1.0
TSH
UD
UD
1.8
following) 5.0 
TRH) 3.6
Week 12 80 1.4 1.6
following) 4.8 
TRH) 3.6
Normal range 55-144 nmol/1 1.4-2.8 nmol/1 <0.8-5.0 mU/1
Gonadotrophins were in the high normal range and responded normally 
to injection of LHRH. Insulin induced hypoglycaemia testing during week 2 
showed a basal serum cortisol of 300 nmol/1 (normal range 200-700 
nmol/1) failing to increase during the test. There was a normal TSH 
response to TRH (increment >2mU/l with 60 minute value <20 minute value).
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Because of low thyroid hormone levels and the poor cortisol response to 
hypoglycaemia he was diagnosed as having hypothyroidism secondary to 
partial hypopituitarism and was treated with thyroxine and glucocorticoid 
replacement therapy. While on this treatment his cardiac failure worsened.
Following specialist referral further scrutiny of the biochemical 
data showed that his blood glucose during the insulin stress test had not 
reached hypoglycaemic levels and when this test was repeated he showed a 
normal cortisol response to adequate hypoglycaemia. Abnormal thyroid 
function tests were then attributed to systemic disease. Endocrine 
replacement therapy was subsequently withdrawn and his condition 
remained stable. Cardiac failure was controlled and he progressed well. 
Four weeks after stopping replacement therapy thyroid function tests were 
repeated (Week 12) and were normal.
Subsequent reading of the literature led to the realisation that hormonal 
changes occur in quite a number of illnesses, different authors having 
made observations relating to their own area of interest. Thus it was 
widely held that endocrine changes in chronic renal failure were caused 
by accumulation of urea and other waste products, in respiratory failure 
they were blamed on hypoxaemia while as a general endocrinologist I 
wondered whether they were non-specific markers of ill health.
Most of the literature relating to the field of endocrine adaptation 
to illness followed the development of specific radioimmunoassays for 
hormones in serum. However, the principle of endocrine adaptation had 
been suggested previously by Hans Selye (Selye, 1936) who proposed the 
term "the general adaptation syndrome" to describe the body's responses 
to insults as diverse as hypothermia, surgery, exercise and noxious drugs. 
With access only to rather crude hormone assay methods and relying 
primarily on animal experimentation, Selye (Selye, 1946) considered the
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anterior pituitary gland to be of central importance to "the general 
adaptation syndrome". He deduced that following exposure to stress the 
anterior pituitary gland secretes a corticotrophic hormone activating the 
adrenal cortex to produce essential glucocorticoid; at the same time 
output of less crucial pituitary hormones, such as reproductive hormones, 
growth hormone and prolactin appeared to decrease. As assay methods have 
progressed allowing detailed endocrine investigation of the stressed 
human being, it has become increasingly clear that a variety of hormonal 
changes do occur with illness although the advantages to survival are not 
always clear.
My earliest project focussed on the hormonal changes accompanying 
chronic renal failure. This subject already commanded an extensive 
literature. The establishment of a new therapeutic technique, continuous 
ambulatory peritoneal dialysis, provided new scope to investigate this 
group of patients. Whereas abnormalities of thyroid function were 
recognised in a variety of illnesses other than chronic renal failure, 
there were much less data available on androgen concentrations. I set out 
to examine the hypothesis that other illnesses would have a similar 
adverse effect on androgen levels as chronic renal failure. My initial 
studies had concentrated on abnormalities of hypothalamic-pituitary- 
testicular function and this system has continued to be of great interest 
throughout the course of my work. As a chance finding in uraemic patients 
I had noted unusually low levels of the most abundant adrenal androgen 
dehydroepiandrosterone sulphate (DHAS) so in subsequent studies adrenal 
androgen status was monitored to discover whether this finding was 
specific to the uraemic state or merely a marker of ill health.
Although most of the subsequent thesis is concerned with the effects 
of illness on endocrine function it was considered important to study 
other forms of stress. The ill patient may experience significant 
psychological stress and indeed physical stress unrelated to illness such
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as might occur during endoscopic or other invasive procedures. Stresses 
during university examinations and following marathon running were 
selected as readily available models for these two differing forms of 
stress.
To the female reader I must apologise for apparent bias as most of 
my work has been performed on males. This was a deliberate manoeuvre as 
studies of endocrine parameters in females are complicated by the 
cyclical nature of their sex hormones. Additional difficulties arise when 
collecting control data from female colleagues as exact details of their 
menstrual cycle as well as oral contraceptive use have to be obtained.
The review of the literature which follows includes some areas which 
although not studied in detail in this thesis are thought to provide the 
reader with a better overall grasp of the field.
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CHAPTER 1
REVIEW OF LITERATURE
This review aims to give the reader a factual summary of the 
literature pertinent to this thesis. Some papers are discussed in more 
depth in the appropriate chapters. Emphasis is placed on those endocrine 
systems which I have investigated in detail, in particular the 
hypothalamic-pituitary-testicular and the hypothalamic-pituitary- 
adrenocortical axes. Changes in hypothalamic-pituitary-thyroid function 
with illness are also discussed as they have been extensively reported in 
the literature. An understanding of how this axis is affected by illness 
may shed light on the mechanisms leading to altered testicular and 
adrenocortical function.
CONTROL OF ANDROGEN SECRETION
Before reviewing the literature relating to hormonal changes with 
illness it is appropriate to describe the mechanisms thought to be 
important in the control of secretion of androgens be they of testicular 
or adrenocortical origin.
PHYSIOLOGY OF HYPOTHALAHIC-PITUITARY-TESTICULAR FURCTIOF
Testosterone secretion from the Leydig cells of the testes depends 
on secretion of luteinising hormone (LH) by the anterior pituitary. The 
classic work of Harris (1955) demonstrated that gonadotrophin secretion 
by the pituitary gland and hence normal gonadal function is dependent on 
hypothalamic factors and on an intact pituitary portal blood supply 
connecting the median eminence to the anterior pituitary. A single 
hypothalamic decapeptide stimulates secretion of both follicle stimulating
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hormone (FSH) and LH (Schally et al., 1971). LH secretion is under 
negative feedback control by testosterone mainly at the level of the 
hypothalamus (Plant & Dubey, 1984) while FSH release may be suppressed 
by inhibin or related proteins produced by the Sertoli cells of the 
testes (Lincoln, McNeilly & Sharpe, 1989).
Ths.LH pulse generator
Krey, Butler, & Knobil (1975) demonstrated that surgical 
disconnection of the medial basal hypothalamus from the rest of the 
central nervous system of the rhesus monkey did not affect control of LH 
secretion, confirming the pivotal role of the hypothalamus rather than 
higher cerebral centres. LII secretion in man is not constant but 
intermittent as can be demonstrated by frequent blood sampling (Nankin & 
Troen, 1971; Naftolin, Yen & Tsai, 1972). Direct sampling of pituitary 
stalk blood in rhesus monkeys has demonstrated that LHRH secretion is 
pulsatile (Carmel, Araki & Ferin, 1976) and simultaneous sampling of 
blood from the jugular veins and pituitary portal system of sheep showed 
that LHRH and LH pulses are synchronous (Clarke & Cummins, 1982). 
Measurement of LHRH in the perifusate of the hypothalamus of 
unanaesthetised sheep also demonstrated LHRH pulses which were 
synchronous with LH pulses (Levine et al., 1982). Thus intermittent 
release of LH is under the control of LHRH secreted by the hypothalamus 
in pulses.
Electrical destruction of the arcuate nucleus in the medial basal 
hypothalamus of the rhesus monkey blocked LH secretion and the negative 
feedback effect of- sex steroid (Plant et al., 1978). Stereotactic 
positioning of multiple electrodes into this area demonstrated electrical 
discharges preceding detection of LH release by a few minutes (Wilson et 
al., 1984). Thus the activation of a hypothalamic pulse generator seems to 
be essential for LHRH and hence LH release. Factors such as alpha
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receptor blockade and barbiturate anaesthesia which reduced these 
electrical discharges also decreased the frequency of LH pulses (Wilson 
et al., 1984; Kaufman et al., 1985).
The intermittent nature of LHRH release is essential for normal 
pulsatile release of LH; LH secretion in hypogonadotrophic monkeys was 
restored by pulsatile but not by constant infusion of LHRH (Belchetz et 
al., 1978). Replacement of the normal pulsatile release of LH by a steady 
state situation as occurs with chronic use of an LHRH agonist in man 
results in very low testosterone levels even though absolute levels of LH 
as measured by radioimmunoassay are less affected (Faure et al., 1982). 
The negative feedback effect of testosterone on LH secretion is mediated 
by a suppressive effect on the hypothalamic pulse generator (Plant & 
Dubey, 1984) although an inhibitory effect at the level of the pituitary 
may also play a part (Caminos, Ma & Snyder, 1977).
LHL_hiplogical activity
A given immunoassay value for LH does not equate with biological 
activity which can be measured in a bioassay such as that based on the 
ability of mouse interstitial cells to secrete testosterone in vitro (Van 
Damme, Robertson & Diczfalusy, 1974). When the biological activity of LH 
is measured following the chronic use of an LHRH agonist it is very low 
even though LH by radioimmunoassay may be normal (St Arnaud et al.,
1986). Biological activity of LH varies in health. For example it reduces 
with age in men (Warner, Dufau & Santen, 1985). LH secreted in a pulse 
has a higher biological activity than that secreted between peaks (Dufau 
et al., 1983; Veldhuis et al., 1983). Oestradiol infusion into normal men 
reduces LH biological activity disproportionately to its effect on LH 
measured by radioimmunoassay (Veldhuis & Dufau, 1987).
Immunoassay of a polypeptide hormone such as LH measures its 
absolute concentration by assessing the ability of the antibody to bind
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to the antigenic determinants of the polypeptide structure. This does not 
necessarily reflect biologically activity (Robertson, Lambert & Loveridge,
1987) which depends largely upon the configuration of that part of the 
molecular structure involved in binding to the receptor on the effector 
cell. The antibody used in the immunoassay may be directed against a site 
discrete from this binding area. The antibody may therefore recognise a 
variety of polypeptides identical at the antibody binding region yet 
differing with respect to this receptor binding site and hence biological 
activity. Moreover most available LH immunoassays employ a polyclonal 
antiserum which may cross-react with a multiplicity of molecular forms 
of LH or indeed with its constituent sub-units.
Heterogeneity of LH
LH in man is known to be heterogeneous with several distinct peaks 
when subjected to electrofocussing on a sucrose density gradient (Strollo 
et al., 1981; Reader, Robertson & Diczfalusy, 1983). The biological 
activity of the LH in each peak (when obtained from human pituitary 
tissue or when secreted from human pituitary cells in culture) has been 
shown to vary with acidic forms having lower biological activity than 
more basic forms (Lichtenberg et al., 1984; Snyder et al., 1989).
LH is a dimer composed of an a subunit and a subunit. The former 
is common to LH, FSH, HCG and TSH with the J3 subunit conferring the 
unique nature of the polypeptide. The heterogeneous nature of LH is not 
caused by changes in the amino acid sequence of the a or p chains but to 
the diverse nature of the type of sugars that bind to these polypeptides 
(Green & Baenziger, 1988). The presence of these sugars may be important 
for activity of polypeptide hormones. Van Hall et al. (1971) showed that 
removal of sialic acid from HCG by enzyme digestion did not alter HCG 
levels measured by radioimmunoassay but reduced biological activity. 
There remained the anxiety that the amino acid configuration of HCG may
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have been damaged by the enzyme digestion and that the altered biological 
activity was caused by this rather than desialylation. Matzuk, Keene & 
Boime (1989) avoided this complicating factor by using mutated cell lines 
secreting HCG dimers which lack oligosaccharides at individual sites on 
the a chain, the £ chain or both. Mutant strains of HCG without 
oligosaccharides on the a subunit while binding apparantly normally to 
the HCG receptor had a reduced biological activity. These mutant strains 
of HCG reduced the ability of native HCG to produce cyclic AMP in vitro 
thus acting as a competitive inhibitor.
There is some evidence that this type of competitive inhibition 
between different molecular forms of the same polypeptide hormone occurs 
in vivo. Administration of an LHRH antagonist to hypogonadal women 
caused a 30% reduction in FSH by radioimmunoassay but 60% by bioassay 
(Dahl, Bicsak & Hsueh, 1988). Chromatography demonstrated four peaks of 
different biological activity, the least active increasing after LHRH 
antagonist administration. This relatively inactive isohormone inhibited 
the ability of native FSH to stimulate oestrogen secretion by ovarian 
granulosa cells. Thus the pituitary does seem capable of producing 
isomers of polypeptide hormones with differing biological activities and 
this may be relevant when the abnormalities of hypothalamic-pituitary- 
testicular function with illness are described later in this thesis.
COITTROL OF ADRENAL ANDROGEN SECRETION
Adrenal androgen is secreted primarily by the zona reticularis of 
the adrenal cortex whilst cortisol is secreted primarily by the zona 
fasciculata. The mechanisms controlling adrenal androgen secretion are 
not fully understood. Adrenal androgens are under the influence of ACTH; 
short term ACTH administration certainly leads to increased output of 
adrenal androgen and intramuscular administration of long-acting ACTH 
over two days results in a sustained increase in DHAS ((Vaitukaitis, Dale
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& Melby, 1969; Yamaji & Ibayashi, 1969). Patients with hypopituitarism and 
secondary adrenocortical insufficiency have low adrenal androgen levels 
which are returned to normal by ACTH administration (Pang et al., 1987; 
Yamaji et al., 1987).
Adrenocortical activation does not necessarily affect cortisol and 
adrenal androgen levels in the same way. For example serum levels of the 
adrenal androgens, DHA and DHAS increase several years before puberty, 
reach a peak in early adult life and gradually decline to levels around 
20% of maximal in old age; all this with little change in the secretory 
rate of cortisol (Parker & Odell, 1980). Adrenal androgen status in 
patients with pituitary dependent Cushing's syndrome is of interest as 
DHAS levels are normal or only modestly elevated in comparison to the 
degree of cortisol excess (Yamaji & Ibayashi, 1969).
Observations such as those in the preceding paragraph have led to a 
debate about factors additional to ACTH which might influence adrenal 
androgen secretion. Two hypotheses exist: one postulates that adrenal 
androgen secretion is under control of a specific adrenal androgen 
stimulating hormone (Parker & Odell, 1980); and the other that secretion 
is affected by morphological and functional changes within the adrenal 
cortex induced locally by changing concentrations of steroid (Anderson, 
1980). In vitro studies using human adrenal tissue have shown that intra­
adrenal enzyme systems are affected in differing ways by build up of 
substrate (Couch, Muller & Vinter, 1986). These authors found that 17,20 
desmolase, the enzyme crucial to adrenal androgen synthesis, is inhibited 
in a more sensitive fashion than other adrenocortical enzyme systems by 
the accumulation of endogenous steroids. Indeed the intraadrenal steroid 
concentrations found in man are sufficient to exert an inhibitory effect 
on 17,20 desmolase (Dickerman et al., 1984). Such mechanisms may be 
involved in the divergence of cortisol and adrenal androgen levels 
mentioned above and described later in this thesis.
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ENDOCRINE RESPONSES TO ILLNESS
ILLHESS AHD THYROID FUHCTIOH
Of all the endocrine changes which occur with illness, those 
affecting thyroid function are most widely recognised. This has arisen 
because thyroid disease is common and has adverse effects on many other 
systems. In addition certain clinical syndromes may mimic thyroid 
disease; the facies in chronic renal failure or hypothermia may resemble 
that of hypothyroidism whilst symptoms and signs of hyperthyroidism may 
simulate heart disease. Such diagnostic confusion is not unusual so an 
ability to interpret thyroid function tests in non-thyroidal illness has 
assumed increasing importance in contemporary clinical practice.
Low T3 concentrations and non-thyroldal illness
Subnormal levels of triiodothyronine (T3) are found in many clinical 
situations, including surgery (Burr et al., 1975), myocardial infarction 
(Viersinga, Lie & Tauber, 1981), diabetic ketoacidosis (Naeije et al., 
1978) and febrile illness (Talwar, Sawhney & Rastogi, 1977). The low T3 
state is not exclusive to illness. Subjects who are fasted show a fall in 
serum T3 levels even if given thyroxine (T4) in sufficient quantities to 
suppress endogenous thyroid hormone secretion (Vagenakis et al., 1975). 
This finding suggested that low levels of T3 are due to altered thyroid 
hormone metabolism rather than reduced secretion of T3.
Serum T3 is largely derived from peripheral conversion of T4. 
Studies using 1 I-labelled T4 administered to patients with severe 
chronic illness have demonstrated reduced conversion of T4 to T3 (Carter 
et al., 1976). Low T3 states are also characterised by a reciprocal 
increase in the metabolically inactive reverse T3 (Vagenakis et al., 1975; 
Chopra et al., 1975). The production rate of reverse T3 in the low T3 
state is not increased, the accumulation of reverse T3 occurring because
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of decreased catabolism (Chopra, 1976; Kaptein et al., 1982a). In vitro 
evidence suggests that the conversion of T4 to T3 and that of reverse T3 
to its diiodothyronine derivative may be regulated by the same 5'- 
deiodinase (Chopra et al., 1978). The inhibition of this enzyme system 
might account for most of the changes in the low T3 state.
Low T4 concentrations and non-thyroidal illness
In more seriously ill patients both T4 and T3 are low (Carter et
al., 1974), a situation commonly referred to as the low T4 syndrome or
the "sick euthyroid syndrome". T4 levels correlate inversely with severity 
of illness, the patients with the lowest levels having the highest 
mortality (Slag et al., 1981; Kaptein et al., 1982b).
The mechanisms leading to low T4 levels are not fully understood. 
Thyroid hormones are protein bound, primarily to thyroxine binding 
globulin (TBG) but also to albumin and in the case of T4 to thyroxine 
binding prealbumin (Hagen ' & Elliott, 1973) and thus alterations in 
binding influence T4 and T3 concentrations. The dialyzable fraction of T4 
which is the free, non-protein bound fraction of T4 is increased in non- 
thyroidal illness despite normal or only slightly reduced levels of T4 
binding proteins (Chopra et al., 1979a). The realisation that absolute 
changes in the concentration of T4 binding proteins in non-thyroidal 
illness are insufficient to account for the increase in the free fraction 
has led to the search for factors in serum which would displace thyroid 
hormones from their binding proteins.
An early study which provided evidence for such an agent 
demonstrated an increase in the free fraction of T4 when serum of
patients with non-thyroidal illness was added to normal serum (Chopra et
al., 1979b). Evidence also exists for inhibition of T4 binding to solid 
matrices as well as to serum proteins (Oppenheimer et al., 1982). When 
estimations of free T4 are calculated from the resin uptake of T3 and the
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total T4 concentration (the free T4 index), as opposed to the more 
reliable equilibrium dialysis method, values are often in the hypothyroid 
range (Chopra et al., 1979a). This discrepancy may thus be explained by 
the presence of an inhibitor in serum which reduces binding not only to
protein but to resin. Further work from Chopra's group revealed a
substance in extrathyroidal tissues that reduces binding affinity to
serum proteins (Chopra et al., 1982). So in ill patients it was postulated 
that such a substance might be released into the circulation perhaps as a 
consequence of tissue damage.
It has been suggested that the T4 binding inhibitor may be a free 
fatty acid such as oleic acid; they displace T4 from binding proteins 
especially when levels of albumin and thyroxine-binding prealbumin are 
low as they often are in non-thyroidal illness (Chopra et al., 1986). Lim 
et al. (1988) confirmed that free fatty acids displace T4 from binding 
proteins but only at concentrations three times those found in man.
Further doubt concerning the role of oleic acid as the binding inhibitor 
was cast by Haynes et al. (1989) who found that T4 concentrations in 
serum of ill patients bore no relation to those of oleic acid or other 
free fatty acids.
Eree-thyrgid frormgne concentrations.
The estimation of free thyroid hormones in serum is fraught with 
difficulty. Equilibrium dialysis methods are commonly considered the gold 
standard but are time consuming and not available for routine use. 
However, by this more reliable method free T4 is usually found to be 
normal or raised and free T3 normal or low in patients with the low T4 
syndrome (Chopra et al., 1979a; Woeber & Maddux, 1981). Several recent 
methods of measuring free T4 permit its routine estimation but most have 
proved disappointing in the evaluation of patients with non-thyroidal
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illness as free T4 levels are often found to be spuriously low (Chopra et 
al., 1980; Melmed et al., 1982).
Recent doubts have been cast on the reliability of equilibrium 
dialysis as a method of detecting free thyroid hormone levels as this 
method usually involves dilution of serum which may alter the effect of 
binding inhibitors (Faber et al., 1987; Surks et al., 1988). Both these 
groups used an ultrafiltration method which employs undiluted serum and 
described normal free T4 levels in ill patients with either normal (Faber 
et al., 1987) or low free T3 levels (Surks et al., 1988).
TSH concentrations and non-thyroidal illness
Unlike the situation in primary hypothyroidism when thyroid 
stimulating hormone (TSH) levels are high, low T4 levels in non-thyroidal 
illness are accompanied by normal TSH levels. TSH responses to 
thyrotrophin releasing hormone (TRH) are often within the normal range in 
individuals but may be diminished in a series of ill patients when 
compared with a healthy control group (Kaptein et al., 1981). The 
contribution, if any, of altered TSH secretion to the low T4 syndrome is 
uncertain. TSH levels of fasting mildly hypothyroid patients sometimes 
fall to within the normal range (Borst et al., 1983). Ill patients given 
iodide which further reduces thyroid hormone levels failed to show the 
expected increase in TSH levels (Maturlo et al., 1980) in contrast to 
fasting but otherwise healthy subjects similarly treated who showed an 
augmented TSH response to TRH (Gardner et al., 1979).
Ill patients with low circulating T4 have a reduced T4 secretion 
rate despite an increased metabolic clearance rate (Kaptein et al., 
1982a). As the main influence on T4 secretion is the circulating TSH 
concentration, it is possible that low TSH levels contribute to the low T4 
state of critical illness. Indeed Bacci, Schussler & Kaplan (1982) have 
demonstrated a rise in TSH as T3 levels rose with recovery from severe
- 29 -
illness. Using more sensitive TSH assays Vehman et al. (1985) found a low 
TSH concentration in association with the low T4 syndrome while both 
Hamblin et al. (1986) and Vehman et al. (1985) found increasing TSH 
levels during recovery. Although these authors suggested that reduced TSH 
secretion may contribute to the low T4 syndrome, other groups have found 
normal TSH levels in ill patients (Faber et al., 1987; Surks et al., 1988). 
This raised the possibility that the changes in TSH concentrations in the 
earlier studies may be a short-lived and secondary phenomenon; thus 
displacement of T4 from its binding proteins at the onset of the low T4 
syndrome would lead to an increase in free T4 and consequent suppression 
of TSH with the reverse occurring during recovery. Romijn & Viersinga 
(1990) found that the nocturnal surge of TSH found in healthy subjects 
was reduced in ill patients. Thus evidence exists to associate 
hypothalamic-pituitary dysfunction with the low T4 syndrome but what 
contribution this makes to the reduction in thyroid hormone levels is 
uncertain.
High T4 concentrations and non-thyroidal Illness
Concentrations of serum T4 may occasionally be high in particular 
groups of patients with non-thyroidal illness. Damaged hepatocytes in 
certain liver diseases, in particular primary biliary cirrhosis aiid 
hepatitis both acute and chronic, release increased amounts of TBG 
resulting in levels of T4 and T3 which are either normal or high 
(Schussler et al., 1978; Gardner, Carithers & Utiger, 1982). TSH levels may 
be raised in some patients with chronic active hepatitis possibly due to 
an associated autoimmune thyroiditis (Schussler et al., 1978), A high 
incidence of hyperthyroxinaemia in acute psychiatric admissions has been 
reported and appears to resolve spontaneously within two weeks (Cohen & 
Swigar, 1979). This association has to be borne in mind if an 
inappropriate diagnosis of thyrotoxicosis is to be avoided.
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Lq m_T4 syndrome - adaptive phenomenon or tissue hypothyroidism?
It is not known whether low T4 and T3 states are a desirable 
adaptation to illness. Conventional wisdom is that only the free fraction 
of thyroid hormones is available for transport into tissues although it 
has been suggested that a proportion of the protein bound fraction may 
also be available (Pardridge et al., 1981). If circulating levels of free 
T3 are low in ill patients, its availability to tissues would be expected 
to be reduced. Why is there not clear evidence of tissue hypothyroidism? 
Physiological correlates of thyroid function such as systolic time 
intervals or ankle jerk relaxation time remain normal (Chopra et al., 
1974; Spector et al., 1975).
More than 50% of T3 within nuclei (where it exerts its main action) 
may be derived from intracellular conversion from T4 (Crantz, Silver & 
Larsen, 1982). When intracellular T3 levels are high, conversion of T4 to 
T3 is inhibited and the converse may also apply (Koenig et al., 1984). 
Such a mechanism would prevent large fluctuations in intracellular T3 
levels when circulating levels are low. The major tissue effects of T3 are 
mediated via T3 nuclear receptor proteins (Samuels et al., 1988). Williams 
et al. (1989) found increased levels of T3 receptor messenger RNA in 
cells of patients with the low T4 syndrome. They suggested that this was 
a compensatory mechanisms; low free T3 levels in serum and then 
intracellularly would promote nuclear receptor messenger RNA synthesis
and hence increased supply of T3 receptor protein which would compensate
for the low free T3 levels and maintain the euthyroid state.
ILLNESS AND TESTICULAR FUNCTION
Gonadal function which would seem to be of little immediate
importance to the management of the ill patient has not been studied in 
such detail as thyroid function. The gonads have two main roles; to 
produce sufficient numbers of spermatozoa and ova for fertility and to
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secrete sex hormones thus maintaining an appropriate endocrine milieu for 
sexual function. There is increasing recognition that both these aspects 
may be abnormal in a variety of illnesses.
Hypothalamiczpituitary-testlcular function and chronic renal failure
Interest in the gonadal status of patients with chronic renal 
failure arose because loss of libido, impotence and infertility are common 
clinical problems (Elstein, Smith & Curtis, 1969; Abram et al., 1974). The 
importance of this subject has increased as advances in the management 
of end stage renal failure have led to longer life expectancy. 
Oligospermia and azoospermia are commonly seen in uraemic men (Lim & 
Fang, 1975). Serum testosterone concentrations are low and are associated 
with raised LH levels. The testes secrete low quantities of testosterone 
which are cleared normally from the circulation (Stewart-Bentley, Gans & 
Horton, 1974). LH levels peak normally after the administration of LHRH 
although they remain elevated longer than usual (Schalch et al., 1975), a 
finding attributable to the reduced metabolic clearance of LH (Holdsworth; 
Atkins & De Kretser, 1977). FSH levels are often raised, the patients with 
azoospermia having the highest values (Lim & Fang, 1975). Normality may 
be restored by renal transplantation but haemodialysis does not improve 
the situation (Lim & Fang, 1975).
The findings are consistent with a primary testicular defect. An 
additional deficit at the hypothalamic-pituitary level may exist as 
patients with the lowest testosterone levels do not necessarily have the 
highest LH levels (Lim, Kathpalia & Henriquez, 1978). Moreover an 
exaggerated LH response to LHRH is seen in other examples of primary 
testicular failure such as Klinefelter's syndrome (De Kretser, Burger & 
Dumpys, 1975) but does not occur in chronic renal failure (Holdsworth et 
al., 1977).
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Hypothalamlc-pltuitary-testlcular function.and liver disease
The gynaecomastia and testicular atrophy of patients with cirrhosis 
have stimulated an interest in the gonadal effects of liver disease. Serum 
testosterone concentrations are low or normal but because of a high sex 
hormone binding globulin (SHBG) capacity, which is surprising in view of 
its hepatic synthesis, free (non-protein bound) hormone levels are 
frankly low (Van Thiel, Lester & Sherins, 1974; Baker et al., 1976). 
Oestradiol levels have been found to be normal or low (Van Thiel et al., 
1974; Baker et al., 1976) whereas oestrogens of lesser potency, oestrone 
and oestriol, are raised the highest levels being seen in patients with 
gynaecomastia (Green et al., 1976). These high levels are thought to be 
due to increased hepatic conversion from adrenal androgens (Van Thiel & 
Loriaux, 1979). Gonadotrophin levels are normal or raised but the 
presence of normal LH levels in some individuals with low testosterone 
values has been cited as evidence for a hypothalamic-pituitary defect in 
addition to a primary testicular abnormality (Van Thiel et al., 1974).
Hypothalamic-pltultary-testicular function, and other Illnesses.
Hypogonadism is a feature of several conditions in which the 
disease process seems to involve the hypothalamic-pituitary-testicular 
axis; for example, haemochromatosis, in which it is probably caused by 
iron deposition in the hypothalamus or pituitary (Bezwoda et al., 1977). 
Patients with lepromatous leprosy frequently have testicular atrophy due 
to direct invasion of the testes by acid fast bacilli (Morley et al., 
1977). Hypogonadism due to primary testicular failure is a characteristic 
feature of myotonic dystrophy (Febres et al., 1975).
Low serum testosterone concentrations have been recognised in other 
clinical situations in which the primary pathology does not relate 
directly to the hypothalamic-pituitary-testicular axis - for example, 
following surgery (Matsumoto et al., 1970), myocardial infarction (Vang et
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al., 1978a), burns (Dolecek et al., 1979a), head injury (Rudman et al., 
1977), malignant disease (Blackman et al., 1988), acute rheumatoid 
arthritis (Gordon et al., 1986) and respiratory failure (Semple et al., 
1981). Investigators have usually sought an explanation specific to the 
condition studied; thus in malignancy the associated malnutrition or 
altered sex steroid metabolism by tumour were proposed as possible 
mechanisms (Blackman et al., 1988). In the case of respiratory failure it 
was suggested that hypoxaemia may have had an adverse effect on 
hypothalamic-pituitary-testicular function. I collaborated with the author 
of this paper (Semple et al., 1981) on a study of men with cyanotic 
congenital heart disease who were otherwise fit and found normal 
hypothalamic-pituitary-testicular function (Semple et al., 1985). This 
finding as well as the disparate nature of the conditions with which low 
testosterone concentrations had been associated suggested to me that they 
may be a non-specific consequence of illness and encouraged me to embark 
on further studies.
Spermatogenesis is less easy to investigate in ill patients. 
Attempts to store semen from men with lymphoreticular malignancy prior 
to chemotherapy are often thwarted by finding unexplained oligospermia 
(Hendry et al., 1983). Abnormal spermatogenesis is often seen in patients 
with chronic renal failure or chronic liver disease (Lim & Fang, 1975; 
Mowat et al., 1976) while patients dying from severe burns not directly 
affecting the gonads have abnormal germinal epithelium on testicular 
histology (Dolecek et al., 1983).
Possible mechanisms leading to hypogonadism following illness.
Several mediators of this anti-gonadal effect have been postulated. 
Cortisol which is often elevated during acute illness (Melby & Spink, 
1958) may adversely affect the gonads directly (Cumming, Quigley & Yen,
1983) as well as cause hypothalamic-pituitary suppression (Luton et al.,
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1977). An intravenous infusion of adrenaline leads to a small decrease in 
serum testosterone concentration (Levin et al., 1967) but there is no 
evidence that endogenous catecholamines might have such an effect.
The only situation in which low LH levels have been unequivocally 
implicated in the low testosterone state is following traumatic brain 
injury when LH levels are low but respond normally or in an exaggerated 
fashion to LHRH (Rudman et al., 1977; Clark, Raggatt & Edwards, 1988). 
This suggests a hypothalamic abnormality in the presence of normal 
pituitary synthesis and storage of LH. Acute rheumatoid arthritis also 
differs from other conditions in which low serum testosterone levels are 
found. LH levels are raised suggesting a defect at the testicular level 
possibly due to rheumatoid vasculitis involving the testes (Gordon et al., 
1986).
Gonadotrophin status in other conditions is complex. Following 
surgery there is a rise in LH concentrations within 60 minutes of the 
first incision falling to below preoperative levels on the second 
postoperative day and increasing above baseline again on the sixth day 
(Aono et al., 1972). The early rise in LH has since been attributed to the 
effects of general anaesthesia (Nakashima et al., 1975). Although some 
authors have confirmed the fall in LH levels within 48 hours of operation 
(Charters, Odell & Thompson, 1969; Hagen, Brandt & Kehlet, 1980), others 
have found no change (Carstensen et al., 1973) or an increase (Vang, Chan 
& Yeung, 1978b). These discrepancies may be explained by differences in 
general anaesthesia or surgical procedure. Low testosterone levels were 
associated with low or normal LH levels in hypoxic men (Semple et al.,
1981) but with raised levels following myocardial infarction (Vang et al., 
1978a). In burned patients with very low testosterone levels Dolecek et 
al. (1979) found no consistent change.
Normal testosterone secretion is accompanied by the presence of 
regular secretory pulses of LH (Nankin & Troen, 1971) which occur
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secondary to the pulsatile release of LHRH by the hypothalamus (Carmel et 
al., 1976). Any factor which interferes with the hypothalamic pulse 
generator might lead to abnormalities in LH pulsatility and reduced 
testosterone secretion. For example the opioid antagonist, naloxone, 
increases the rate and amplitude of LH pulses in normal men (Grossman et 
al., 1981) suggesting that excessive opioid tone might depress LH 
pulsatility. Endogenous opioid peptides are increased concurrently with 
adrenocorticotrophic hormone (ACTH) and thus are likely to be increased 
in ill patients (Guillemin et al., 1977). Evidence of lack of LH 
pulsatility was found in two severely ill post-menopausal women during 
multiple sampling (Varren et al., 1977). An abnormal hypothalamic signal 
in ill patients resulting in a failure to generate normal LH pulses might 
contribute to the low testosterone state. This hypothesis has been 
investigated in more detail in my own studies.
ILLNESS AND ADRENOCORTICAL FUNCTION
The adrenal cortex secretes three different types of steroid; 
glucocorticoid, mineralocorticoid and adrenal androgens.
Cortisol levels and Illness
Urinary excretion of glucocorticoid is increased after surgery and 
other trauma, the duration and extent of the elevation increasing with 
severity of the insult (Moore et al., 1955; Espiner, 1966). Serum levels 
may be high (Melby & Spink, 1958) but are sometimes within the normal 
range (Carey, Cloutier & Lowery, 1971; Bane et al., 1974).
About 7 percent of cortisol is free or unbound, the rest bound to 
corticosteroid binding globulin (CBG) and to a lesser extent albumin 
(Daughaday & Mariz, 1961). CBG is saturated by levels of serum cortisol 
around 550 nmol/1 above which the percentage of cortisol which is free 
increases rapidly (Daughaday & Mariz, 1961). Studies on ill subjects which
- 36 -
have included measurement of the free cortisol fraction in the circulation 
have found that this increases more than total cortisol (Murray, 1967; 
Barton & Passingham, 1981). Those authors who have found high normal 
total cortisol levels in ill subjects (Carey et al., 1971; Bane et al., 
1974) might have found unequivocally raised free cortisol levels had 
these been measured. Plasma ACTH concentrations although rarely measured, 
correlate poorly with cortisol levels (Vaughan et al., 1982) possibly 
reflecting the insensitivity of earlier ACTH assays to changes within the 
physiological range.
Aldosterone levels and illness
Secretion of the major mineralocorticoid aldosterone is influenced 
by ACTH although the main controlling factor is the renin-angiotensin 
system. The rise in aldosterone values seen following surgery and burns 
injury is accompanied by activation of the renin-angiotensin system and 
may persist for several weeks in burned patients (Bane et al., 1974; 
Griffiths et al., 1983). This probably protects by counteracting the 
volume depletion of trauma or other acute illness. In contrast to burned 
patients, Zipser et al. (1981) found inappropriately low aldosterone 
levels with raised cortisol and renin values in persistently hypotensive 
patients in an intensive care unit. Luger et al. (1984) compared ten 
patients on admission to an intensive care unit with ten who had been 
there for one week; the more chronically ill had lower aldosterone levels 
than the recent arrivals despite higher angiotensin II levels, a 
phenomenon they attributed to concurrent drug administration. Findling, 
Waters & Raff (1987) found that 21 per cent of seriously ill patients had 
a low serum aldosterone level despite a high plasma renin activity. Wade 
et al. (1988) found raised aldosterone levels in men within 24 hours of 
admission to an intensive care unit, the extent of the elevation depending
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upon severity of illness. It appears therefore that only the more
chronically ill may have unexpectedly low aldosterone levels.
Adrenal androgen levels and illness
Because adrenal androgens are influenced by ACTH (Vaitukaitis et al.,
1969), one might expect adrenocortical activation following illness to
lead to increased adrenal androgen levels.
Early investigators found little or no change following surgery in
the excretion of urinary 17-ketosteroids in contrast to the pronounced 
rise in urinary excretion of glucocorticoids (Forbes et al., 1947; Moore 
et al., 1955). Urinary 17-ketosteroids represent the excretory products of 
a number of androgenic steroids and contain a variable gonadal component. 
As previously discussed, serum testosterone concentrations may fall after 
surgery and other illnesses. Failure of urinary 17-ketosteroid excretion 
to increase with illness could be due to a fall in serum gonadal steroid 
levels masking an increase in adrenal androgen secretion or alternatively 
adrenal androgen concentrations may not increase despite adrenocortical 
activation.
Until recent years the data on adrenal androgens in serum of ill 
men have been scanty. Low levels of DHAS had been found in uraemic 
patients (Zumoff et al., 1980), a finding refuted by Winer et al. (1982) 
who found normal values. The earlier paper used sera from normal subjects 
as a control whereas the latter used sera from chronically ill patients. 
An alternative explanation for the findings of Winer and colleagues 
(1982) might be that all chronically patients whether uraemic or not have 
low levels of DHAS. This hypothesis is investigated further in this 
thesis.
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ILLNESS AND OTHER HORMONES
Hormones and energy supply
During illness energy requirements alter and there is an increased 
demand for supply of energy substrate. Activation of the sympathetic 
nervous system in ill patients leads to catecholamine release, usually 
short-lived but sometimes prolonged in very ill patients in whom there 
may be a rapid fall before death (Benedict & Grahame-Smith, 1978). 
Catecholamines promote hepatic glycogenolysis and gluconeogenesis as well 
as stimulating lipolysis with subsequent release of free fatty acids and 
glycerol. They also stimulate glucagon release and inhibit insulin 
secretion (Gerich, Karam & Forsham, 1973).
Glucagon is therefore raised in illness, usually in proportion to its 
severity; insulin levels are inappropriately low in relation to the 
elevated blood glucose values (Rocha et al., 1973). This alteration in the 
balance between insulin and glucagon secretion despite hyperglycaemia 
allows persistence of glucagon-mediated events in the liver, in particular 
glycogenolysis and gluconeogenesis using the products of enhanced 
lipolysis and protein breakdown.
Plasma growth hormone also increases after injury despite levels of 
plasma glucose which in the normal person would be expected to inhibit 
its secretion (Carey et al., 1971). Levels usually fall rapidly to normal 
although raised levels may be sustained for weeks in severely burned 
patients (Wilmore et al., 1975).
The elevated cortisol levels previously described have multiple 
effects on glucose metabolism. In most tissues glucocorticoid inhibits 
glucose uptake; in the liver glycogen synthesis and gluconeogenesis is 
stimulated an effect enhanced by its catabolic effect on protein leading 
to increased supply of amino acids as a substrate for gluconeogenesis. 
(Baxter & Forsham, 1972).
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These endocrine changes explain the hyperglycaemia which is a 
common accompaniment of illness. It may be distinguished from diabetes 
mellitus by normal glucose tolerance following recovery.
Hormones and calcium metabolism
Calcium is essential for a wide variety of metabolic processes and 
in health serum levels are kept within a narrow range by endocrine 
homeostatic mechanisms. A number of factors may alter total serum 
calcium including changes in serum albumin caused by reduced protein 
synthesis in ill health, venostasis or changes in posture which alter 
total serum calcium but not ionised calcium.
Low total serum calcium levels are common in severely ill patients. 
Chernow et al. (1982) found 64% of intensive care unit patients to be 
thus affected. A reduction in both total and ionised calcium has been 
found in a number of conditions including burns (Szyfelbein, Drop & 
Martyn, 1981), sepsis (Taylor et al., 1978) and acute pancreatitis 
(Robertson et al., 1976). Changes are usually short-lived although in 
severely burned patients hypocalcaemia may persist for a number of weeks 
(Szyfelbein et al., 1981).
The hormones primarily involved in calcium homeostasis are 
parathyroid hormone (PTH), vitamin D and to a lesser extent calcitonin. 
Hypocalcaemia, which is the main physiological stimulus to PTH secretion, 
does not cause the expected hormone rise in ill patients and therefore 
suppression of PTH has been suggested as the main cause of hypocalcaemia 
(Robertson et al., 1976; Taylor et al., 1978). Paradoxically, a rise in 
both PTH and calcitonin has been found in hypocalcaemic burned patients 
(Lov6n, Nordstrom & Lennquist, 1984). However, problems with PTH assay 
methodology render changes within the normal range difficult to 
interpret. Much of the data on ionised calcium may be suspect as the 
electrodes employed can give misleading results in the presence of low
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albumin levels which are so often a feature of ill patients (Payne, 1982). 
Thus the mechanism of these ionic changes is unclear and may not be 
attributable solely to endocrine changes.
ENDOCRINE RESPONSES TO EXERCISE
The endocrine system is intimately involved in the physiological 
response to exercise. Resulting hormonal changes are reviewed with 
particular emphasis on the systems later investigated in my own studies.
Exercise and thyroid function
Serum T4 levels have been found to be increased (Refsum & Stromme, 
1979; Schurmeyer et al., 1984) or unchanged (Galbo et al., 1977) after 
single bouts of prolonged exercise. A five day combat course led to a 
fall in both T4 and T3 levels (Aakvaag et al., 1978a) while in other 
situations T3 values have been found to be increased (Refsum & Stromme,
1979) or unchanged after exercise (Galbo et al., 1977). Literature on TSH 
levels is similarly contradictory with values after exercise described as 
increased (Refsum & Stromme, 1979), unchanged (Terjung & Tipton, 1971) or 
decreased (Grossman et al., 1984). Doubt also exists whether thyroid 
hormone levels are significantly altered by training. A six week training 
programme resulted in 11 percent reduction in T4 with no change in T3 
(Balsam & Leppo, 1975). However, running more than 30 miles per week for 
at least two weeks led to 9 percent reduction in T3 with no change in T4 
or TSH values, although the latter showed an exaggerated response to TRH 
(Boyden et al., 1982).
The field is complicated by the variety of exercise programmes 
investigated. Resulting fluid shifts might be expected to cause changes in 
serum concentration of hormones. Failure to find any major change in 
thyroid hormones with exercise does not necessarily imply constant
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secretion as metabolism of thyroid hormone may change with exercise. 
Irvine (1968) reported increased degradation of T4 with unchanged serum 
hormone levels after one week of a training programme and therefore 
suggested an increased thyroidal secretion but Balsam and Leppo (1975) 
found decreased degradation rate in a similar situation.
Changes in the hypothalamic-pituitary-thyroid axis with exercise are 
so minor and contradictory that it would be surprising if this system 
played an important role in physiological response to exercise or 
training.
Exercise and testicular function
After short term exertion, serum testosterone concentrations 
increase (Sutton et al., 1973; Galbo et al., 1977; Kindermann et al., 1982; 
Grossman et al., 1984). Levels of LH have been found unchanged (Sutton et 
al., 1973) or increased (Grossman et al., 1984). No change in SHBG 
capacity accompanies the increase in serum testosterone concentrations 
(Sutton et al., 1973) which has been attributed to factors other than 
increased secretion such as plasma volume changes (Kindermann et al.,
1982) or a decreased metabolic clearance rate due to reduced hepatic 
blood flow (Sutton, Coleman & Casey, 1978; Keizer, Poortmann & Bunnik,
1980).
The increase in serum testosterone concentration wanes after more 
prolonged exercise (Galbo et al., 1977) and may fall below baseline values 
in association with unchanged or reduced LH levels (Dessypris, 
Kuoppasalmi & Adlercreutz, 1976; Aakvaag et al., 1978b; Kuusi et al., 1984; 
Schurmeyer, Jung & Nieschlag, 1984). The low serum testosterone 
concentration in one study was attributed to low SHBG capacity (Kuusi et 
al., 1984) but was accompanied by increased SHBG capacity in another 
(Aakvaag et al., 1978b).
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Trained female athletes often have secondary amenorrhoea with 
consequent reduction in oestradiol levels (Baker et al., 1981). In male 
athletes the situation is less clear. Seven fit athletes had higher serum 
testosterone concentrations than an unfit age matched but strikingly 
overweight control group (Young et al., 1976). 39 army recruits showed a 
significant increase in concentrations of testosterone, androstenedione 
and LH after a six month physical training programme (Remes, Kuoppasalmi 
& Adlercreutz, 1979). In contrast to these results, 31 endurance athletes 
had lower serum testosterone concentrations but similar SHBG capacity and 
gonadotrophin levels when compared to an age matched control group 
(Wheeler et al., 1984). These studies are difficult to compare because of 
differences in the type of training programme, in the timing of blood 
samples with respect to the most recent exercise and in the choice of 
control subjects.
Prolonged exercise like illness seems to affect hypothalamic- 
pituitary-gonadal function. This stimulated my own studies which 
attempted to compare and contrast the hormonal status of ill patients 
with the hormonal changes occuring with exercise and training.
Exercise and adrenocortical function
Mild to moderate exercise leads to a reduced or unchanged serum 
cortisol concentration (Cornil et al., 1965; Raymond, Sode & Tucci, 1972; 
Davies 8s Few, 1973). Serum cortisol levels seem only to increase with 
higher work loads, in particular when oxygen uptake exceeds 60 percent of 
the individuals' maximum (Davies & Few, 1973). Disappearance of cortisol 
from blood accelerates progressively with severity of exercise, possibly 
due to increased uptake by skeletal muscle and other tissues (Few, 1974). 
Any increased production of cortisol with modest effort is masked by 
increased disposal. At higher exercise intensity a substantial release of 
glucocorticoid will overwhelm any increased elimination and serum levels
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will rise. It is logical that glucocorticoid levels should increase only 
with strenuous effort as it is in this situation that there is a greater 
requirement for glucocorticoid activation of gluconeogenesis and 
mobilisation of amino acid and fat stores.
Aldosterone levels also increase with exercise in relation to its 
intensity and this is largely due to activation of the renin-angiotensin 
system although ACTH stimulation may also contribute (Grossman et alM
1984). This allows for retention of sodium and water by the kidney in a 
situation where there are increased losses in sweat and breath, thus 
promoting conservation of the intravascular volume.
Adrenal androgens have not been studied frequently in this situation 
but both androstenedione and dehydroepiandrosterone sulphate (DHAS) 
levels appear to increase following long distance running (Dessypris et 
al., 1976; Baker et al., 1982).
Exercise and other hormones
Activation of the sympathetic nervous system is an essential 
component of the cardiovascular response to exercise. Adrenaline and 
noradrenaline levels rise in proportion to severity of exercise with 
noradrenaline increasing at a lower work intensity than adrenaline 
(Galbo, Holst & Christensen, 1975).
Catecholamines have important effects on the endocrine pancreas 
and, as in acute illness, glucagon levels rise and insulin levels fall 
although to a lesser extent in trained than untrained individuals 
(Gyntelberg et al., 1977). Exercise results in greater insulin sensitivity 
(Leblanc et al., 1981) with trained individuals showing evidence of 
increased membrane binding of the insulin molecule (Leblanc et al., 1979). 
Unlike acutely ill patients, exercising individuals often have low plasma 
glucose concentrations which may partly account for the release of 
catecholamines (Felig et al., 1982). Growth hormone also increases with
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exercise (Schalch, 1967), a finding commonly exploited as a test of 
growth hormone deficiency. As in acute illness counterregulatory hormones 
predominate leading to increased catabolism and substrate supply.
Calcium regulatory hormones do not appear to play a significant 
part in the physiological response to exercise (Ljunghall et al., 1984).
ENDOCRINE RESPONSES TO PSYCHOLOGICAL STRESS
Psychological stress and thyroid function
An increase in serum protein bound iodine (PBI), measured as a 
marker of thyroid hormone levels, was found in the venous effluent of 
exteriorized thyroid glands of sheep following exposure to fireworks or 
barking dogs (Falconer & Hetzel, 1964). An increase in circulating PBI 
was also found in monkeys following a 72-hour avoidance session (Mason 
et al., 1968a). An eight hour period of sensory deprivation in humans led 
to a small increase in TSH levels without any change in PBI levels 
(Zuckermann et al., 1966). A small increase in TSH without any change in 
serum T4 was observed in eight subjects in anticipation of a novel and 
exhausting exercise session (Mason et al., 1973). As previously discussed, 
some patients with acute psychiatric disturbance have a raised serum T4 
level (Cohen & Swigar, 1979). Whereas psychiatric illness may affect 
thyroid hormone concentrations, psychological stress in humans appears 
not to do so to any significant extent.
Psychological stress and testicular function
Although it is recognised that the female menstrual cycle, and thus 
hypothalamic-pituitary-ovarian function, may be affected by psychological 
stress (Lachelin & Yen, 1978), it is uncertain whether the hypothalamic- 
pituitary-testicular axis may be similarly affected.
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Monkeys subjected to continuous psychological stress for 72 hours 
had low urinary excretion of testosterone (Mason et al., 1968b). Rats 
exposed to chronic immobilisation stress showed reduced serum 
testosterone and LH levels even if previously adrenalectomized, suggesting 
that any changes in the hypothalamic-pituitary-testicular axis had 
occurred independently of adrenocortical activation (Tache et al., 1980).
Early work in humans had shown unchanged excretion of urinary 
androgen metabolites following academic examination stress (Connell, 
Cooper & Redfearn, 1958) but reduced excretion in soldiers awaiting 
battle (Rose et al., 1969). Low serum testosterone concentrations with 
unchanged LH levels were found in eight army cadets during a 
psychologically stressful combat course (Aakvaag et al., 1978b). A similar 
study showed lower serum testosterone concentrations during the early 
stressful part of an officer examination course of six months duration 
compared with the less stressful later part (Kreuz, Rose & Jennings, 
1972). The effects of exercise which was an integral part of both these 
military courses were not taken into consideration in either of these 
studies.
Thus evidence exists to suggest that hypothalamic-pituitary- 
testicular function may be altered by psychological stress. However, 
human studies have been complicated by failure to examine this in 
isolation from physical effort.
Psychological stress and.adrenocortical function
The human adrenal cortex is able to respond to psychological stress, 
as it does to illness and exercise, but in a less consistent fashion. 
Students were found to have a twofold elevation of serum cortisol 
following an examination (Hodges, Jones & Stockham, 1962). Patients in 
the 24 hours preceding cardiac surgery were found to have similar serum 
cortisol concentrations to controls except for a surge whilst undergoing
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preoperative skin preparation (Czeisler et al., 1976). Urinary excretion of 
glucocorticoids was normal in soldiers awaiting attack in Vietnam but had 
been previously raised during combat training with its accompanying 
heavy exercise programme (Rose et al., 1969). Heterogeneous responses to 
cardiac catheterisation were seen with calm patients having unchanged but 
anxious patients raised serum cortisol concentrations (Greene et al.,
1970). A varied response was also seen in air crews following aircraft
carrier landings: pilots showed much greater increases in serum and
urinary cortisol levels than navigators despite similar levels of anxiety 
as judged by psychological testing (Millar et al., 1970).
There is considerable variation between subjects in '.the
glucocorticoid changes with psychological stress, individuals who are
able to cope with stress better having a lesser adrenocortical response
(Rose, Poe & Mason, 1968; Miyabo et al., 1976). In general acute stresses
seem to have a greater effect than chronic stresses such as awaiting 
combat or surgery. The response varies with the magnitude of the stress.
The data on adrenal androgen responses to psychological stress is 
sparse. Stressed monkeys had decreased excretion of androgen metabolites 
with increased urinary excretion of glucocorticoid (Mason et al., 1968c). 
Soldiers awaiting attack had reduced excretion of urinary androgen 
metabolites (Rose et al., 1969). The data from these papers do not permit 
differentiation between gonadal and adrenal origin of these changes.
Psychological stress and other honaones.
Other hormones are well known to be affected by psychological 
stress. Goodall & • Berman (1960) showed that urinary catecholamine 
excretion increased in human volunteers in anticipation of centrifugation 
of the person which involved rapid rotation to a 12G forward
acceleration. Naval aircrew likewise showed increased excretion following 
aircraft carrier landings (Rubin et al., 1970). Growth hormone and
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prolactin levels rose during a demanding flight in novice but not 
experienced pilots (Pinter et al., 1979). Similarly neurotic subjects 
showed increased growth hormone levels during psychological stress but 
normal subjects did not (Miyabo et al., 1976).
Thus several endocrine systems may be affected by psychological 
stress. The field has proved a difficult one to research because this type 
of stress is so difficult to quantify. A situation may be stressful to one 
individual but not to another. This contrasts with exercise where 
comparable subjects can be stressed accurately to a specified percentage 
of their predicted maximal capacity. In addition, psychological stress is 
often associated with other factors such as exertion or illness which may 
alter endocrine function independently.
The observation that psychological stress might affect the 
hypothalamic-pituitary-testicular axis raised the possibility that some 
of the hormonal changes occurring with illness might be related to 
associated psychological stress. It was clear that many studies in this 
field had been complicated by other factors which might alter endocrine 
systems and so I resolved to search for a suitable model to investigate 
the effects of psychological stress free from contamination by illness, 
exercise or other relevant parameters.
In Chapter 2 which follows the methodology involved in the various 
projects is detailed. In Chapters 3 to 7 the endocrine changes in various 
clinical situations are described. The effects of exercise and 
psychological stress are documented in Chapters 8 to 10. The mechanisms 
involved in the changes occurring with illness are investigated in 
Chapters 11 to 14.
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CHAPTER 2
METHODS
Assay Methodology
Estimations of blood glucose, serum creatinine, haemoglobin, albumin 
and arterial pH were performed using standard laboratory techniques.
Testosterone was measured in ether extracts of serum using a double 
antibody radioimmunoassay based on a rabbit anti-testosterone-3-0- 
carboxymethyl oxime-BSA serum and a 12SI radioligand prepared from the 
histamine derivative of testosterone-3-O-carboxymethyl oxime. The sex 
hormone binding globulin (SHBG) capacity of serum was assessed by 
saturation with [3H]-dihydrotestosterone using a modification of the 
method of Rosner (1972). Derived free testosterone concentrations were 
obtained by multiplying the total serum testosterone concentration by the 
percentage free testosterone concentration as calculated from the 
formula:-
percentage free testosterone = 2.28 - 1.38 x logio SHBG
(Anderson et al., 1975).
Serum cortisol was estimated in a direct, solid-phase radio­
immunoassay system (McConway & Chapman, 1986). Urinary free cortisol 
(UFC) was measured without prior extraction in the same assay system and 
was expressed as the cortisolicreatinine ratio.
Androstenedione analysis involved ether extraction prior to radio­
immunoassay which utilises a sheep antiserum raised against 
androstenedione - carboxyethylthioether ovalbumin (Guildhay Reference No. 
Hp/S/673-1A), tl,2,6,7-3H] androstenedione (Amersham TRK 454), and double 
antibody separation (reagents from the Scottish Antibody Production Unit, 
Law Hospital, Lanarkshire, Scotland). The assay for DHAS was an 
unextracted radioimmunoassay using a rabbit antiserum (Dr B T Rudd,
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Birmingham), C7 H^] DHAS (New England Nuclear) and double antibody 
separation.
Serum FSH, LH and prolactin were measured using conventional double 
antibody radioimmunoassays (Beastall et al., 1987). Gonadotrophin assays 
were standardised using the Second International Reference Preparation 
MRC 78/549 for FSH and the First International Reference Preparation MRC 
68/40 for LH. The prolactin assay was calibrated against MRC 75/504. The 
LH antibody employed was raised in the rabbit against human pituitary LH 
(code 87/2, a gift from Professor W.R. Butt, University of Birmingham). 
Iodinated LH tracer was produced using material obtained from the Chelsea 
Hospital for women, London. The assay performance based on external 
quality controls from the National External Quality Assessment Scheme for 
gonadotrophins was within the accepted limits of bias and variability 
«9%).
Serum thyroxine (T4) and triiodothyronine (T3) were measured using 
a modification to previously published radioimmunoassays in which sheep 
antibodies were coupled to microfine cellulose particles (Challand, 
Ratcliffe & Ratcliffe, 1975). Serum TSH was estimated using an 
immunoradiometric assay employing an 12 s I-label led monoclonal antibody 
covalently linked to Sepharose (McConway, . Biggart & Chapman, 1987). 
Following a series of saline washes sensitivity of at least 0.8 mU/1 may 
be achieved.
Urine metadrenalines were measured by an adaptation of the method 
of Pisano (1960) and were expressed as the metadrenaline:creatinine ratio 
in order to correct for possible incomplete urine collection.
Serum for assay was separated and stored at -20 C. To exclude the 
effects of intei— assay variation all samples from the same individual
were assayed together.
Reference ranges and Coefficients of Variation are shown in Table 1.
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TABLE 1 Coefficients of variation and reference ranges (male) of 
assays used in this thesis.
Reference range
Coefficient of Variation (Z) 
Intra-assay Inter-assay
T4 55-144 nmol/1 4.5 9. 0
T3 1.4-2.8 nmol/1 5.5 9.0
TSH <0.8-5.0 mU/1 3.5 10. 0
Testosterone 11-36 nmol/I 7. 0 9.0
SHBG capacity 5-45 nmol/I 7. 0 12. 0
FSH* UD-6.4 U/l 
(24-60 years)
5.5 10. 0
LH* UD-8.6 U/l 
(24-60 years)
3.1 8.0
Prolactin UD-360 raU/1 5. 0 10.0
Cortisol 280-720 nmol/I 7. 0 9. 0
Androstenedi one 2-11 nmol/1 7.5 15. 0
DHAS* UD-9 pmol/1 7.5 15.0
Urinary free 
cortisol
<25 pmol/mol 
creatinine
7.5 15. 0
Urinary
metadrenaline
<300 pmol/mol 
creatinine
6. 0 9. 0
UD = undetectable
* Reference range of these hormones varies with age.
The intra-assay CV was calculated from the results obtained using 20 
replicates of pooled serum run within the same assay. The inter-assay 
CV was the mean CV of three serum pools containing different analyte 
concentrations run in 20 consecutive assays.
Dynamic testing
The ability of the pituitary gland to secrete TSH and/or
gonadotrophins was tested by measuring TSH, FSH and LH at standard time 
intervals (0, 20 or 30, and 60 minutes) after the intravenous injection of 
TRH (200 jig) and/or LHRH (100 jig).
The ability of the testes to secrete testosterone was tested by 
measuring the serum testosterone concentration on day 5 after the
intramuscular injection of 2000 units of human chorionic gonadotrophin 
(HCG) on days 1 and 3. A normal capacity of the testes to secrete
testosterone is usually accepted when levels double and reach the normal 
range by day 5 (Anderson et al., 1972).
LH-blQasaay
The biological activity of LH was measured using a modification of 
the isolated interstitial cell bioassay (Van Damme et al., 1974). Two male 
mice were killed by cervical dislocation. Their testes were removed, 
decapsulated and placed in Dulbecco's Modified Eagle's Minimum Medium 
(DMEM) without bicarbonate and with HEPES (20 mM) containing 4% donor 
calf serum. The testes were cut into small pieces using fine scissors and 
were dispersed by mechanical agitation for 10 minutes at 37 *C in air. The 
resulting cell suspension was filtered through nylon (100 jim mesh),
collected by centrifugation (150g, 5 minutes at 4*C), resuspended in DMEM 
with serum and allowed to incubate for one hour at 37 *C with gentle 
shaking. Cells were collected again by centrifugation, resuspended in
medium at a concentration of 0.66 x lO*5 viable cells per ml. Routine cell 
viability is in excess of 90% as assessed by the trypan blue exclusion 
method. Three quality controls, graded doses of LH (First International
Reference Preparation MRC 68/40) or dilutions of unknown plasma samples
each at 50 fil were dispensed into a 96 well tissue culture plate and
treated with 50 jjl of cell suspension.
- 51 -
After a four hour incubation culture plates were frozen until 
testosterone levels could be estimated in duplicate samples by standard 
radioimmunoassay. All samples from the same individual were assayed 
within one assay to eliminate inter-assay variation. Each plasma sample 
was assayed at two dilutions thus allowing calculation of the intra-assay 
coefficient of variation for each assay run. This figure was consistently 
less than 6%. Human FSH, TSH, ACTH , LHRH, growth hormone, prolactin, 
oxytocin and antidiuretic hormone did not influence the bioassay method 
at levels likely to be found in biological samples. Parallelism in the 
dose response curve was observed between the plasma samples and the 
reference preparation. The sensitivity of this assay (defined as the 
minimum concentration of LH that was significantly different from 
control) was 1.9 U/l.
The biological activity of LH is usually expressed as the ratio of 
LH as measured by bioassay to that measured by radioimmunoassay (B: I 
ratio) (Dufau et al., 1983; Warner et al., 1985).
LH. Eulsatlllty Studies.
These are described in Chapters 12 and 14 because different 
sampling procedures and methods of pulse analysis were employed in the 
various studies described.
Presen tat ion of. data.
Error bars in illustrations represent the standard error of the mean 
of the data (SE). Values given in text and tables refer to mean ± SE.
Because much of the data in this thesis were not normally 
distributed statistical analyses were performed using non-parametric 
methods. Wilcoxon Rank tests for paired and unpaired data were used to 
test for significance between groups and Spearman Rank tests were used 
to obtain correlation coefficients.
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Hospital ethical committee permission was granted for all projects 
in this thesis and informed consent obtained from patients prior to 
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CHAPTER 3
ENDOCRINE FUNCTION IN CHRONIC RENAL FAILURE
Comparison of Haemodialysis (HD) and 
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Theoretical reasons had existed for suspecting that CAPD 
might alter the hormonal milieu of uraemic patients but this 
study found pituitary-thyroid and pituitary-testicular 
function disturbed to a similar extent in patients treated 
by HD and by CAPD. The incidental and unexpected finding of 
low levels of DHAS in uraemic patients raised the 
possibility that adrenal as well as testicular androgen 
levels might be affected by chronic illness.
Introduction
My earliest researches into the endocrine consequences of illness 
were on patients with chronic renal failure. The advent of a new form of 
renal replacement therapy, Continuous Ambulatory Peritoneal Dialyis 
(CAPD), stimulated study of thyroid and testicular function in patients 
undergoing this form of treatment.
Abnormalities of thyroid and testicular function are common in 
chronic renal failure (Spector et al., 1975; Lim & Fang, 1975). Compared 
to Haemodialysis (HD), CAPD is more efficient at removing molecules of 
500-5000 daltons (Moncrief et al., 1978). These "middle molecules" may be 
responsible for some of the manifestations of chronic renal failure 
(Nolph, 1977) and their more efficient clearance might account for the 
improved biochemical control and higher haemoglobin levels found in CAPD 
patients (Gokal et al., 1980). If these "middle molecules" were to affect 
the hormonal milieu adversely, then CAPD might be expected to lead to 
improved thyroid and testicular function. On the other hand, peritoneal 
dialysis has been shown to remove thyroid hormones from thyrotoxic rats 
(Herrmann, Schmidt & Kruskeraper, 1973) and has been used therapeutically
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in patients with thyroid crisis (Herrman et al., 1971). Thus by clearing 
hormones from the circulation, CAPD might have an unfavourable effect on 
the endocrine status of uraemic patients.
This study was designed to compare the pituitary-thyroid and 
pituitary-testicular axes of uraemic patients on CAPD with those of 
patients on HD and with healthy control subjects.
Methods
Nine male patients (age range 43-60, mean 52 years) who had been on 
CAPD for at least six months were compared with nine men on HD (age 
range 34-60, mean 48 years) and nine healthy men (age range 40-65, mean 
50 years). Because of the novelty of CAPD at the time of study it was not 
possible to match for duration of dialysis which was longer in the HD 
group (range 6-40, mean 24 months) than the CAPD group (range 6-12, mean 
9 months). There was no significant difference in the mean serum 
creatinine concentrations between the two uraemic groups (CAPD v HD, 1000 
v 1050 pmol/1) at the time of sampling.
In CAPD patients two litres of dialysis fluid remain within the 
peritoneal cavity for at least four hours and overnight during the last 
cycle of the day. After filling the peritoneal cavity the empty bag was 
attached to the belt until the next exchange when it was used to drain 
fluid. Each patient had five exchanges per day. Haemodialysis patients 
were in an intermittent thrice weekly hospital based dialysis programme.
All studies were performed between 0900 and 1200 hours before the 
second exchange of the day in CAPD patients and before dialysis in the 
HD group. Basal blood samples were withdrawn from an indwelling venous 
cannula and thereafter stimulation testing with LHRH and TRH was 
performed.
Comparisons were made using the Vilcoxon Rank Sum test for unpaired
data.
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Results
Basal endocrine results are shown in Table 2. Serum T4 and T3 
concentrations were lower than controls in both dialysis groups with T3 
being lower in the CAPD than the HD group. Basal TSH concentrations were 
similar in the three groups but TSH responses to TRH (Figure 1) were 
blunted in both dialysis groups to a similar extent.
Mean serum testosterone concentrations were below the control mean 
in both dialysis groups but the reduction was only statistically 
significant in the HD group. Because the sex hormone binding globulin 
(SHBG) capacity tended to be high in the uraemic patients, the derived 
free testosterone levels in both the CAPD and HD patients were 
significantly depressed as compared with the control group. Although 
serum FSH levels tended to be higher in the uraemic groups, the 
differences were not significant as there was a wide scatter of results 
with most patients having normal results but several having high values 
in the range compatible with damage to the germinal epithelium. LH 
concentrations were elevated to a similar extent in both dialysis groups. 
FSH and LH responses to LHRH were similar in all three groups (Figure 1). 
Hyperprolactinaeraia was found to a similar degree in both patient groups.
Concentrations of the major adrenal androgen DHAS were measured and 
were found to be low when all uraemic patients were compared to the 
control group (p<0.001). Both dialysis groups had lower concentrations 
than the control group but this only reached statistical significance 
with respect to the HD group (p<0.01).
Discussion
Hormone results were similar in both dialysis groups although 
higher haemoglobin concentrations in the CAPD group as compared with the 
HD group (mean, 8.3 g/dl v 7.2 g/dl) implied a more efficient clearance of
"middle molecules".
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TABLE 2 Hormone levels in nine male patients on continuous
ambulatory peritoneal dialysis (CAPD) or haemodialysis 
(HD) compared with nine normal controls (mean ± SE).
CAPD HD CONTROLS
T4 (nmol/l) 78.1 ± 7.5* 68.7 ± 7.6** 103 ± 7. 0
T3 (nmol/l) 1.0 ± 0.If**,a 1.4 ± 0. 1** 2.2 ± 0. 1
TSH (mU/1) 2. 0 ± 0.5 2.7 ± 0.6 2. 1 ± 0.4
Testosterone (nmol/1) 12. 0 ± 1.4 9.7 ± 0.7** 15. 1 ± 1.2
SHBG (nmol/l) 52.4 ± 4.5** 42.6 ± 3.6 34. 1 ± 2. 1
Derived free 
Testosterone (pmol/1) 153 ± 15** 138 ± 10*** 238 ± 17
FSH (U/l) 6.6 ± 1.8 15. 0 ± 6. 1 4.3 ± 1.3
LH (U/l) 19.8 ± 4.5** 18.9 ± 6. 0* 6.5 ± 0.5
Prolactin (mU/1) 2575 ± 1308*** 2778 ± 1828*** 189 ± 27
DHAS (pmol/1) 3.5 ± 1.3 2.0 ± 0.9** 6.3 ± 0.5
CAPD or HD vs controls : * p<0.05, ** p<0.01, *** pCO.OOl. 
CAPD vs HD : a p<0.05.
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Serum TSH, FSH and LH responses (mean ± SE) of CAPD 
patients, HD patients and an age and sex matched control 
group to the intravenous injection of TRH + LHRH expressed 
as an increment (A) over basal values.
The groups differed significantly only with respect to T3 
concentrations which were lower in the CAPD patients. The duration of 
dialysis was longer in the HD than in the CAPD patients yet thyroid 
function is not thought to be improved by increasing duration of dialysis 
(Silverberg et al., 1973). T3 might be lost in the dialysate so this was 
examined in five patients. Using conventional assays for T4 and T3, 
dialysate concentrations were below the detection limit of the assays (10 
nmol/1 and 0.5 nmol/1 respectively). The dialysate concentration was also 
below the detection limit of a free T4 assay (2 pmol/1) that is based on 
a two step principle and so is unaffected by variations in protein
content. As 10 litres of dialysate are exchanged every day significant 
quantities of thyroid hormones might be lost even if concentrations in 
the dialysate were below the sensitivity of the assays. More recent work 
using a sophisticated concentrating technique has revealed only minute 
amounts of T3 but up to 10% of total thyroxine output in the peritoneal 
dialysate (Kerr et al., 1986). Four CAPD patients were receiving £- 
adrenergic blocking drugs in contrast to only one HD patient. This
provides a likely explanation for the lower T3 levels in the CAPD 
patients as these drugs inhibit conversion of T4 to T3 (Lotti et al., 
1977).
The sex hormone status of uraemic patients is more profoundly 
suppressed than reflected by routine serum testosterone estimations.
Their high SHBG capacity leads to increased protein binding leaving a
smaller free fraction as represented by the low derived free testosterone 
levels found in both groups. There was no important loss of testosterone 
in the peritoneal dialysate as pooled dialysate from eight patients was 
examined and only 4 nmol of this steroid was measured over a 24 hour 
period as compared with an estimated production rate in uraemic patients 
□f 9-25 pmol/24 hours (Stewart-Bentley et al., 1974). The tendency 
towards higher SHBG capacity in uraemic patients probably only reflects
- 57-
their hypogonadal state as low testosterone concentrations are associated 
with high SHBG capacity (Vermeulen et al., 1969). Raised prolactin 
concentrations were found in both HD and CAPD patients. There was a large 
scatter of results as expressed in the high standard error (range 
260-10900 mU/1, CAPD: 250—17300 mU/1, HD) but there was no significant 
correlation between the degree of hyperprolactinaemia and the serum 
testosterone concentration (r=-0.02, CAPD; r=0.38, HD). These findings were 
similar to those of Hagen et al. (1976) and Cowden et al. (1978).
This study was the first to show that levels of thyroid and 
testicular hormones of CAPD patients are not favourably affected by the 
improved removal of "middle molecules" and uraemic toxins by this process 
(Semple et al., 1982a; Semple et al., 1982b). There has been no similar 
work examining pituitary-testicular function in the two different dialysis 
modalities although other investigators have investigated the pituitary- 
thyroid axis in later years.
Selgas et al. (1983) found reduced levels of T4 and T3 in serum of 
16 CAPD patients with no detectable T4 or free T4 in the dialysate; 
results were compared with a normal control group but not with HD
patients. Thysen et al. (1983) compared thyroid hormone levels of nine
CAPD patients with those of eight HD patients and a normal control group; 
T4 and T3 concentrations were reduced in both dialysis groups, the T4 
levels being lower in the HD than the CAPD group. Reverse T3 levels were 
also measured in this study and were reported to be high in the CAPD 
patients and low in the HD patients. It is of interest that the same 
authors were less sure of this finding in a different rendering of the
same data (Chary tan et al., 1983); they stated that "serum rT3
concentrations were within normal limits in both treatment populations, 
(though a markedly elevated value in one CAPD patient caused a 
significant upwards displacement of the mean) . Ross et al. (1985) studied 
thyroid function in larger groups of CAPD and HD patients with similar
findings. Kerr et al (1986) compared eight CAPD patients with eight HD 
patients and a normal control group; patient groups were matched for 
duration of dialysis, an advantage not available to earlier workers 
because of the novelty of CAPD in the early 1980's. T4 and T3 were 
depressed to a similar extent in both patient groups as were free T4, 
free T3 and reverse T3 although no mention was made of the difficulties 
in measuring free hormone levels in the serum of ill patients.
The incidental finding of low DHAS levels in uraemic patients was 
unexpected and was not included in the original description of this 
research (Semple et al., 1982b). The significance of this observation only 
arose at the time of planning the studies described in the following 
chapters. Review of the literature then revealed controversy about adrenal 
androgen status in chronic renal failure. Zumoff and colleagues (1980) 
found low levels of DHAS in the sera of uraemic patients but Winer et al. 
(1982) were unable to confirm this association. The discrepancy between 
these two papers is explained by the choice of control populations, the 
earlier paper using sera from healthy subjects in contrast to the later 
paper in which sera from hospitalised patients with stable chronic 
illnesses were used. This divergence of results could thus be explained if 
chronic illness of any kind leads to depressed adrenal androgen levels. 
The hypothesis that serum concentrations of androgens of either 
testicular or adrenocortical origin are depressed in ill men is 
investigated in subsequent chapters.
The study which followed set out to examine whether the abnormal 
androgen levels which were found in uraemic patients were also found in 
patients with a variety of medical illnesses.
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CHAPTER 4
AITDRQGEJf LEVELS Ilf MEDICALLY ILL MEM
To investigate whether androgen levels in serum are 
depressed as a non-specific consequence of illness 30 
medically ill men were compared with 30 healthy men. Serum 
testosterone concentrations were reduced in acute and 
chronic illness while serum DHAS concentrations were 
depressed only in those ill for more than two weeks. The 
reduction in serum testosterone levels could not be 
explained by altered concentrations of binding proteins, 
gonadotrophins or prolactin.
Introduction
As a low serum testosterone concentration had been discovered in a
number of unrelated conditions, it appeared possible that this change was
a general response to illness as opposed to being a specific consequence 
of certain disorders.
The finding of unusually low levels of the adrenal androgen DHAS in 
serum of uraemic patients led to the suspicion that this might be a 
further general marker of illness. Ill patients often have elevated serum 
and urinary cortisol levels suggesting adrenocortical activation (Melby & 
Spink, 1958; Espiner, 1966). Urinary excretion of 17-ketosteroids is 
modestly raised in the early days following trauma but may be reduced in 
the chronically ill (Forbes et al., 1947). 17-ketosteroids are the 
metabolites of androgens of both testicular and adrenocortical origin. 
Alterations in the excretion of 17-ketosteroids may reflect changes in 
secretion, metabolism or renal handling of androgen and give little clue
about serum levels of testicular or adrenal androgen.
I embarked on a study of medically ill men in an effort to discover 
whether serum levels of testosterone and adrenal androgens are depressed 
as a general response to illness.
-60-
Methods
Blood samples were withdrawn between 0B00 and 1000 hours from 30 
ill men (mean age 45, range 18-65 years) who were in-patients with a 
broad spectrum of medical illness (Table 3). Samples were also obtained 
at the same time of day from a healthy age and sex matched control group 
(mean age 44, range 20-66 years). No patients or controls were on drugs 
known to influence adrenocortical or gonadal function. No patient had 
significant renal or hepatic impairment as judged by standard laboratory 
tests. Patients who had recently undergone surgery or who were suffering 
from any condition associated with low serum testosterone concentrations 
were excluded.
Samples were assayed for T4, T3, testosterone, SHBG capacity, FSH, 
LH, prolactin, androstenedione and DHAS. Statistical analyses were 
performed using the Wilcoxon Rank test for unpaired data. Correlation 
coefficients were calculated using the Spearman Rank test.
Results (Table 4)
Serum testosterone levels were decreased in the ill patients with 50 
percent having levels lower than the normal controls range (Figure 2). 
The mean value of serum SHBG capacity was somewhat higher in patients 
than controls though not significantly so. The difference could be 
attributed largely to high values in two patients with bronchial 
carcinoma (85,156 c.f. control SHBG range 14-64 nmol/1). Derived free 
testosterone and total testosterone concentrations were depressed to a 
similar extent. There was no significant difference in levels of FSH, LH, 
and prolactin between the groups. Serum concentrations of androstenedione 
(Figure 3) were increased whereas those of serum DHAS (Figure 4) were 
reduced in the ill group as compared to the control group.
To investigate these findings further the ill patients were 
subdivided; 14 who had been ill for two weeks or less and 16 who had
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TABLE 3 Clinical details of 30 medically ill men
Patient Age Diagnosis Duration of Illness
(years) (weeks)
1 50 pneumonia <1
2 54 subarachnoid haemorrhage <1
3 64 pneumonia <1
4 48 gastrointestinal bleed <1
5 63 bronchial carcinoma 12
6 65 acute myeloid leukaemia 12
7 64 acute myeloid leukaemia 8
8 64 pneumonia 1
9 35 acute lymphatic leukaemia 4
10 58 bronchial carcinoma 8
11 21 meningitis 1
12 26 infective endocarditis 4
13 28 gastrointestinal haemorrhage <1
14 49 pneumonia 1
15 37 subarachnoid haemorrhage 8
16 56 septic arthritis 6
17 63 bronchial carcinoma 12
18 42 Crohn's disease 2
19 62 gastric carcinoma 4
20 46 Crohn's disease 12
21 40 empyema 4
22 29 hypertensive encephalopathy 1
23 56 bronchial carcinoma 12
24 47 necrotizing fasciitis 4
25 18 Stevens-Johnson syndrome 3
26 19 diabetic ketoacidosis <1
27 30 diabetic ketoacidosis <1
28 50 diabetic ketoacidosis <1
29 28 diabetic ketoacidosis <1
30 50 diabetic ketoacidosis 3
TABLE 4 Hormone levels of 30 medically ill men and 
30 age matched healthy men (mean ± SE).
Testosterone (nmol/I)
SHBG (nmol/1)
Derived free (pmol/1)
Testosterone
FSH (U/L)
LH (U/l)
Prolactin (mU/1)
Androstenedione (nmol/l)
DHAS (pmol/1)
T4 (nmol/l)
T3 (nmol/l)
ILL PAT I BUTS
8.9 ± 1.1 p<0001
39.3 ± 4.9
131 ± 15 p<°.°°i
5.6 ± 1.1
8.3 ± 1.2 
208 ± 42
6.6 ± 0.7 p<0-001
3.4 ± 0.6 p<0001 
84 ± 5 P<°.oa
1.3 ± 0.1 R<0001
CONTROLS
18.2 ± 1.4 
33.6 ± 2.3 
288 ± 22
3.7 ± 0.5 
5.4 ± 0.4 
199 ± 29
4.0 ± 0.3
6.0 ± 0.7 
100 ± 4
2.1 ± 0.1
p<0.001 p< 0.005 p<0.001
30 -
TESTOSTERONE
(nmol/l)
20 -
10 -
Controls All Patients Patients ill Patients ill 
< 2 weeks > 2 weeks
Figure 2 Serum testosterone concentrations of 30 healthy men and 30 
medically ill men further subdivided into those ill for 
for less than two weeks (14) and those ill for more than, 
two weeks (16). P values are for comparison with the 
control group.
(19) (19)
A'DIONE 
(nmol/l)
Figure  3
* * X
p<0.001 p<0.001 p<0.005
10 -
- p<0.02 -
Controls All Patients Patients ill Patients ill
< 2 weeks > 2 weeks
Serum androstenedione concentrations of 30 healthy men and 
30 medically ill men further subdivided into those ill for 
less than two weeks (14) and those ill for more than two 
weeks (16). The number in brackets at the top of the 
figure refers to a patient with high levels off the end of 
the scale. P values * are for comparison with the control 
group and # for comparison between groups.
*
p<0.001
X
p<0.001
16
DHAS 
(jimol/l)
8 -
p<0.001-
Controls ah patients Patients ill 
< 2 weeks
Patients ill 
> 2 weeks
Figure 4 Serum DHAS concentrations of 30 healthy men and 30 
medically ill men further subdivided into those ill for 
less than two weeks (14) and those ill for more than two 
weeks (16). P values * are for comparison with the control 
group and # for comparison between adjacent groups.
been ill for more than two weeks. Serum testosterone concentrations 
(Figure 2) were depressed to a similar degree in the acutely ill 
(10.6 ±1.7 nmol/1, p<0.005 c.f. controls) as in the more chronically ill 
(7.4 ± 1.4 nmol/1, p<0.001 c.f. controls). Levels of serum androstenedione 
(Figure 3) were higher in the acutely ill (8.0 ± 1.1 nmol/1) than in the 
chronically ill (5.4 ± 0.7 nmol/1, p<0.02) whereas those of serum DHAS 
(Figure 4) was lower in the chronically ill (1.7 ±0.4 pmol/1) than in the 
acutely ill (5.3 ±1.0 pmol/1, p<0.001).
Serum testosterone concentrations of the ill patients showed 
statistically significant correlations with serum T3 (r=0.423, p<0.05) but 
not with serum T4 (r=0.339), SHBG capacity (r=0.340), FSH (r=0.135), 
LH (r=0.059), or prolactin (r=-0.299> concentrations. Serum DHAS 
concentrations failed to correlate significantly with serum levels of T4 
(r=0.119>, T3 (r=0.285), testosterone (r=0.328) or any other hormone 
measured.
Discussion
This study (Semple, Gray & Beastall, 1987a) demonstrated that 
reduced serum testosterone concentrations occur commonly in a variety of 
illnesses both acute and chronic and are not merely a consequence of 
certain illnesses such as chronic renal failure or respiratory failure as 
the literature had previously suggested. This study (Semple, Gray & 
Beastall, 1987b) also confirmed and extended the findings of Parker and 
colleagues (Parker, Levin & Lifrak, 1985) who had found low levels of 
DHAS in the critically ill and who published their paper during the final
stages of my own study.
Low serum testosterone concentrations were found in patients with a 
variety of illnesses. Few patients were extremely ill as patients were 
studied in a general medical ward rather than in an intensive care unit 
where drugs such as steroids, dopamine and opiates are often
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administered. Two patients (one with necrotising fasciitis, one with 
infectious endocarditis) died within two weeks of sampling and had very 
low levels of testosterone (<2 nmol/1). Three others (one with diabetic 
ketoacidosis, one with empyema and one with bronchopneumonia) had 
similarly low levels but survived. Like low T3 states, low testosterone 
levels do not seem to confer a particularly poor prognosis. Parallels 
between serum T3 and testosterone concentrations are not confined to 
illness and it is interesting to note that levels of both hormones fall 
in healthy men who are fasted (Vagenakis et al., 1975; Klibanski et al., 
1981).
Although there was a significant correlation between levels of 
testosterone and T3 and although low testosterone levels may be found in 
patients with low T4 and low T3 states, there is no evidence to suggest 
that a common mechanism is involved in their evolution. Low T4 states are 
primarily due to changes in protein binding of T4 whilst reduced 
peripheral conversion of T4 to T3 is the main mechanism leading to low 
T3 states. Testosterone is secreted in the male directly from the testes 
and in the circulation is bound by SHBG and albumin. No significant 
change in the binding capacity of SHBG was seen in medically ill patients 
in contrast to uraemic patients. Changes in serum albumin concentration, 
which occur commonly with illness, may alter protein binding of 
testosterone. However due to the low affinity low saturation nature of 
albumin binding, alterations in albumin concentrations are unlikely to 
lead to substantial reductions in serum total testosterone concentrations 
(Dunn, Nisula & Rodbard, 1981). The correlation between testosterone and 
T3 in this study may just represent parallel changes in these hormones 
with illness rather than imply a biologically significant association.
Metabolism of testosterone is decreased in ill patients (Zumoff et 
al., 1971) so altered metabolism will not account for low serum 
concentrations. Increased clearance is a possible mechanism but normal
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17-ketosteroid excretion during illness makes this unlikely (Forbes et
al., 1947). Reduced testicular secretion seems likely to be a major factor 
leading to the low testosterone state associated with illness.
LH levels of men with normal hypothalamic-pituitary function 
increase in response to low serum testosterone concentrations indicating 
primary testicular failure as in Klinefelter's syndrome. On the other 
hand, if hypothalamic-pituitary suppression with subsequent secondary 
testicular failure was the only factor leading to low testosterone 
concentrations, one would expect to find low LH levels. The lack of any 
correlation between the LH and testosterone concentrations of ill patients 
suggests that factors other than hypothalamic-pituitary suppression are 
implicated in the genesis of the low testosterone state and that it 
cannot be explained on the basis of classical primary or secondary
testicular failure. Nor in view of the lack of correlation between serum 
testosterone and serum prolactin and SHBG capacity can low serum
testosterone levels be attributed to changes in SHBG capacity or
hyperprolactinaemia.
There are other possible explanations for this state of relative 
hypogonadism. Normal LH levels using a single radioimmunoassay 
determination do not necessarily imply physiological secretion which is 
normally episodic with pulses every 60-120 minutes (Nankin & Troen, 
1971). Moreover LH can be secreted in biologically active or inactive 
forms possibly due to secretion of LH fragments which are biologically 
inactive but cross-react with LH antiserum (Dufau et al., 1983). Thus 
alterations in biological potency or pulsatility of LH might lead to 
reduced testosterone secretion without changing absolute LH 
concentrations.
DHAS levels were low in patients ill for more than two weeks. This 
might be due to reduced adrenocortical secretion, reduced sulphation of 
dehydroepiandrosterone (DHA) or increased metabolism. Reduced sulphation
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is unlikely to be a factor as low levels of both DHAS and the unsulphated 
DHA in the critically ill have recently been described (Parker et al., 
1985). The metabolism of DHA has been shown to be reduced in ill patients 
(Zumoff et al. 1971) so it is unlikely that low DHAS concentrations in 
this context are due to accelerated metabolic clearance. Reduced 
adrenocortical secretion seems probable.
Serum androstenedione concentrations did not follow the same 
pattern as DHAS in medically ill patients. Rather than fall levels of 
androstenedione rose in the acute situation only to fall to control values 
after two weeks. The physiological role of adrenal androgens is at 
present uncertain and likewise the reason for the blood levels of 
androstenedione and DHAS behaving differently is unclear.
Thus androgens of both testicular and adrenocortical origin join T4 
and T3 in a list of hormones which show a non-specific adaptation to 
illness. In the following three chapters these endocrine changes are 
studied in patients with diabetes mellitus, following burns injury and 
fallowing surgery.
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CHAPTER 5
ANDROGENS AND DIABETES MELLITUS
Patients in varying degrees of diabetic ketoacidosis had low 
serum testosterone levels which rose following recovery but 
glycaemic control of non-ketotic diabetic men was unrelated 
to testosterone levels. Although previous authors had 
suggested that adrenal androgens might be abnormal in 
diabetic men, their levels were found to be similar to those 
of healthy non-diabetic men.
Introduction
Interest in the sex steroid profiles of men with diabetes arose 
because impotence is such a common feature of this condition and may
occur in up to 50 percent of patients (Schoffling et al., 1963). Early
endocrine studies of such impotent patients reported conflicting findings,
urinary excretion of 17-ketosteroids being low (Miller & Mason, 1945), 
normal (Faerman et al., 1972) or high (Schoffling et al., 1963).
Most authors measuring serum hormone concentrations rather than 
urinary metabolite levels have found normal serum testosterone
concentrations in diabetic men whether impotent or not (Ellenberg, 1971; 
Faerman et al., 1972; Kolodny et al., 1974) and it is now commonly 
accepted that the impotence of diabetes is not caused by androgen
deficiency. However, several papers have reported Serum testosterone 
concentrations of diabetic men to be lower than those of control 
populations. Shah wan et al. (1978) found such concentrations in 
sulphonylurea-treated diabetic men to be lower than in either insulin 
requiring patients, patients on diet alone or normal control subjects. A 
study of 41 diabetic men (age range 23-55, mean 37.5 years), only five of 
whom were receiving insulin, showed serum testosterone levels less than 
control values but usually within the normal reference range (Ando, 
Rubens & Rottiers, 1984) while levels of newly diagnosed and mildly
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ketotic insulin dependent diabetic men have been reported to rise 
following insulin therapy (Gluud et al., 1982).
The low serum testosterone concentrations found in the studies of 
Shahwan et al. (1978) and of Ando et al. (1984) might have been due to 
general ill health consequent to poor diabetic control. The latter study 
employed a relatively young group of diabetic men the majority of whom 
one would have expected to be on insulin therapy; the fact that only five 
of 41 were so treated makes it unlikely that they were well controlled. 
Sulphonylurea therapy was implicated as a possible cause of the low 
testosterone levels in the former study but again from the data supplied 
it is not possible to exclude an effect of poor glycaemic control.
In view of my own interest in depression of serum testosterone 
concentration as a consequence of ill health it was logical to investigate 
whether ill diabetic men with ketoacidosis are similarly affected and 
also whether blood glucose control in patients without ketoacidosis 
influences testicular function.
Scanty reports of alterations in serum or urine levels of adrenal 
androgens or their metabolites in diabetic patients have appeared in the 
literature but seemed of little clinical relevance. For example Schoffling 
et al. (1963) found that diabetic men had increased urinary excretion of 
DHA but not of other androgens; on the contrary Alasandro et al. (1982) 
found reduced excretion of DHA as well as other androgens. Szpunar, Blair 
& McCann (1977) found raised androstenedione and DHA levels in plasma of 
diabetic females but adolescent diabetic boys had low DHAS levels when 
matched for bone age with boys who had presented with constitutional
delayed puberty (Cohen et al., 1984).
Recent research has suggested that adrenal androgen levels of 
diabetic patients may be of more than academic significance. Feeding DHA 
or DHAS to genetically obese diabetic mice prevented hyperglycaemia and 
the progressive islet cell atrophy usually found in this animal model
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(Coleman, Schwizer & Leiter, 1984). Low serum levels of adrenal androgens 
if found in adult men as reported in adolescent diabetic boys might then 
have a deleterious effect on islet cell activity. Moreover recent work has 
suggested that a low level of DHAS may be an independent risk factor for 
coronary artery disease and premature death both worrying problems to 
diabetic patients and their physicians (Barrett-Connor, Khaw & Yen, 1986). 
The time seemed ripe to investigate the adrenal androgen status of adult 
males with diabetes raellitus.
Methads.
To investigate the effect of diabetic ketoacidosis on testicular
function eight male patients affected to a varying extent by this 
complication (Table 5) were venesected within 24 hours of hospital 
admission and following recovery at the same time of day four weeks 
later. The diagnosis of diabetic ketoacidosis was made on the basis of
acidaeraia (i.e. pH<7.3) or heavy ketonuria by ketostix testing (i.e. > ++
ketonuria). Paired samples were assayed for testosterone and SHBG 
capacity.
The androgen status of men with diabetes mellitus was studied by 
comparing 15 patients with insulin dependent diabetes (age range 19-61, 
mean 41 years) as well as 15 with non-insulin dependent diabetes (age 
range 37-59, mean 52 years) with appropriately age matched healthy non­
diabetic men. Patients were selected from the diabetic out-patient clinic 
at random apart from the following exclusions.— ketonuria, patients on 
drugs known to affect hypothalamic-pituitary-testicular function, the 
presence of other illnesses as far as could be elicited from history
taking and inspection of the case record, and age over 60 years because
of difficulties in finding healthy controls in this age group.
Blood sampling was performed between 0900 and 1100 hours in 
patients and controls, the samples being assayed for glycosylated
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TABLE 5 Clinical details and serum testosterone levels during acute 
episode and following recovery from diabetic ketoacidosis.
Age of Patient
(years)
42
55
37
25
50
19
28
Cl i nical Erntdem Testosterone level
Early
longstanding diabetes;
pH - 7.0; 1.2
glucose - 70 mmol/1
sulphonylurea failure;
12 Kg weight loss; 8.7
ketonuria +++; 
glucose 25 mmol/I
sulphonylurea failure;
10 Kg weight loss; 4.6
ketonuria ++++; 
glucose 22 mmol/I
newly diagnosed 
diabetes; ketonuria ++++; 10.2
glucose 17 mmol/I
newly diagnosed 
diabetes; pH - 7.2; 5.2
glucose 32 mmol/I
newly diagnosed 
diabetes; pH - 6.95; 
glucose 101 mmol/1
longstanding diabetes; 
pH - 7.1, glucose 40 mmol/1 9.5
longstanding diabetes; 
pH - 7.1; glucose 35 mmol/I 0-5
(nm l/12
Recovery
10. 1
9.8
11.2
12. 1
19.8
22.0
15. 0
9.8
haemoglobin to give a measure of glycaemic control as well as for 
testosterone, SHBG capacity, androstenedione and DHAS. Glycosylated 
haemoglobin was measured by agar gel electrophoresis using a commercial 
kit (Corning Medical and Scientific Ltd) which has a normal range of 6—9 
percent.
Statistical analyses were performed using the Vilcoxon Rank test for 
unpaired data and the Spearman Rank test to calculate correlation 
coefficients.
Results
The mean serum testosterone concentration of the patients with 
ketoacidosis was 5.4 ± 1.3 nmol/1 increasing to 13.7 ±1.7 nmol/1 four 
weeks later (p<0.02). Individual values are shown in Table 5. There was 
no significant difference in mean SHBG capacity at these two times 
(28.6 ± 3.6 v 36.2 ± 6.0 nmol/1). Derived free testosterone increased from 
95 ± 26 nmol/1 to 203 ± 25 nraol/1 (p<0.02).
There was no significant difference in serum levels of testosterone, 
androstenedione and DHAS between either insulin dependent or non-insulin 
dependent diabetic men as compared with the appropriate control groups 
(Table 6). Glycaemic control was variable with glycosylated haemoglobin 
values ranging from 7.1 percent to 15.6 percent (mean 11.5 percent) in 
patients receiving insulin and 7.2 percent to 16.6 percent (mean 10.9 
percent) in the non-insulin dependent group. To assess the effect, if any, 
of glycaemic control on testicular function both diabetic groups were 
considered together; there was no significant correlation between 
glycosylated haemoglobin and serum testosterone concentration (r-0.17).
Discussion
This study was the first to demonstrate that diabetic ketoacidosis 
is associated with a reduction in serum testosterone concentrations and
TABLE 6 Androgen status of diabetic men (mean ± SE).
Grrnft under study Testosterone Androstenedione dhas 
(age, years) (nmol/1) (nmol/1) (fimol/1)
Insulin dependent 19.7 ± 1.5 5.3 ± 0.5 7.4 ± 1.0
diabetes 
(40.6 ± 4.0)
Control group 20.0 ±2.4 4.6 ± 0.6 7.2 ± 0.8
(40.7 ± 3.8)
Non-insulin dependent 14.2 ± 1.2 5.9±0.5 4.0 ± 0.7
diabetes 
(52.1 ± 6.0)
Control group 
(52.6 ± 5.3)
14.9 ± 1.2 5.4 ± 0.7 4.5 ± 0.3
that glycaemic control in stable non ketotic patients does not correlate 
with serum testosterone concentrations (Semple, Gray & Beastall, 1988). 
This suggests that hyperglycaemia does not adversely affect testosterone 
production in the absence of ketacidosis.
The observation that DHAS therapy was beneficial to diabetic rats 
(Coleman et al., 1984) raises the possibility that DHAS deficiency might 
be deleterious to islet cell function. The finding of normal adrenal 
androgen status in adult diabetic men was the first such observation 
(Semple et al., 1988) and suggests that the abnormal islet cell function 
found in insulin dependent and non-insulin dependent diabetic patients is 
unlikely to be related to alteration in adrenal androgen levels. Moreover
the increased susceptibility of diabetic patients to atheroma formation 
and early mortality is unlikely to be related to low serum DHAS 
concentrations which have recently been shown to be an independent risk 
factor for cardiovascular disease (Barrett-Connor et al., 1986).
Thus early studies had suggested that different forms of illness 
might lower both testicular and adrenal androgen levels. Further studies 
were performed on burned patients as outlined in the following chapter in 
an attempt to discover the time of onset and duration of these 
abnormalities.
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CHAPTER 6
ENDOCRINE CONSEQUENCES OF BURNS INJURY
19 men were investigated for four weeks following admission 
for treatment of burns. Profound depression of serum 
testosterone concentrations was found. This often persisted 
for several weeks and could not be accounted for by 
alterations in protein binding, serum prolactin or LH 
levels. Serum DHAS concentrations were also depressed one 
week after injury and remained low over the period of study.
Introduction
Burns injury represents one of the greatest stresses to which the 
human body can be exposed. Clinically significant burns are accompanied 
by marked metabolic changes many of which are controlled by endocrine 
systems. These patients are particularly suitable for investigation as 
they are usually previously healthy and thus are not already in receipt 
of medications known to alter endocrine function. Opioid analgesics may 
be given following admission but their use in the Vest of Scotland Burns 
Unit is usually short term as it is felt that chronic use may prejudice 
long term recovery by depressing appetite and promoting chest infections. 
Indeed many patients do not require potent analgesia because full 
thickness burns are painless due to damage to peripheral nerve endings. 
Inpatient treatment tends to be protracted and thus serial measurements 
are relatively straightforward to perform.
Previous studies have shown substantial reductions in serum 
testosterone concentrations (Dolecek et al., 1979a; Vogel, Peake & Rada, 
1985). In the latter study mean levels were depressed to 19 percent of 
control values; this compares with a reduction to 48 percent following 
surgery (Vang et al., 1978b), 65 percent in respiratory failure (Semple et 
al., 1981) and only 83 percent following myocardial infarction (Vang et 
al., 1978a). Only patients in deep coma following head injury have shown
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a greater suppression (to 5 percent of control values) and here the 
picture was complicated by high dose dexamethasone treatment. Head injury 
also differs from these other clinical situations in that definite 
hypothalamic pituitary suppression has been observed with gonadotrophin 
levels below the normal reference ranges (Rudman et al., 1977).
Dolecek et al. (1979a) found LH levels to be raised within 48 hours 
of burns injury, returning to normal thereafter; FSH levels were subnormal 
within 48 hours and remained low for several weeks. Serum testosterone 
concentrations were low within 48 hours of injury, reached a nadir during 
the second week, and often remained low for several weeks. Gonadotrophin 
responses to LHRH appeared depressed during the second or third weeks 
after injury although no control data were available for comparison 
(Dolecek et al., 1983). Serum testosterone concentrations increased 
following stimulation with HCG but failed to reach the normal range in 
patients who had very low basal levels (Dolecek et al, 1979a). Vogel et 
al. (1985) found low LH levels within the first week of injury but levels 
were similar to control values in the ensuing weeks despite low serum 
testosterone concentrations. FSH levels were not measured in this study. 
SHBG capacity was lower than that of a control group in the first post­
burn week only.
Burns trauma is similar to other pathological states with regards to 
changes in thyroid hormone levels. Low serum T3 concentrations are found 
and may persist for several weeks (Smeds et al., 1981). Low T4 levels are 
also seen especially in those with more extensive burns (Dolecek et al.,
1979b; Vaughan et al., 1985).
Adrenocortical activation as indicated by increased urinary
excretion of cortisol metabolites is found in more severely burned
patients (Wilson, Lovelace & Hardy, 1955). Serum cortisol, a less
sensitive measure of adrenocortical activation, has been found to be
normal or increased in this situation (Balogh et al., 1984; Dolecek, 1984).
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Little information is available on adrenal androgen responses. Urinary 
excretion of 17-ketosteroids show a short-lived increase before falling 
to subnormal levels (Wilson et al., 1955). Dolecek (1984) apparently found 
normal serum androstenedione and low levels of serum DHAS but failed to 
provide supporting data.
As most previous authors had concentrated on each system in 
isolation, it was decided to study testicular, thyroid and adrenocortical 
function following burns trauma in a coordinated fashion in the same 
patient group.
Methods
19 men (age range 20-69, mean 37 years) admitted to a regional 
burns unit were studied. Burns injury varied in intensity from 4 to 70 
percent of total surface area (mean 20 percent). Blood samples were 
obtained between 0800 and 1000 hours within 24 hours of admission and 
thereafter at weekly intervals for four weeks. Not all patients were able 
to be studied at each time interval due to death (2 patients), early 
discharge, inadequate venous access or an insufficient serum sample. The 
number of patients on whom data are based is given in parenthesis in the 
appropriate figure. Samples were obtained at the same time of day from 19 
healthy men (age range 20-66, mean 38 years). Samples were assayed for 
serum concentrations of testosterone, SHBG capacity, FSH, LH, prolactin, 
T4, T3, cortisol, androstenedione and DHAS.
It was not possible to exclude entirely the effects of drugs in this 
study as six patients received parenteral opiates within 24 hours of 
admission. None received this treatment for more than 48 hours. Analgesia 
was provided where necessary with a paracetamol mixture containing only
16 mg codeine per dose.
Statistical analyses were performed using the Wilcoxon Rank test for 
paired data. Correlations were performed using Spearman's Rank test.
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Results
Serum testosterone concentrations (Figure 5> were low following 
admission (week 1) (6.8 ± 1.8 v 18.9 ± 1.4 nmol/1, p<0.001> and remained
low during the study, reaching a nadir of 4.1 ± 1.4 nmol/1 in week 3. 
SHBG capacity (Figure 5) was low on admission (21.2 ±3.2 v 29.9 ± 1.8 
nmol/1, p<0.02) but increased to levels higher than control values by week 
4 (38.2 ± 4.1 nmol/1, p<0.02). Derived free testosterone levels (Figure 5) 
showed a trend similar to total testosterone concentrations. FSH 
concentrations (Figure 6) were lower than in the control group on 
admission though not significantly (2.1 ± 0.4 v 3.2 ± 0.5 D/1) but became 
so by week 2 (1.7 ± 0.4 U/l, p<0.05). LH levels (Figure 6) were unchanged 
and similar to control values throughout the study. Prolactin levels on 
admission (Figure 6) were not significantly different from controls 
(247 ± 58 v 204 ± 18 mU/1) showing only a slight and insignificant
tendency to increase.
Both T4 and T3 levels (Figure 7) were low on admission (50 ± 4.1 v 
100 ± 4.2 nmol/1, p<0.001; 1.0 ± 0.1 v 2.2 ± 0.1 nmol/1, p<0.001) and
remained lower than controls for the duration of the study.
There was evidence of adrenocortical activation following injury. 
Serum cortisol concentrations (Figure 8) were high following admission 
(661 ± 91 v 359 ± 30 nmol/1, p<0.005) and remained high over the study 
period. Serum androstenedione concentrations (Figure 8) were also high 
following admission (7.5 ± 1.0 v 3.9 ± 0.3 nmol/1, p<0.02) and remained 
Higher than the control group thereafter although there was a downward 
drift. Serum DHAS concentrations (Figure 8) were similar to control 
values in week 1 (6.8 ± 1.2 v 5.2 ± 0.7 pmol/1), fell to levels
significantly lower than controls reaching a nadir in week 3 and remained
low for the duration of the study.
Figure 9 illustrates the serum testosterone and DHAS concentrations 
of three patients who had further estimations performed up to 24 weeks
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Figure 9 Serum testosterone and DHAS concentrations of 
burned patients who were studied for up to 24 
following injury.
after injury. Concentrations of both steroids returned to within the 
normal range.
The size of the burn showed a significant correlation with serum T4 
concentrations on admission (r=-0.742, p<0.002) but not with any other 
variable. Serum testosterone concentrations on admission did not 
correlate with any other hormone level measured.
Discussion
This study confirmed the finding of low serum testosterone 
concentrations following burns injury. A low SHBG capacity was also found 
but this was shortlived and levels increased to greater than control 
values three weeks after admission. It is possible that the fall in SHBG 
capacity is due to changes in testosterone binding similar to those 
occuring between T4 and its binding proteins in ill patients. Indeed free 
fatty acids which have been proposed as the thyroid hormone binding 
inhibitor in the low T4 syndrome (Chopra et al., 1986) may reduce the 
binding of testosterone to SHBG and albumin (Mooradian, et al., 1988). 
Alternatively the increased protein breakdown occurring following burns 
injury may allow increased catabolism of SHBG. This question is addressed 
further in Chapter 11. In any case the changes in SHBG did not correlate 
with alterations in serum testosterone concentrations and were not of 
significant magnitude to account for these changes. One might expect 
increased catabolism of circulating albumin in this situation; this might 
lead to small changes in serum testosterone concentrations but not of the 
magnitude of those seen in many of our patients (Dunn et al., 1981).
Like the situation in medically ill patients LH levels were 
unchanged despite low testosterone levels. FSH levels were significantly 
depressed. The failure of LH to increase in response to a reduction in 
serum testosterone concentrations does imply hypothalamic pituitary 
dysfunction although one would expect to find levels of LH below control
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values if this were the main mechanism leading to low serum testosterone 
concentrations. Prolactin concentrations showed a tendency to increase 
but, because of the wide scatter of results, this did not achieve 
statistical significance. Hyperprolactinaemia can cause low testosterone 
levels but levels required are usually many times higher than those found
in our patients (Carter et al., 1978).
The LH in serum of burned and ill patients does not seem effective 
in stimulating testosterone secretion. Perhaps this is because the LH 
secreted in these patients is structurally abnormal and therefore 
biologically inactive but sufficiently similar to LH in healthy men to be 
measured in standard LH radioimmunoassays. Possibly the regular secretory 
pulses of LH found in healthy men (Nankin & Troen, 1971) are disrupted 
by illness and the consequent non-pulsatile LH secretion is less active 
in promoting testicular steroidogenesis. A relative insensitivity to the 
action of LH at the level of the testes might also occur in association 
with either or both of these putative abnormalities of hypothalamic- 
pituitary function. These possibilities are investigated in more detail in 
Chapters 13 and 14.
Prolonged depression of serum T4 and T3 concentrations were seen in
burned patients. The mean nadirs were 52 and 55 percent of mean control
values as compared with 22 percent in the case of serum testosterone 
concentrations which seem more sensitive to this type of stress. For 
example one patient, a 60 year old man with a relatively minor burn of 
only four percent involving his cheek, had a serum testosterone 
concentration of only 2.6 nmol/l two weeks after injury subsequently 
recovering to 12.0 nmol/l; T4 and T3 levels reached a nadir of 58 and 1.2 
nmol/l compared with levels of 77 and 2.3 nmol/l after recovery. Thus not 
only men very severely burned are affected in this way. As many as 12 of 
our 19 patients had serum testosterone concentrations within the female 
range «2 nmol/l) on at least one occasion. Indeed serum testosterone
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concentrations are so sensitive to burns injury that they give no 
indication of severity; hence the lack of correlation between surface area 
affected and serum testosterone concentration.
It is only fair to state that the observations made with regard to 
serum testosterone concentrations in this study (Semple et al., 1987c) in 
part duplicated the findings of previous workers (Dolecek et al., 1979a; 
Vogel et al., 1985) although my own study was in progress at the time of 
the latter publication. The extent and duration of the depression of serum 
testosterone concentrations as confirmed in this study as well as the 
comparatively sparing use of drugs confirmed that burned patients would 
be particularly suitable for investigation of the underlying mechanisms 
leading to low serum testosterone levels in ill men; these further studies 
are detailed in Chapters 13 and 14.
There was definite evidence of sustained adrenocortical activation
fallowing burns injury. Despite the prolonged increase in serum cortisol
and to a lesser extent androstenedione concentrations, serum DHAS levels
were normal on admission, fell to low levels one week thereafter and 
remained low for the remainder of the study period. This divergence
between serum concentrations of androstenedione and DHAS is reminiscent 
of the situation in those patients who had been medically ill for more 
than two weeks. It is reassuring to note that both serum testosterone and 
DHAS levels do ultimately return to normal.
While this study was being carried out, there was no previous
detailed assessment of adrenal androgen levels in burned patients.
However I was beaten to press (Semple et al., 1987b) by Parker & Baxter 
(1985) who found a progressive reduction in serum DHAS concentrations 
over four weeks after burns injury in 19 adult men. Further work by this 
group (Lephart, Baxter & Parker, 1987) revealed that the low DHAS levels
in these patients are accompanied by normal or reduced levels of urin y
17-ketosteroids. This suggests that the low serum DHAS levels are not the
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result of increased urinary excretion of DHAS or of lt8 17-ketosteroid
metabolites. Moreover serum levels of DHA were low demonstrating that low 
DHAS levels are not due to impaired ^  ^  ^
sulphakinase. Serum levels of androstenedlol and Its sulphate were also
low; these are metabolites of DHA and DHAS respectively and this finding
is in favour of reduced synthesis rathery &ib ratner than increased metabolism being
the cause of low DHA and DHAS levels in burned men.
In a search for further situations which would be suitable for the
serial study of hormone changes with illness, the situation following
surgical stress was examined In an investigation outlined in the
following chapter.
CHAPTER 7
HQRMOJTAL CHARGES FOLLOW IJTG CHOLECYSTECTOMY
Gonadotrophin levels of post-menopausal females were reduced 
following surgery. Increased serum and urine cortisol levels 
were accompanied by a transient elevation of androstenedione 
concentrations although DHAS levels fell below baseline one 
week after surgery.
Introduction
Having shown that both medically ill and burned men had altered 
hormonal status with respect to adrenocortical and testicular 
steroidogenesis I decided to continue my observations in patients 
following surgery.
The finding of normal LH levels in medically ill and burned patients 
with low serum testosterone concentrations was intriguing. Although low 
serum testosterone concentrations following surgery have been described 
by several authors there is no consensus as to whether gonadotrophin 
levels of men in this situation are unchanged (Carstensen et al., 1973), 
high (Wang et al., 1978b) or low (Charters et al., 1969; Hagen et al., 
1980).
Depressed gonadotrophin levels had been reported previously in 
elderly medically ill women (Warren et al., 1977) and in post-menopausal 
women who also had the low T4 syndrome (Quint & Kaiser, 1985). Post­
menopausal women have high gonadotrophin levels due to reduced negative 
feedback fron declining oestrogen secretion. These high levels may be 
particularly sensitive to the effects of illness. High gonadotrophin 
levels are only found in men with primary testicular failure such as in 
Klinefelter's syndrome. It would be of great interest to study such men 
following illness or surgery but due to their relative scarcity this is 
n°t practical. I considered it of interest to study the gonadotrophin
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levels of post-menopausal women following surgery in order to look for 
evidence of hypothalamic-pituitary suppression. Surgery also provided a 
model for the further study of adrenal androgen secretion. Would 
adrenocortical activation following surgery lead to increased DHAS levels 
or would the postoperative period be associated with low levels of DHAS 
as in chronically ill and burned men?
Methods.
Nine female post-menopausal patients (mean age 57, range 49-64 
years) undergoing elective cholecystectomy agreed to take part in this 
study. No patients were taking any drugs known to affect endocrine 
function. An aliquot of urine and a blood sample were collected between 
0800 and 1000 hours on the day prior to surgery (day -1) and on days +1, 
+4, +8 and +28 post-operatively.
Patients received an intramuscular opiate in combination with 
atropine as pre-medication. Induction of anaesthesia was obtained with 
thiopentone sodium supplemented in some patients by opiate analgesia. 
Maintenance of anaesthesia was achieved with a nitrous oxide/oxygen 
mixture supplemented by either halothane or enflurane and/or opiate 
analgesia. All patients received either suxamethonium or vecuronium as a 
muscle relaxant as well as parenteral opiate analgesia for between 48 and 
72 hours following surgery.
Urine samples were assayed for urinary free cortisol (UFC) and 
expressed as the cortisol:creatinine ratio. Serum samples were assayed 
for FSH, LH, prolactin, cortisol, androstenedione and DHAS.
Statistical analyses were performed using the Wilcoxon Rank test for 
paired data.
Results.
Serum cortisol and UFC (Figure 10) showed the expected rise in the 
first post-operative day (day +1) before gradually returning to baseline 
values. Serum androstenedione (Figure 11) increased from 4.3 ± 0.5 to 
6.3 ± 0.7 nmol/l (p<0.05) on day +1 but returned to normal thereafter. 
Serum DHAS (Figure 11) was unchanged on day +1, fell to a nadir on day 
+8 (1.7 ± 0.6 v 0.5 ± 0.2 pmol/1, p<0.02) but had returned to baseline
levels by day +28.
Both FSH (22.7 ± 2.9 v 48.3 ± 7.2 U/l, p<0.02) and LH (18.4 ± 5.4 v
50.5 ± 13.5 U/l, p<0.02) were significantly decreased on day +1 (Figure 
12) but rapidly returned to normal. All patients had pre-operative 
gonadotrophin levels within the range consistent with the post-menopausal 
state 030 U/l). Four patients had LH levels on day +1 less than 10 U/l. 
Serum prolactin concentrations (Figure 12) were raised post-operatively 
but to a relatively modest extent with day +1 levels ranging from 65 to 
1260 mU/1 (pre-operative range 20-530 mU/1).
Discussion
Adrenocortical activation following surgery was demonstrated in the 
early years of scientific endocrinology by investigators who found 
increased urinary excretion of 17-hydroxycorticoids in the absence of any 
appreciable change in 17-ketosteroids (Forbes et al. 1947; Moore et al.
1955). UFC gives a measure of the rate of clearance of cortisol from the
circulation and relects the free, non-protein bound and presumed 
physiologically active moiety of serum cortisol. A comparison of the 
changes in UFC and serum cortisol in the first post-operative day is of 
interest; the former increased by a factor of 14 while the latter
increased only by a factor of two (Figure 10). This highlights the 
importance of the interaction between cortisol binding globulin (CBG) and 
cortisol when the adrenal cortex is activated. CBG capacity readily
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before (day -1) and after cholecystectomy (days +1, +4,
+8, +28) in 9 post-menopausal women. P values are for
comparison with the pre-operative day.
becomes saturated leading to much greater increases in free as opposed to 
total cortisol (Daughaday & Mariz, 1961).
Our description of adrenal androgen changes in serum of post­
operative patients was the first in the literature (Semple et al.f 1987b). 
Adrenocortical activation was not reflected in any substantial change in 
adrenal androgens. Androstenedione levels showed a small increase on day 
+1 only while DHAS showed no early change but fell to below basal levels 
on days +4 and +8 (Figure 11). There are similarities here with the 
results in our medically ill and burned patients. Acute medical or 
surgical stress may lead to a short-lived increase in androstenedione 
levels but more prolonged stresses seem to lead to a fall in DHAS levels.
Surgical stress was accompanied by modest hyperprolactinaemia and a 
reduction in gonadotrophin concentrations to pre-menopausal levels in 
several patients suggesting a transient hypogonadotrophic state 
(Figure 12). This change cannot simply be attributed to surgical stress 
as these patients received a variety of drugs both intra-operatively and 
post-operatively. All our subjects received parenteral opiates for 48 
hours post-operatively and it would obviously not be ethical to study 
patients after major surgery without such potent analgesia. Previous 
studies in men have suggested that the drugs used in general anaesthesia 
may increase rather than decrease gonadotrophin concentrations 
(Nakashima et al., 1975). However prolonged usage of opioid drugs as in 
the case of drug addicts has an adverse effect on hypothalamic-pituitary- 
testicular function (Mendelson & Mello, 1975) and it is possible that 
short-term but intensive administration of opiates post-operatively may 
contribute to the fall in gonadotrophin levels.
Stress following surgery like that associated with medical illness 
and burns is accompanied by profound changes in the hormonal milieu. 
Changes in adrenal androgen levels were found which closely mirrored 
those found in burned patients except that the latter group seemed to be
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affected in a more profound and longlasting way. The hope that the data 
on gonadotrophin levels of these postoperative patients might shed light 
on the mechanisms leading to a reduction in serum testosterone levels in 
ill men proved simplistic. Interpretation of the early changes in 
gonadotrophin levels in these patients was complicated by multiple drug 
administration. In particular the liberal use of parenteral opiates in the 
post-operative period rendered this data of little value.
Thus far several clinical situations had been studied and
abnormalities of androgen levels in serum had been found to be common.
Hormonal activation is found in other forms of stress such as following 
exercise or psychological stress. Were the abnormalities found in the 
situations already described specific to illness or would they be found
in other stressful circumstances? The search for the answer to this
question is addressed in the following three chapters.
CHAPTER 8
ENDOCRINE RESPONSES TO MARATHON RUNNING
10 men were studied one week before and on completion of a 
marathon, A massive rise in serum cortisol and a small 
increase in androstenedione and DHAS concentrations were 
found. Serum testosterone and LH concentrations fell. 
Extreme physical effort lowers testosterone levels but to a 
lesser degree than occurs during illness and unaccompanied 
by low levels of DHAS,
Introduction
The finding of abnormal gonadal function in ill men stimulated 
interest in endocrine function during other stressful situations. Ever 
since a soldier from the defending Greek army ran to Athens from the 
battlefield at Marathon, announced victory and died, it has been widely 
held that marathon running is the supreme test of physical fitness and 
provides a physiological stress which is difficult to surpass. Indeed the 
above soldier was not to be the last individual to die at or near the 
finishing line. In the years preceding this study (pre-1984) marathon 
running had increased greatly in popularity providing the opportunity for 
study of participants who would not be classified as top class athletes.
Exercise is known to lead to increased blood levels of several 
hormones in particular adrenocortical and adrenomedullary hormones, 
growth hormone and prolactin. Several studies had suggested that short 
term physical effort could increase serum testosterone concentrations 
(Sutton et al., 1973; Galbo et al., 1977; Kindermann et al., 1982; Grossman 
et al., 1984) but other investigators had found that levels had fallen 
with more intense exercise (Dessypris et al., 1976; Aakvaag et al., 1978a). 
When my interest arose in this subject only one previous study had 
described endocrine responses to marathon running, reporting a fall in 
mean serum testosterone concentrations in 13 runners from 23.9 before to
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15.6 nmol/1 after a marathon (Dessypris et al., 1976). However the ambient 
temperature was 30 C during the race which might have resulted in major 
fluid shifts and indeed might have been an additional stressor in its own 
right. No attempt was made to estimate the extent of dehydration in these 
athletes.
An investigation of endocrine function following marathon running 
was therefore performed in an effort to discover whether the stress of 
illness and extreme effort have any common effects on the hormonal 
milieu.
Methods.
10 healthy adult males (age range 23-49, mean 33 years) agreed to 
take part in this study. All had been in training for at least three 
months for the Glasgow marathon but none were competitive runners. Pre- 
marathon samples were withdrawn during the week before the race between 
1230 and 1330 hours, considered to be the likely finishing time. Fluids 
were freely available en route and weather conditions were cool with the 
average temperature 12*C. Post-marathon sampling was performed within 30 
minutes of the finish (range 6-30, mean 20 minutes).
Samples were assayed for testosterone, SHBG capacity, FSH, LH, 
prolactin, cortisol, androstenedione and DHAS. To assess hydration status 
each individual's microhaematocrit was measured before and after the race 
using the Hawksley method after centrifugating anticoagulated blood 
samples at 13000 G for five minutes.
Statistical analyses were performed using the Wilcoxon Rank Test 
for paired data.
Results (Table 7)
All 10 runners completed the race in reasonable physical condition 
(mean duration 232, range 182-258 minutes). There was no significant
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TABLE 7 Hormone levels in 10 men before and after marathon running 
(mean ± SE).
PRE-MARATHON POST-MARATHON
Cortisol (nmol/l) 338 ± 46 1640 ± 280 F><0 . Ol
Androstenedi one (nmol/l) 3.6 ± 0.3 7. 1 ± 0.4 F><0 . Ol
DHAS (jimol/l) 6.7 ± 1.0 9.8 ± 1.7 p<0.Ol
Testosterone (nmol/l) 18.5 ± 1.6 14.9 ± 1.1 p><0 . Ol
Derived free 
Testosterone
(pmol/1) 312 ± 32 245 ± 30 p<0.Ol
SHBG (nmol/l) 30.5 ± 2.8 30.0 ± 2.3
FSH (U/l) 3.7 ± 0.5 3.4 ± 0.3
LH (U/l) 4.1 ± 0.6 2.5 ± 0.4 p<0.06
Prolactin (mU/1) 140 ± 32 334 ± 90 p<0.Ol
difference between the microhaematocrit before and after the race 
(47 ± 0.8 v 46 ± 0.4 percent).
Adrenocortical activation was reflected in a massive increase in 
serum cortisol concentrations with a smaller but statistically significant 
rise in the adrenal androgens, androstenedione and DHAS. A fall in serum 
testosterone concentrations was accompanied by a drop in LH levels, an 
increased prolactin level but unchanged SHBG levels. Changes in levels of 
cortisol, testosterone and LH are shown in Figure 13.
PiggyggjQn
A small but statistically significant reduction in serum 
testosterone concentrations occurred as a consequence of marathon running 
(Semple, Thomson & Beastall, 1985) confirming the earlier work of 
Dessypris et al. (1976) and the more recent study of Kuusi et al. (1984). 
In the latter study the fall in testosterone levels could be accounted for 
by a similar fall in SHBG capacity leading to an unchanged derived free 
testosterone concentration. In the study described in this chapter SHBG 
capacity was unchanged and derived free testosterone closely mirrored the 
changes in total testosterone. The finding of a fall in LH levels 
contrasted with unchanged levels found by Dessypris et al. (1976) but 
agreed with the findings of Kuusi et al. (1984) in men and Hale et al. 
(1983) in women.
The finding that the microhaematocrit of athletes was unchanged by 
the race shows that they were not signficantly dehydrated so any 
alteration in hormone levels could not be attributed to fluid shifts. This 
finding is perhaps a little surprising in view of the duration and 
intensity of exercise but weather conditions were cool and participants 
were supplied with plentiful fluids at regular intervals.
The suppression of testosterone levels seen with effort differs in 
several ways from that following illness. Firstly it is less pronounced;
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Figure 13 Serum cortisol, testosterone and LH of 10 men during the 
week prior to and immediately after a marathon.
for example the burned patients described in Chapter 6 had very low 
serum levels of testosterone whereas all the marathon runners had levels 
within the normal male range. While in athletes there is a massive 
outpouring of glucocorticoid the reduction in serum testosterone 
concentration with illness may occur in the absence of demonstrable 
adrenocortical activation. Thus extreme physical effort may lead to a 
reduction in testosterone levels but of lesser degree than that associated 
with illness and unaccompanied by low levels of the adrenal androgen 
DHAS.
Endogenous opioid peptides have an inhibitory effect on 
hypothalamic-pituitary-testicular function (Grossman et al., 1981) and it 
had been widely suspected that the "anti-gonadal" effect of exercise in 
men and women might be mediated by an increase in these substances with 
exercise. Early work using assays of low specificity had suggested that 
0-endorphin was increased by exercise (Colt, Wardlaw & Frantz, 1981; 
Farrell et al., 1982) but Elias et al. (1986) using more specific assays 
observed a 0-lipotropin increase but no 0-endorphin response to acute 
exercise. As mentioned above the fall in LH levels with exercise is not 
consistent. Indeed when pulsatile LH release was examined immediately 
following exercise no change in LH pulse frequency was found as compared 
with pre-exercise values (McColl et al., 1989). Hyperprolactinaemia may 
exert an "antigonadal" effect but at much higher levels than found in this 
study and this effect is mediated centrally. There remains then the 
difficulty in explaining a reduction in serum testosterone levels in the 
absence of any obvious change in central control. An alteration in the 
biological activity of LH with exercise is a possiblity but has not been
investigated in the literature.
Increased glucocorticoid levels in this situation were expected but 
the extent of the elevation was surprising. In a previous publication 
(Seraple et al., 1982c) the mean serum cortisol concentration after
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injection of pharmacological doses of synthetic ACTH (Synacthen) into 10 
heathy men was 865 nmol/l as compared with 1640 nmol/l after marathon 
running. Metabolism of cortisol increases with exercise (Few, 1974) and 
thus the increased serum levels found in this situation are likely to be 
due to increased secretion rather than reduced elimination. This intense 
adrenocortical activation was also reflected by an increase in the 
adrenal androgens, androstenedione and DHAS. This contrasts with patients 
following surgery, burns injury and medical illness in whom 
androstenedione but not DHAS levels increased . This may be related to 
the duration of the stresses involved. In the marathon they were 
relatively short-lived and of great intensity.
In the chapter which follows I studied androgen levels of men who 
undertook regular levels of physical exertion over many years, the so 
called veteran athletes. Would the chronic nature of this stimulus and 
presumed recurrent adrenocortical activation lead to any lasting changes 
in androgen levels?
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CHAPTER 9
GOFADAL FUFCTIOF IF VETERAF ATHLETES
13 veteran athletes were compared with 13 sedentary 
controls. Extreme and longstanding physical fitness had no 
discernible effect on pituitary-testicular function or on 
adrenal androgen levels.
IntCQdUQtiQh
Menstrual abnormalities such as amenorrhoea or oligoraenorrhoea are 
common in female athletes (Baker et al., 1981). Amenorrhoeic runners have 
low serum oestradiol levels (Baker et al., 1981). Evidence suggesting 
hypothalamic-pituitary-testicular suppression had been found following 
prolonged exertion and this raised the possibility that exercise of this 
nature, repeated and prolonged over many years, might have a more
permanent "anti-gonadal" effect. If the low DHAS levels found in ill men 
are caused by adrenocortical adaptation to chronic stimulation then might 
the same effect be present in veteran athletes whose repeated and
sustained exertions might be expected to lead to repeated and sustained 
adrenocortical activation.
The opportunity arose to study members of the Scottish Veteran 
Harriers Club which is comprised of members over 40 years old most of 
whom had been distance training for many years.
Methods
13 men, age range 44-60 years agreed to take part in this study. All 
had been running more than 25 miles per week (range 25-110 miles) for at 
least 20 years (range 20-39 years). To avoid the acute effects of 
exertion subjects were asked not to train during the 24 hours prior to
sampling. Blood samples were obtained between 0800 and 1000 hours from
these subjects and from age matched normal controls who did not take
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regular exercise. Samples were assayed for serum concentrations of 
testosterone, SHBG capacity, FSH, LH, androstenedione and DHAS.
Statistical analyses were performed using the Wilcoxon Ranh test for 
unpaired data.
Results (Table 8)
There was no significant difference between the athletes and the 
controls with regard to any of the parameters measured.
Discussion
Several previous papers have addressed this question and their 
conclusions are summarised below
Authors
Young et al., 1976
Remes et al., 1979
Wheeler et al., 1984
Kuoppasalmi & 
Adlercreuz, 1985
SubjGGtS 
7 "high fit" v 7 "low fit"
39 recruits- 6 month training 
31 athletes v 18 controls
16 athletes v 7 controls
Testosterone
t
t
l
no difference
MacConnie et al., 1986 6 athletes v 6 controls no difference
Wheeler et al., 1986
Hackney, Sinning & 
Bruot (1988)
49 athletes v 18 controls 
11 trained v 11 untrained
When low serum testosterone concentration were found following 
marathon running it seemed unlikely that athletes in the resting state 
would have increased testosterone levels as the literature available at 
that time suggested. The results of Wheeler et al. (1984) then spurred me 
on to perform my own study the results of which are similar to
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TABLE 8 Hormone levels of 13 veteran athletes
and 13 age matched controls (mean ± SE).
VETERAN ATHLETES CONTROLS
Age (years) 53.6 ± 1.5 52.7 ± 1.8
Years in training 25 ± 5 —
Miles per week 51 ± 7 —
Testosterone 
(nmol/l>
15.8 ± 1.2 16.6 ± 1.8
SHBG capacity 
(nmol/l)
41.2 ± 3.3 36.6 ± 2.8
Derived free 
Testosterone (pmol/1)
225 ± 11 248 ± 22
Androstenedione (nmol/l) 4.9 ± 0.7 4.5 ± 0.7
DHAS (pmol/1) 4.3 ± 0.4 4.2 ± 0.7
FSH (U/l) 5.3 ± 0.8 4.6 ± 0.8
LH (U/l) 5.4 ± 0.6 6.0 ± 0.5
Kuoppasalmi & Adlercreuz (1985) and MacConnie et al. (1986). What 
explanation might there be for these differing results?
The first study cited was very small; moreover the control group 
seemed strikingly overweight (mean weight 73 Kg v 94 Kg), a factor which 
can have an adverse effect on gonadal function (Glass et al., 1977). 
Veteran athletes in the study described in this chapter were leaner than 
control subjects (mean body mass index 22.0, range 19.5-24.5 v 24.1, 22.0- 
26.5) but none of the latter were obese (obesity = body mass index > 30). 
The second study employed recruits before and after a six month training 
course. It is possible serum testosterone concentrations might rise over 
this relatively short term yet return to normal when, as in the case of 
the veterans, training is sustained over many years. Wheeler et al. (1984) 
and Hackney et al (1988) studied athletes similar to the Scottish 
veterans. Differences in training schedules, age ranges and timing of 
sampling in relation to exercise might account for the different results. 
That this might be the case is suggested by the later work of Wheeler et 
al. (1986) in an extension to their earlier study (Wheeler et al. 1984). 
49 athletes were examined using different training schedules; only those 
running more than 40 miles per week showed a statistically significant 
fall in serum testosterone concentrations whereas those running between 
25 and 40 miles per week did not.
A recent review of this subject has come down in favour of a mild 
lowering of testosterone levels with heavy training (Gumming, Wheeler & 
McColl, 1988). However, there may be a bias towards positive results 
reaching publication; reearchers finding no difference between trained 
athletes and controls may (like myself) not have submitted their work for 
publication or if they have done so it may not have been of sufficient
interest to merit acceptance.
Evidence for abnormalities of LH secretion of trained athletes is 
equally conflicting. Female athletes have evidence of an abnormality of LH
- 91 -
pulsatility whethei menstruating normally or amenorrhoeic (Cumming et 
al., 1985; Veldhuis et al., 1985). MacConnie et al (1986) found decreased 
frequency and amplitude of LH pulses in male athletes despite normal 
levels of serum testosterone and suggested that increased levels of 
testosterone occurring after oft-repeated short term exertion (Sutton et 
al., 1973; Galbo et al., 1977; Kindermann et al., 1982; Grossman et al., 
1984) might lead to a degree of hypothalamic-pituitary suppression. 
However Rogol and colleagues (1984) found no evidence of abnormal LH 
pulsatility in endurance trained athletes although their sampling period 
commenced just after the completion of a 10-15 mile run. Hackney et al. 
(1988) found normal LH pulsatility in their group of endurance trained 
athletes who had had no exercise for 36 hours and who had lower 
testosterone levels than their control group.
In my study I was unable to detect any evidence of low testosterone 
levels with long term endurance training. If any "anti-gonadal" effect 
does occur it must be of a minor degree; it is unlikely to have adverse 
physiological sequelae; and it bares no similarity to the profound and 
prolonged reduction in serum testosterone concentrations found in ill 
men.
Veteran athletes had adrenal androgen levels similar to controls. 
Thus regular exercise with presumed oft repeated adrenocortical 
activation has no discernable effect on adrenal androgen levels in serum.
Illness is usually accompanied by a considerable degree of 
psychological stress. Might the endocrine changes in ill patients 
described in earlier chapters be related to this psychological stress 
rather than to the illness itself? In the project which follows I studied 
the endocrine response to examination stress to discover whether there 
there were any similarities with the results found in ill men.
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CHAPTER 10
ENDOCRME EFFECTS OF EXAM MAT IOBT STRESS
To determine the effects of pure psychological stress on 
endocrine function, nine men were studied 16 weeks before 
and immediately after Final Degree examinations. Increased 
psychological stress was accompanied by increased urinary 
excretion of metadrenalines but there were no significant 
changes in gonadal or adrenocortical hormones.
Introduction
Having demonstrated that the stress associated with exercise and 
illness may alter levels of hormones not usually considered "stress 
hormones", I decided to investigate endocrine function associated with 
psychological stress which is often a consequence of illness. Previous 
studies in this field had proved difficult to interpret because of the 
presence of stressors such as illness or exercise while certain factors 
which influence endocrine function such as medication or alcohol 
ingestion had been ignored.
Psychological stress may lead to increased secretion of gluco­
corticoids and catecholamines (Hodges et al., 1962; Rubin et al., 1970) but 
responses vary considerably between individuals and depend on the type 
of exposure. For example pilots show a much greater adrenocortical 
response to the stress of aircraft carrier landings than do navigators 
despite having lower levels of anxiety and fear (Miller et al., 1970) and 
individuals who cope well with stress have a lesser response than those 
who cope badly (Miyabo et al., 1970).
Interest in testicular function associated with psychological stress 
was stimulated by the finding of reduced urinary excretion of androgen 
metabolites in soldiers awaiting attack (Rose et al., 1969) although 
unchanged excretion had been demonstrated previously during examination 
stress (Connell et al., 1958). Low serum testosterone concentrations were
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found in eight army cadets during a five day combat course; although this 
was undoubtedly a psychologically stressful experience, the study was 
complicated by the stress of intense physical training (Aakvaag et al., 
1978b). Similarly, during a 23 week officer training course low serum 
testosterone levels were found during the third as compared with the 
penultimate week (Kreuz et al., 1972); while the authors related this 
observation to a reduction in psychological stress, it is possible that 
the physical training component of the course led to increased fitness 
with a reduction in the physical stress of exercise in the later weeks of 
the course.
The aim of the current study was to examine hormone changes 
associated with university examination stress whilst taking into account 
other factors known to affect endocrine function.
Methods
Mine final year physiology students (age range 20-22, mean 21 
years) agreed to take part in the study, permission having been obtained 
from University authorities. Following a four week vacation and 16 weeks 
prior to Final examinations initial blood sampling was carried out 
between 1200 and 1300 hours. Repeat venepuncture was performed at the 
same time of day immediately following a three hour written examination 
in the middle of a series of Final Degree examinations. Twenty four hour 
urine collections were obtained terminating at 0900 hours on the days of 
each venepuncture as well as 10 ml aliquots of urine from the first 
sample of the day for estimation of urinary free cortisol. All subjects 
had endured six hours of written examinations during the 24 hours 
preceding the second venepuncture.
Serum samples were assayed for cortisol, androstenedione, 
testosterone, SHBG capacity, DHAS, FSH, LH, and prolactin. Aliquots of 
early morning urine were measured for urinary free cortisol and 24 hour
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collections were assayed ior urinary metadrenaline excretion as expressed
as pmol/mol creatinine in order to correct for possible incomplete urine 
collection.
Subjects were asked to fill in a questionnaire regarding exercise, 
cigarette smoking (Deslypere & Vermeulen, 1984) and alcohol ingestion 
(Gordon et al., 1976) all factors which may alter gonadal endocrine 
function. No subject was taking any drugs or medication.
In order to assess the extent of psychological stress, subjects were 
asked to complete two self-rating anxiety assessments during the 24 
hours preceding each venepuncture. The Zung self-rating anxiety scale 
(Zung, 1971) consists of 20 statements which encompass many 
physiological consequences of anxiety; for example - "I feel more nervous 
and anxious than usual" and "I have to empty my bladder more often". 
Subjects were asked to rate each of the 20 items as to how it applied to 
him during the past week in the following terms:- none or a little of the 
time, some of the time, part of the time, most or all of the time. Each 
reply was scored a value of 1, 2, 3, or 4 in such a way that less anxious 
subjects have a low score on the scale which ranges from a minimum of 25 
to a maximum of 100 when expressed as a percentage. As the Zung scale
had been designed to assess anxiety associated with psychiatric
disorders, further assessment was made using a visual analogue scale 
(Figure 14) employing the subjects' responses to the following words 
tense, excited, fearful, relaxed, 'wound up', apprehensive, confident,
worrying, calm, and tremulous. Subjects were asked to place a cross on a 
10 cm line indicating the extent to which each word applied to them at 
the present time or during the preceding week. Results were expressed on 
a scale of zero to 100, the higher the score the greater the anxiety.
Statistical analyses were performed using the Vilcoxon Rank Sura
test for paired data. The chances of statistical significance being 
fortuitously obtained increases with the number of parameters measured.
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ANALOGUE BATTNO Rr.fim
Below you will see a list of words which describe how a person feels 
or acts. You have to consider each description carefully and decide 
how true it could be of you during the past week / or at the present 
time. Place a cross anywhere along the line opposite each description 
to indicate how true it could be. Obviously the closer you put the 
cross to the "extremely" end the more true you feel the description is 
and so on.
TENSE not at all____________   extremely
EXCITED _______________
FEARFUL
RELAXED
WOUND UP
APPREHENSIVE
CONFIDENT
WORRYING
CALM
SHAKY or TREMULOUS
Figure 14 This visual analogue rating scale was completed in the 24 
hours prior to both pre—exam and post-exam blood 
sampling. Each response was scored out of 10 with the aid 
of a ruler in such a way that higher scores indicated 
greater anxiety. All 10 scores were added up to give a 
total score out of 100.
When this study was submitted for publication to Clinical Science it was 
suggested that the Bonferroni correction ((Wallenstein, Zucker & Fleiss, 
1980) be invoked. To reduce the chance of a false positive statistical 
result to less than the 5% level in this study of 13 variables 
significance was only claimed when P was less than 0.004 (i.e. 0.05 4- 13).
Results. (Table 9)
Both anxiety rating scales showed significant increases during the 
post-examination assessment period. The mean pre-examination value for 
the Zung scale was 36.1 and was similar to that found by Zung (Zung, 
1971) in 100 normal controls (33.8) supporting the assumption that 
students were not unduly stressed during the pre-examination sampling 
period. There was no significant change in exercise taken or alcohol or 
cigarettes consumed between the two study periods (Table 10). 24 hour 
urinary metadrenalines reflected increased psychological stress with all 
subjects showing increased excretion at the time of examinations. No 
other hormone levels showed any significant change.
Discussion
This study (Semple et al., 1988) demonstrating an unchanged 
hypothalamic-pituitary-testicular axis with psychological stress was 
unusual in that confounding factors such as exercise and alcohol were 
taken into consideration and in that the presence of definite 
psychological stress was confirmed by psychological testing. In a similar 
study Johansson et al. (1988) found serum testosterone levels of medical 
students unchanged immediately prior to a three hour examination but LH 
levels were reduced. Whilst it may be premature on the strength of these 
findings to exclude any effect of psychological stress on serum 
testosterone concentrations, previous literature has often failed to take 
into consideration other important factors such as the effect of exercise.
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TABLE 9 Psychological assessment and hormone levels before and 
after examinations in 9 male university students.
PRE-EXAM POST-EXAM
Zung anxiety rating 36. 1 ± 1.7 46.5 ± 2.8 p<0,004
Visual analogue scale 32.2 ± 4.4 60.9 ± 3.8 p<0.OOl
Urinary metadrenalines 108.7 ± 12.7 190.9 ± 12.7 p><0 . OOl
(pmol/mol creatinine)
Urinary free cortisol 10.4 ± 1.2 13.3 ± 3.0
(pmol/mol creatinine)
Cortisol (nmol/l) 409 ± 40 318 ± 38
Androstenedione 
(nmol/l)
6.3 ± 0.5 6. 1 ± 0.5
DHAS (jrnol/1) 9.3 ± 0.5 9. 1 ± 0.8
Testosterone (nmol/l) 24.3 ± 1.8 21. 0 ± 1.9
SHBG (nmol/l) 33.6 ± 4.3 32.7 ± 4.3
Derived free
Testosterone (pmol/1) 390 ± 37 343 ± 30
FSH (U/l) 3.2 ± 0.5 2.8 ± 0.5
LH (U/l) 5.3 ± 0.6 6.2 ± 0.9
Prolactin (mU/1) 155 ± 38 71 ± 21
TABLE 10 Three other variables which have previously been 
described as influencing endocrine function in 
9 male university students.
SUBJECT SO. EXERCISE 
(mil es/week)
CIGARETTES
(cigs/day)
ALCOHOL
(Uni ts/week)
PRE POST PRE POST PRE POST
1 30 17 0 0 20 0
2 0 0 0 0 1 1
3 0 0 0 0 1 2
4 3 3 5 5 50 20
5 0 0 0 0 40 30
6 0 0 0 0 0 0
7 0 0 0 0 8 6
8 6 0 10 10 40 50
9 0 0 0 0 16 8
The subject is of some clinical relevance as it has been suggested that 
altered testosterone secretion with stress may contribute to the 
increased risk of coronary artery disease in subjects with Type A 
personalities (Henry, 1986). Until further studies have refuted these 
findings it should not be assumed that pure psychological stress 
depresses serum testosterone concentrations.
The timing of sample collection posed particular problems during 
this study. It was not considered practical to collect urine during the 
course of examinations themselves. Thus blood and urine samples were not 
obtained at the same time of day. It is possible that urine was collected 
prior to examinations when psychological stress may have been greater 
than following examinations when venesection was performed and when 
anxiety may have been waning.
The stress of examinations was reflected in an increase in urinary 
catecholamine excretion but serum and urinary cortisol concentrations 
were unaffected. Adaptation occurs more rapidly with cortisol; once the
stressful situation has lost its novelty, cortisol secretion may not
increase while catecholamine secretion remains responsive to stress 
(Rubin et al., 1970; Rose et al., 1969; Czeisler et al., 1976).
In clinical practice it is widely assumed that a raised prolactin 
level may be explained by psychological stress such as attendance at an 
out-patient clinic. When factors such as drugs, trauma, illness and
exercise are carefully excluded, the association between psychological 
state and prolactin levels is less clear (Brooks et al., 1986). The 
students studied in this chapter had a reduced prolactin level following 
examinations (p<0.05, not significant following Bonferroni correction). 
There are several possible explanations for this failure to find prolactin 
concentrations increasing with psychological stress. Firstly, prolactin 
secretion may not increase with pure psychological stress; secondly,
blood sampling may have been performed after the time of maximum anxiety
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and a prolactin peak may have been missed; thirdly, adaptation may occur, 
as in the case of cortisol secretion, so that only novel or acute stresses 
rather than familiar or chronic ones increase prolactin levels; finally, 
continued stimulation of prolactin secretion with prolonged psychological 
stress may have resulted in depletion of a readily releasable pool. The 
observation that prolactin levels of medical students were raised
immediately prior to examinations but fell to below control levels
immediately afterwards suggests that adaptation may occur (Johansson et 
al., 1983). Allen et al. (1985) found that both cortisol and prolactin 
levels were increased after a 15 minute oral examination but that there 
was no significant trend in prolactin levels with increasing 
psychological stress prior to examinations. However, novel stresses such 
as preparing for a first parachute jump have failed to elevate prolactin 
levels (Noel et al., 1976). Thus considerable doubt still remains as to 
whether prolactin secretion is affected by psychological stress.
The endocrine responses to stress associated with examinations seem 
to have little in common with the changes seen following marathon 
running or during illness. There is no evidence of adrenocortical 
activation or suppression of adrenal androgen secretion; pituitary- 
testicular function is not affected.
The studies described so far in this thesis have mainly involved
observation of endocrine changes with illness and other stressful
situations. The chapters which follow describe studies which were 
designed to study the mechanisms involved in these changes particularly 
with respect to pituitary-testicular function.
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CHAPTER 11
THE NATURE OF PROTEIN BINDING 
OF TESTOSTERONE IN BURNED PATIENTS
Changes in SHBG capacity following burns injury were closely 
mirrored by changes in SHBG concentration measured by 
immunoradiometric assay suggesting that low SHBG capacity is 
due to a fall in absolute concentration rather than an 
alteration in binding affinity. Burned men with low serum 
total testosterone concentrations also had low levels of 
free testosterone measured by equilibrium dialysis.
Introduction
The main abnormality leading to low T4 levels in ill patients is an 
alteration in the binding of T4 to its binding proteins so free T4 levels 
measured by equilibrium dialysis are not usually low. A similar 
abnormality might contribute to the low serum testosterone concentrations 
found in ill men. The SHBG capacity of burned men following admission 
was low; this might be due to changes in testosterone binding similar to 
those occuring between T4 and its binding proteins in ill patients. 
Indeed free fatty acids which have been proposed as the thyroid hormone 
binding inhibitor in the low T4 syndrome (Chopra et al., 1986) may reduce 
the binding of testosterone to SHBG and albumin (Mooradian, et al., 1988). 
Alternatively the increased protein breakdown occuring following burns 
injury may allow increased catabolism of SHBG and lead to fall in the 
absolute concentration of SHBG. To investigate whether the changes in 
serum SHBG capacity following burns injury were due to altered binding 
kinetics or a change in its absolute concentration, SHBG was measured by 
an immunoradiometric assay (SHBG-IA) as well as by the more usual
binding capacity method.
The free (non-protein bound) component of total testosterone is 
usually considered the physiologically active moiety as it is able to
pass intracellularly although Pardridge & Mietus (1979) found that
albumin binding did not inhibit transport of testosterone into rat brain 
cells and thus albumin bound testosterone may also be important. It is 
thus of interest to investigate whether free testosterone measured 
directly (rather than derived as in previous chapters in this thesis) is 
reduced to a similar extent to total testosterone. Accordingly free
testosterone levels were measured by equilibrium dialysis and compared 
with total testosterone and derived free testosterone levels.
Methods - Assays
The absolute concentration of SHBG (SHBG-IA) was measured using a 
non-competitive immunoradiometric assay (Farmos Diagnostica, Finland) in 
which a mouse 12BI-labelled anti-SHBG monoclonal antibody and rabbit 
anti-SHBG antiserum are added to the serum sample. Following incubation 
solid phase donkey anti-rabbit IgG antiserum is added. The mixture is 
then centrifuged with the resulting pellet containing radioactivity in 
proportion to the concentration of SHBG. The SHBG in the unknown sample 
is extrapolated after reference to a standard curve. The intra-assay and 
intei— assay coefficients of variation were 3.2 and 11.2 percent
respectively. SHBG capacity was measured as described in Chapter 2.
Equilibrium dialysis was performed with small aliquots of serum
using the Dianorm dialysis machine (Veber, Schildknecht & Kesselring,
1971). 200 pi of serum is injected into one half of a Teflon cell and is 
separated by a cellulose dialysis membrane (Spectropore 2 - Pierce, UK, 
Ltd) from H.E.P.E.S. buffer (N-2-Hydroxyethylpiperazine-N '-2-Ethane- 
sulphonic acid) pH Y.4 in the other side of the cell. The cells rotate in
the machine for 12 hours at 37 X  allowing equilibration of the unbound
testosterone with the buffer solution. The concentration of testosterone 
in the buffer side of the cell should be the same as the free
testosterone concentration in the serum sample at equilibrium.
Testosterone in the buffer solution is measured after ether extraction by 
radioimmunoassay with a second antibody separation system. The key to 
this procedure is the use of a high specificity, high sensitivity 
testosterone antiserum which was raised in sheep against testosterone-3- 
carboxymethyloxime linked to bovine serum albumin and was used with a 
testosterone-3-carboxymethyloxime-iodohistamine label (Vebb et al., 1985). 
This assay will measure free testosterone concentrations >10 pmol/1 and 
shows only significant cross-reactivity (12%) with 5a:-dihydro- 
testosterone. Results produced by this procedure were shown to be 
independent of the degree of sample dilution.
Methods - Patients studied
SHBG studies were performed on 17 burned men for whom sera was 
available from their first venesection after admission. 14 of these 
patients were also studied using sera from the venesection performed 
either in the third or fourth week after admission. Data were compared 
with results from 15 age-matched healthy men.
Serum testosterone, free testosterone by equilibrium dialysis and
the derived free testosterone concentrations were measured in 12 burned
men with low serum testosterone concentrations and in 13 age matched 
healthy men.
Results were compared using the Vilcoxon Rank Test for unpaired
data while correlation coefficients were calculated using the Spearman
Rank Test.
Results
The SHBG capacity of burned men on admission was 20.4 ±2.9 nmol/1 
increasing to 36.8 ±4.2 nmol/1 with recovery as compared with 33.5 ±3.1 
nmol/1 in the control group. The SHBG-IA concentrations of burned men on 
admission were 21.1 ±2.6 nmol/1 increasing to 33.4 ±3.4 nmol/1 with
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recovery at> compared with 30.5 ± 3.0 nmol/1 in the control group. There 
was no significant difference between the SHBG capacity and the SHBG-IA 
results in any of these groups. Correlation coefficients between the two 
methods were:- r=0.90, p<0.001 for all three groups combined, r=0.80, 
p<0.002 for the burned patients following admission and r=0.93, p<0.001 
for the control group. The relationship between SHBG capacity and SHBG-IA 
is shown graphically in Figure 15.
In burned men with low serum testosterone levels (0.3-10.1, mean 4.0 
nmol/1) the mean free testosterone concentration was not significantly 
different from the derived free testosterone (free testosterone
76.9 ± 21.7 v derived free testosterone 73.4 ± 15.6 pmol/1). Free
testosterone correlated significantly with total testosterone (r=0.78,
p<0.01) and derived free testosterone (r=0.69, p<0.05). In normal men the 
mean free testosterone concentration was not significantly different from 
the derived free testosterone (273 ±20 v 270 ± 26 pmol/1). Free
testosterone correlated significantly with total testosterone (r=0.71,
p<0.02) and derived free testosterone (r=0.65, p<0.05). The relationships 
between free testosterone and total testosterone and free testosterone 
and derived free testosterone are shown in Figure 16.
Discussion
SHBG when measured by immunoradiometric assay closely correlated 
with that measured by the binding capacity method. This study has 
demonstrated for the first time that the low SHBG level following burns 
injury is due to a genuine fall in the concentration of this binding 
protein rather than 'to a change in its affinity for testosterone. This 
contrasts with the situation in the low T4 syndrome where there is a fall 
in the affinity of binding proteins for T4 with little or no change in 
their absolute concentration. A reduction in the hepatic synthesis of SHBG 
would not be expected to result in such an early fall in its
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Figure 16 The relationship between free testosterone measured by 
equilibrium dialysis and total testosterone and derived 
free testosterone.
concentration. Burns injury is followed by an intense catabolic state and 
it is possible that this early fall after burns injury is due to increased 
metabolism of this protein. Alternatively the fall may be due to 
extravasation at the site of injury.
The finding that burned patients with low serum testosterone 
concentrations had low levels of free testosterone is also novel. The 
relationships between free testosterone and derived free testosterone 
were similar in ill patients and normal controls. This suggests that the 
normal relationship between testosterone and its binding proteins holds 
true in this context despite a fall in serum albumin concentrations (mean
37.5 ± 1.7 v 45.0 ± 1.3 g/1 in control group). Moll & Rosenfield (1979) 
found that changes in albumin concentrations within the normal range had 
little effect on testosterone binding and Dunn et al. (1981) calculated 
that it would require a reduction in serum albumin concentrations of 
around 65% for the free testosterone fraction to double.
The fall in total testosterone concentrations found following burns 
injury and probably in other pathological situations is likely to lead to 
a reduction in testosterone available to cells. The physiological 
consequences of this reduced tissue exposure to testosterone are 
uncertain.
CHAPTER 12
LH PULSATILITY STUDIES II KEH WITH CHROIIC REHAL FAILURE
The pulsatile nature of LH secretion was studied in six 
healthy and six uraemic men. Only two of the latter but all 
six healthy men had evidence of LH pulses. This difference 
may contribute to the low testosterone levels found in 
uraemia and raised the possibility that disordered LH 
pulsatility might account for the low levels found in other 
clinical situations.
Introduction
In chapter 3 it was shown that a low serum testosterone
concentration is a consistent feature in uraemic men irrespective of the
nature of renal dialysis therapy but the mechanism leading to this is
uncertain. Stimulation with human chorionic gonadotrophin (HCG) leads to 
an increase in serum testosterone concentrations in such men (Chen et 
al., 1970) but probably not to the same extent as in the healthy
(Holdsworth et al., 1977). The usually elevated LH levels would point to a 
primary testicular defect although these levels are often less high than 
one would expect if this were the sole mechanism. So there may be an 
additional abnormality of the hypothalamic-pituitary system in the 
uraemic state.
LH secretion in normal man has an intermittent quality (Nankin & 
Troen, 1971; Naftolin et alM 1972) probably due to the pulsatile release 
of LHRH by the hypothalamus (Carmel et al., 1976). If this varying 
pattern of LH secretion is abolished by the administration of LHRH 
agonists, serum testosterone concentrations fall to the range seen in 
castrated men even though absolute LH concentrations may remain within 
the normal range (Faure et al., 1982; St Arnaud et al., 1986). It seemed 
possible that uraemic men might lack normal LH pulsatility leading to 
less effective stimulation of testosterone secretion.
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It was decided therefore to investigate the mode of LH secretion in 
uraemic men to discover whether levels are constant or pulsatile in 
nature.
Methods.
Six uraemic men (age range 20-49 mean 34 years) who had been on 
dialysis (HD - 5, CAPD - 1) for 1-10 years and six age-matched healthy 
men were studied. In addition a 20-year old man known to have 
Klinefelter's syndrome but otherwise healthy was investigated to obtain 
an example of the LH pulse profile associated with a pure primary 
testicular defect.
Statistical analyses were performed using the Wilcoxon Rank test for 
unpaired data.
Methods - Pulsatility Studies
At 0900 hours on the day of study an indwelling venous cannula was 
inserted in the antecubital fossa and kept patent with 0.5 ml heparin 
solution (10 U/ml). 5 mis of blood were withdrawn every 15 minutes for 
six hours. Serum was stored at -20 “C prior to assay and all samples from 
the same individual were assayed in the same assay batch.
t
Pulse analysis was performed by a modification of the method of 
Santen and Bardin (1973). These authors defined a significant pulse as an 
increment from nadir to peak greater than 20 percent. Their sampling 
interval was 20 minutes but it has since been demonstrated that more 
pulses are detected if this is shortened (Crowley et al., 1985; Veldhuis 
et al., 1986). An interval of 15 minutes was chosen in order not to 
subject patients to the additional blood loss of more frequent sampling. 
To minimise the possibility of random changes in LH concentrations being 
labelled as a secretory pulse a significant peak had to include two 
points each with a nadii— to-peak increment of at least 20 percent.
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Results from each subject are expressed as the mean of all LH levels 
obtained, the number of pulses during each six hour study period, the 
inter pulse interval denoting the time in minutes between pulses and the 
mean amplitude of each subject's pulses. The amplitude was calculated by 
subtracting values from the preceding nadir from the mean of the two 
values constituting a peak, expressed both as a percentage and an 
absolute increment.
Results (Table 11)
The serum testosterone concentrations of the uraemic patients were 
less than those of the controls (13.1 ± 2.1 v 24.4 ± 4.4 nmol/l) although 
with the small numbers involved this did not reach statistical 
significance.
The mean LH level of all samples from each individual was greater 
in the uraemic subjects than controls (p<0.005). The patient with
Klinefelter's syndrome had similar raised values. LH pulsatility was 
demonstrated in all normal subjects but in only two of the six uraemic 
patients (p<0.02). The patient with Klinefelter's syndrome had LH pulses 
of greater amplitude than those of either groups.
The LH pulse profile of a normal man, a uraemic patient and the 
patient with Klinefelter's syndrome are represented in Figure 17.
Discussion
The normal controls had LH levels which were not constant but
variable with peaks every 90-120 minutes. The patient with Klinefelter's
syndrome also had' LH pulses which were of greater amplitude than those 
of either normal or uraemic subjects, a finding consistent with the
results of Winters and Troen (1983).
Uraemic patients appear to have less LH pulsatility than normal and 
certainly do not have the exaggerated pulsatility seen in patients with
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TABLE 11 LH pulsatility in uraemic and normal men and a patient 
with Klinefelter's syndrome. Values for LH, inter-pulse 
interval and amplitude are the mean for each pulse 
series. The testosterone value refers to a single 
estimation from the first sample taken during the 
pulsatility study.
TESTOSTERONE MEAN LH PULSES INTER-PULSE AMPLITUDE
(nmol/l) (U/l) per 6 hrs INTERVAL (mins) (%) (U/l)
Control subjects,
11.6 4.1 3 95 51 1.8
14.6 3.7 3 140 42 1.3
37.8 4.0 3 85 72 2.7
30.0 6.1 4 55 51 2.6
33.0 3.4 3 95 85 2.0
19.2 4.2 3 125 50 1.6
mean 24.4 4.3 3.2 99 58 2.0
Uraemic subjects
12.6 17.3 3 HO  39 5.7
17.8 6.4 2
4.9 13.5 0
19.4 13.6 0
11.8 9.6 0
12.3 18.4 0
mean 13.1 13.1
lt>5 29 2.0
0.8 142 34 3.8
(p<0.005) (p<0.02)
Klinefelter* s
10.2 17.3 120 H O  13.0
Normal control
LH
(U / l )
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3
2
120 180 240 300 360
LH
(U/l )
Renal Failure
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12 -
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Klinefelter's syndrome
30
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36030024018012060
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Figure 17 LH pulse profiles of three subjects: a normal man, a
patient with chronic renal failure and a patient with 
Klinefelter’s syndrome. Asterisks denote LH pulses.
pui e primary testicular failure. These results suggest the presence of a 
hypothalamic-pituitary abnormality. Other groups have investigated this 
subject. Rodger et al. (1985) published their study whilst my own was in 
its final stages. Their findings were essentially very similar. They 
compared six uraemic and six normal men finding 3.0 pulses per six hours 
in the former and 0.25 pulses per six hours in the latter with only one 
of the six patients having detectable pulses. They also demonstrated 
normal LH pulsatility in renal transplant recipients whose gonadal
function is known to be superior to that of uraemic men (Lim & Fang,
1975). Wheatley et al. (1987) found that seven of ten of their uraemic 
patients had pulses but with a mean frequency of only 1.0 in seven hours 
as compared with 3.3 in normal men.
It is appropriate at this stage to insert a note of caution in the 
interpretation of these findings. The reduced LH pulsatility of uraemic 
patients may not necessarily be due to impaired hypothalamic release of 
LHRH. LH metabolism is known to be inhibited in chronic renal failure 
(Holdsworth et al., 1977) and this might lead to elevated LH levels 
swamping LH secretory surges of normal amplitude. Whatever the mechanism 
the reduction of LH pulsatility may lead to loss of effective stimulation 
of testosterone secretion. Although intermittent release of LHRH seems to 
be critical for normal hypothalamic-pituitary-testicular function, it is
less certain that LH secretion requires to be pulsatile in order to 
stimulate testosterone secretion. Twice weekly intramuscular 
administration of LH in the form of HCG while effectively stimulating 
this secretion is likely to lead to constant rather than pulsatile LH 
concentrations. Thus although the constancy of LH concentrations of 
uraemic men may be a marker of a hypothalamic abnormality it is not 
necessarily the sole explanation for the hypogonadism seen in these
patients.
-107-
The finding of altered LH pulsatility in these patients raised the 
possibility that hypothalamic-pituitary dysfunction might contribute to 
the low testosterone levels associated with other types of illness.
The following chapter describes my more detailed observations on 
hypothalamic-pituitary-testicular function of burned men including an 
assessment of LH pulsatility similar to that detailed in this 
chapter.
CHAPTER 13
AH IHVEST IGATIOH OF THE HECHAHISHS LEADIHG TO 
LOV SERUM TESTOSTEROHE COHCEHTRATIOHS IH BURHED MEH
Five of six burned men showed a normal response of serum 
testosterone to HCG stimulation. Five had a normal LH 
response to LHRH with one having an exaggerated response.
Three showed an impaired FSH response to LHRH. LH 
pulsatility was variable with two patients having no pulses.
LH biological activity of burned men with low serum 
testosterone concentrations was less than that of healthy 
men and of the same patients when testosterone levels had 
returned to normal. Changes in LH pulsatility and biological 
activity may be factors leading to low testosterone 
concentrations.
Introduction
A low serum testosterone concentration seems to be an inevitable 
consequence of a clinically significant burn (Chapter 6). This could not 
be explained on the basis of an alteration in the levels of LH, changes 
in SHBG capacity nor by hyperprolactinaemia. Burns injury provides a 
suitable model for study of the mechanisms leading to the low 
testosterone state associated with illness because the abnormality is so 
profound and persistent. In addition because those patients with 
relatively minor burns are thus affected it is possible to study patients 
who are ambulant, otherwise healthy and who have good venous access.
The finding of reduced LH pulsatility in uraemic subjects (Chapter 
12) raised the possibility that altered hypothalamic-pituitary function 
might contribute to the low serum testosterone levels found in patients 
with chronic renal failure and possibly other illnesses. Lack of 
pulsatility of LH levels in uraemic patients might be related to altered 
metabolism of LH in this condition (Holdsworth et al., 1977) rather than 
to hypothalamic-pituitary dysfunction. I therefore decided to investigate
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in detail the hypothalamic-pituitary-testicular axis of burned patients 
with normal renal function.
Methods.
During the second week following burns injury seven men underwent 
studies of LH pulsatility. Prior to pulsatility testing all had been found 
to have a subnormal serum testosterone level. To assess pituitary 
responsiveness to appropriate stimulation LHRH testing (as decribed in 
Chapter 2) was performed on completion of the pulsatility study. 
Thereafter an HCG stimulation test was carried out (as decribed in 
Chapter 2). One patient declined to undergo the LHRH and HCG tests. 
Although all patients studied had a low serum testosterone level at some 
stage after burns injury, one patient had a level within the normal range 
at the time of study. The age, surface area of burn, the minimum serum 
testosterone and the serum testosterone (testo) concentrations on the day 
of the pulsatility study are illustrated as follows:-
AGE SURFACE TESTO (day after burn) TESTO (day of study)
(years) AREA (nmol/l) (nmol/l)
20 20% 4.5 (day 3) 12.6 (day 14)
51 19% 0.5 (day 1) 2.3 (day 7)
60 4% 2.6 (day 14) 2.6 (day 14)
25 10% 5.1 (day 2) 8.2 (day 10)
30 20% 1.7 (day 7) 1.7 (day 7)
36 14% 1.0 (day 7) 1.0 (day 7)
33 15% 2.0 (day 3) 4.5 (day 10)
To analyse the biological potency of LH eight burned men were 
studied and compared with eight age matched healthy men. Sera were
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available at a time when serum testosterone levels were low and later 
when these had recovered towards the normal range.
Results
The data from the HCG stimulation tests are shown graphically in 
Figure 18. A normal capacity of the testes to secrete testosterone in men 
with low serum testosterone concentrations is usually accepted when 
levels double and reach the normal range by day 5 (Anderson et al.,
1972). Five patients showed a normal response while one showed no
response whatsoever.
LHRH stimulation tests are shown in Figure 19. The shaded area 
demonstrates the the range of responses found in ten healthy men (Semple 
et al., 1982d). Five patients showed a normal LH response to LHRH with 
one showing an exaggerated response. This patient had a serum 
testosterone concentration of 1.0 nmol/l and a very low mean LH of 1.0
U/l through the pulsatility study. Three patients had a reduced FSH
response.
An analysis of LH pulsatility is shown in Table 12. Six of the seven 
burned patients had very low serum testosterone concentrations at this 
stage of the investigation and these are considered together. The 
remaining patient had a level within the normal range at the time of
study although a previously measured serum testosterone concentration had 
been unequivocally low (4.5 nmol/l). As this patient seemed to have 
entered a recovery phase his results were considered separately. The six 
with low serum testosterone levels had significantly fewer pulses than 
normal controls (p<0.02) although they were similar with regard to mean 
LH levels. Pulses when present were similar in character to those of the 
controls. The patient whose serum testosterone level had already 
recovered had a normal pulse frequency but increased amplitude. The LH 
pulse profiles of a normal man, a burned patient with a low serum
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TABLE 12 LH pulsatility in burned and normal men. Values for LH, 
inter-pulse interval and amplitude are the mean for each 
pulse series. The testosterone value refers to a single 
estimation from the first sample taken during the 
pulsatility study.
TESTOSTERONE LH PULSES INTER-PULSE AMPLITUDE
(nmol/l) (U/l) per 6 hours INTERVAL (mlns) (%) (U/l)
Control sub/lects
11.6 4.1 3 95 51 1.8
14.6 3.7 3 140 42 1.3
37.8 4.0 3 85 72 2.7
30.0 6.1 4 55 51 2.6
33.0 3.4 3 95 85 2.0
19.2 4.2 3 125 50 1.6
24.4 4.3 3.2 99 58 2.0
Burned subjects.
2.6 4.1 0
2.3 5.8 3 95 39 1.9
1.7 5.1 2 100 72 2.7
mean
8.2 5.5 1
4.5 3.8 1
1.0 1.0 0
mean
Burned subject. 
recovery phase
58 2.9
250 4.0
3.4 4.2 1.2 98 105 2.9
(p<0.005) (p<0.02)
12.6 12.1
90 82 7.6
Testosterone 
( nmol/l)
30
20 _
Day 1 Day 5
Figure 18 Serum testosterone responses of six burned men to HCG 
stimulation. The shaded area represents the range of 
serum testosterone concentrations of 19 healthy men.
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Figure 19 Serum FSH and LH responses of six burned men to the 
intravenous injection of LHRH expressed as an increment 
over basal values (A). The shaded area represents the 
range of responses found in 10 healthy men.
testosterone level and the burned patient who had entered a recovery 
phase are shown in Figure 20.
LH bioactivity data are shown in Figure 21. The serum testosterone 
concentrations of these eight patients increased from 2.4 ± 1.0 nmol/l to
15.6 ±2.1 nmol/l. LH measured by radioimmunoassay (LH-RIA) showed no 
significant change <6.2 ± 1.3 v 6.4 ± 1.3 U/l). LH measured by bioassay 
(LH—BIO) increased but not in a statistically significant manner (17.3 ± 
2.7 v 23.1 ±3.3 U/l). It is widely accepted that LH biological activity is 
more appropriately expressed in terms of the B:I ratio (LH-BIO 4- LH-RIA) 
(Varner et al., 1985; St-Arnaud et al., 1986). The B:I ratio was 
significantly lower in the burned patients with low serum testosterone 
concentrations (3.2 ± 0.6) than in the control group (4.4 ± 0.5, p<0.005) 
or indeed in the same patients following recovery (4.2 ± 1.0, p<0.02).
Discussion
Five of six patients showed brisk responses to HCG suggesting that 
the testes in this situation are able to react normally to appropriate 
stimuli. Dolecek et al. (1979a) found that some patients with particularly 
severe burns failed to respond to HCG. The complete absence of a response 
in one subject is difficult to explain as this patient was not exceptional
with regard to the severity of his burn (14%).
There was a normal LH response to LHRH in most patients suggesting 
a satisfactory secretory reserve of LH. It is interesting that the single 
patient with the exaggerated response had a very low level of LH before 
LHRH stimulation. This raises the possibility that LH may be synthesised 
and stored but not released in some burned patients reminiscent of the 
situation in men following head injury (Clark et al., 1988). Basal FSH 
levels had been shown to be depressed in Chapter 6. Three patients
showed subnormal FSH responses to LHRH. This may be of relevance to the
disruption of the germinal epithelium described by Dolecek et al. (1983)
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Figure 20 LH pulse profiles of three subjects: a normal man, a
burned patient with a low serum testosterone
concentration (2 nmol/l) and a burned man whose serum 
testosterone concentration had returned to within the 
normal range. Asterisks denote LH pulses.
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Figure 21 Serum testosterone concentrations, LH concentrations by 
radioimmunoassay (LH-RIA) and LH biological activity (B:I 
ratio) of eight men during the early and late weeks 
following burns injury.
in post-mortem specimens of severely burned men. In vitro work using 
cultured porcine Leydig cells has suggested that FSH may stimulate the 
Sertoli cells of the testis to secrete proteins which enhance the action 
of LH (Benahmed et al., 1985). The low FSH levels found in burned men 
could also contribute to the inhibition of testosterone secretion.
The literature on LH pulses in illness is scanty. Warren et al.,
1977) failed to observe any variation in LH concentrations during serial 
LH sampling of two ill post-menopausal women. Reduced LH pulsatility has 
been described in conditions such as hyperprolactinaemia (Winters & 
Troen, 1984) and amenorrhoea related to weight loss (Reame et al., 1985) 
but not in non-endocrine disorders until recent work demonstrating
reduced pulse frequency in men with chronic renal failure (Rodger et al., 
1985; Wheatley et al., 1987) and liver disease (Bannister et al., 1986). 
Neither of these latter conditions are ideal models for the study of 
gonadal function in non-endocrine disorders because both result in 
altered sex hormone metabolism (Holdsworth et al., 1977; Gordon et al., 
1975).
LH levels of burned patients with low serum testosterone 
concentrations were less pulsatile than LH levels of controls. When these 
data were published (Seraple et al., 1987c), they were the first 
description of LH pulsatility in non-endocrine disease other than renal 
and kidney failure. Some readers objected to ray interpretation of the 
data because of the exclusion of the patient whose serum testosterone
concentration had risen to within the normal range at the time of the
pulsatility study. If all seven patients were compared with the control 
group the difference in LH pulsatility would have failed to reach 
statistical significance. I considered that my analysis of the data was 
justified because the initial aim of the study was to examine LH 
pulsatility in burned men with low serum testosterone levels and I 
therefore considered it acceptable to exclude from analysis the patient
-113-
with the normal serum testosterone concentration. What is certainly true 
is that some burned patients have absent LH pulsatility although some 
may pulse normally. It may be that soon after burns injury these patients 
all pass through a stage of reduced LH pulsatility which after a variable 
time interval gradually recovers. The heterogeneous nature of these 
results may merely reflect the stage at which sampling occurs.
The realisation that the detection of LH in serum by radio­
immunoassay is not synonymous with biological activity is relatively
recent (Dufau et al., 1983). B:I ratios are higher during an LH peak than
a nadir (Dufau et al., 1983; Veldhuis et al., 1983). Warner, Dufau & Santen 
(1985) found a reduced B: I ratio in 20 ill men who had LH and
testosterone levels similar to a control group. Although there was a
reduced LH B:I ratio in burned men in my own study, this change was
small in comparison with the fall in serum testosterone concentrations. 
It is not clear what a modest reduction in LH bioactivity, as measured 
using mice Leydig cells in vitro, means in the human subject. Thus while 
it is premature to suggest that low biological potency of LH is a major 
factor leading to low serum testosterone levels, it is tempting to assume 
that it may at least contribute.
Burns injury provides a suitable model for the study of endocrine 
changes following non-endocrine illness. The available evidence points to 
an abnormality at the level of the hypothalamus and/or pituitary leading 
to secretion of LH of reduced biological potency and with reduced 
pulsatility.
The study which follows describes a more detailed investigation of
LH biological activity and pulsatility and their relationship to
testosterone levels in burned men.
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CHAPTER 14
A FURTHER INVESTIGATION OF LH PULSATILITY IN BURNED MEN
Further pulsatility studies using a 10 minute sampling interval were 
performed in six burned patients and compared with data from 11 
normal men. All samples were assayed for LH-BIO, LH-RIA and 
testosterone. There was no significant difference in frequency of 
bioactive or immunoreactive pulses although one burned patient had 
no pulses. In normal men the B:I ratios were higher at a pulse peak 
than at the nadir and an increase in serum testosterone levels 
usually followed an LH peak. In burned men B;I ratios were lower at 
a pulse peak than a nadir and an increase in the serum testosterone 
concentration did not usually follow an LH peak.
Introduction
When my paper entitled "Mechanisms leading to hypogonadism in 
burned men" was published in 1987 (Semple et al., 1987c), it was the 
first such study in burned men and indeed was the first paper to include 
an assessment of both LH pulsatility and biological activity in ill men. 
B:I ratios are higher during an LH peak than during an inter-pulse 
interval in normal subjects (Dufau et al., 1983; Veldhuis et al., 1983) and 
the low B: I ratio described in burned patients with low serum 
testosterone concentrations in Chapter 13 might merely reflect reduced LH 
pulsatility. I therefore decided to investigate LH levels by both 
radioimmunoassay (LH-RIA) and bioassay (LH-BIO) through the whole 
sampling period.
Lincoln (1977) demonstrated a temporal association between LH and 
testosterone peaks. More recently Veldhuis et al. (1987) demonstrated 
testosterone pulses in men at a mean frequency of 3.3/6 hours with a mean 
amplitude of 8.4 nmol/l. Testosterone pulses correlated with LH pulses 
with a time lag of between 50 and 70 minutes. Testosterone levels were 
therefore measured through pulse profiles to investigate whether
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testosterone peaks were present and whether they had any temporal 
relationship to LH peaks.
Assessment of the increasing literature on methods of pulse 
detection led me to question some of my earlier methodology. Veldhuis et 
al. (1983) in their earlier studies had used a sampling interval of 20 
minutes but in their later work demonstrated that pulses were 
increasingly likely to be missed as the sampling interval increased 
beyond five minutes (Veldhuis et al., 1986). The sampling interval was 
therefore decreased to 10 minutes as a compromise between the ideal 
study design and patients' comfort and health. Over the last few years a 
perplexing array of methods for pulse analysis have been developed 
(Crowley et al., 1985). Manual methods compare favourably with complex 
computerised systems and have the advantage that the presence or absence 
of a pulse can be checked by visual inspection (Reame et al., 1984). Vith 
the increasing trend in the literature to more precise methods of pulse 
analysis, a further modification (Tsatsoulis et al., 1989) of the method 
of Santen & Bardin (1973) was employed and is described in the Methods 
section.
Methods - Subjects
The characteristics of the burned men are described as follows
Age Surface mean serum testosterone day after burn
(years) area during sampling period (nmol/l)
31 10% 7.4 daY 19
25 15% 12.9 day I4
4.3 day 10
1.5 day 25
7 .4 clay 23
6.6 day 25
29 23%
24 60%
21 18%
21 20%
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11 normal men (age range, 20-40 years, mean age 27 years) were 
studied. As mentioned in the Declaration, studies on normal men were not 
carried out by the author in person. Values were derived from Talbot et 
al. (in press). All samples were, however, treated in the same manner and 
all assays were carried out in the same laboratory.
Methods..- Blood Sampling and Assays
Pulsatility studies were carried out on six burned men and 11 
normal controls using a six hour sampling period between 1400 and 2200 
hours. Vhen this study was being performed there was some doubt about
the stability of LH as measured by bioassay although it has since been
demonstrated to be unaffected by temperature changes or by being left at 
room temperature for several hours (Lambert et al., 1986). Samples were 
collected as described in Chapter 12 except that blood was withdrawn 
every 10 minutes and transferred into Lithium Heparin tubes on ice and 
centrifuged with plasma being snap frozen and stored at -20°C until
hormone assay.
All samples were assayed in duplicate for LH-RIA, LH-BIQ and 
testosterone so that a mean coefficient of variation could be calculated 
for each set of samples from each patient. All samples from a subject 
were assayed in the same assay.
The LH bioassay is described in Chapter 2. Although the radio­
immunoassays of testosterone and LH were carried out in a different
laboratory, they were essentially the same as those described in Chapter 
2. (The LH tracer was obtained from the Chelsea Hospital for Women. The 
tracer used in the testosterone assay was testosterone-3-0- 
(carboxymethyl)— histamine-1 aB I [AmershamD. The intra-assay and inter 
assay coefficients of variation for LH were 5.3% and 6.1% respectively. 
The intra-assay and inter-assay coefficients of variation for the 
testosterone assay were 3.8% and 7.1% respectively.
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Methods - Pulse Definition
A pulse was detected if there were at least two points greater than
the preceding nadir by at least three times the mean intra-assay
coefficient of variation for the samples in that pulse profile. Each peak 
also had to have a descending limb (Tsatsoulis et al., 1989). A 
testosterone peak was defined in a similar manner with the additional 
criterion of a minimum increment from nadir to peak of )2nmol/l.
Results
Serum testosterone concentrations of the burned patients were lower 
than controls <6.7 ± 1.5 v 19.6 ± 2.4 nmol/1, pCO.Ol). Mean LH-BIO levels 
were 12.5 ± 1.7 U/l in burned patients as compared with 11.9 ±1.3 U/l in 
the controls. Mean LH-RIA levels were 6.3 ± 0.9 U/l compared with 4.7 ±
0.5 U/l (MS). LH-RIA levels were lower than LH-BIO in all samples.
There was no significant difference in LH pulsatility between the 
two groups. Examples of pulse profiles of normal men are shown in 
Figures 22 and 23 and of burned men in Figures 24, 25 and 26. LH 
secretion was pulsatile in all normal subjects with 23 bioactive (mean 
2.1/6 hours) and 19 immunoreactive pulses (mean 1.7/6 hours) detected. In 
burned men there were 13 bioactive (mean 2.2/6 hours) and 12 
immunoreactive pulses (mean 2.0/6 hours). One patient showed no 
pulsatility. All Immunoreactive pulses were synchronous with bioactive 
pulses. Frequency, amplitude, fractional amplitude and interpulse intervals 
of bioactive and immunoreactive pulses were similar in both groups and 
are shown in Tables 13 and 14.
The mean B:I ratio was greater (p<0.01) in normal subjects (2.6 
± 0.2) than in burned patients (1.9 ± 0.1). In normal subjects the B:I 
ratios were higher (p<0.01) at pulse peaks than at the nadirs (2.9 ± 0.2 
v 2.2 ± 0.1). In contrast B:I ratios of burned men were lower <p<0.01) at 
pulse peaks than at the nadirs (1.8 ± 0.1 v 2.0 ±0.1). The changes in
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TABLE 13 Characteristics of bioactive LH (LH-BIO) pulses. Values 
for testosterone, LH-BIO, inter-pulse interval and 
amplitude are the mean for each pulse series.
TESTOSTERONE LH-BIO PULSES INTER-PULSE AMPLITUDE
(nmol /I) (U/l) per 6 hrs INTERVAL (mins) (%) (U/l)
Control subjects
16.3 8.9 1 — 142 8.6
16.1 21.3 3 60 88 14.4
10.9 11.1 3 105 71 5.6
11.5 13.5 3 135 86 8.2
10.9 7.1 2 170 123 11.8
14.3 6.8 1 — 116 5. 0
23.9 9.7 2 190 45 3.6
25.9 11. 0 1 — 48 4.2
35.5 19.3 2 140 67 10. 0
23.9 12.9 2 160 95 9.6
25.9 15.3 3 120 68 8.4
mean 19.6 12.5 2.1 135 86 8. 1
Burned, subjects.
4.3 10.4 2 200 33 3. 1
12.9 16.6 1 — 62 9.2
1.5 11.4 4 80 35 3.4
7.4 18.0 4 90 84
10.6
6.7 8.3 2 80 101 6.3
7. 4 6.5 0
mean 6.7 11.9 2.2 112
63 6.5
(p<0.01)
TABLE 14 Characteristics of immunoreactive LH (LH-RIA) pulses.
Values for testosterone, LH-RIA, inter-pulse interval 
and amplitude are the mean for each pulse series.
TESTOSTERONE LH-RIA PULSES INTER-PULSE AMPLITUDE
(nmol/l) (U/l) per 6 hrs INTERVAL (mins) <%> (U/l)
Control subjects
mean
16.3 3.2 1 —  135 3.7
16.1 4.9 2 150 78 5.5
10.9 3.4 2 100 153 3.5
11.5 5.5 2 200 119 6.3
10.9 4.9 2 190 96 3.3
14.3 2.8 1 —  98 2.0
23.9 4.7 1 —  73 2.5
25.9 4.6 1 —  38 1.5
35.5 5.7 2 140 63 2.9
23.9 5.6 2 160 81 3.5
25.9 5.9 3 115 55 2.8
19.6 4.7 1.7 150 90 3.4
Burned sub.iecta
4.3 5.2 2 190 60 2.7
12.9 9.3 1 “  78 7,1
1.5 6.7 4 80 66 3.4
7.4 8.2 4 100 95 5.1
6.7 4.6 1 “  185 6’°
7.4 3.5 0
mean 6.7 6.3
(p<0.01)
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Figure 22 LH and testosterone pulse profiles of a normal man.
LH-BIO denotes LH measured by bioassay and LH-RIA denotes 
LH measured by radioimmunoassay. Asterisks indicate 
pulses.
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Figure 23 LH and testosterone pulse profiles of a normal man.
LH-BIO denotes LH measured by bioassay and LH-RIA denotes 
LH measured by radioimmunoassay. Asterisks indicate 
pulses.
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F i g u r e  24 LH and testosterone pulse profiles of a burned man.
LH-BIO denotes LH measured by bioassay and LH-RIA denotes 
LH measured by radioimmunoassay. Asterisks indicate 
pulses.
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Figure 25 LH and testosterone pulse prof ilea of a burned man.
LH-BIO denotes LH measured by bioassay and LH-RIA denotes 
LH measured by radioimmunoassay. Asterisks indicate 
pulses.
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Figure 26 LH and testosterone pulse profiles of a burned man.
LH-BIO denotes LH measured by bioassay and LH-RIA denotes 
LH measured by radioimmunoassay. Asterisks indicate 
pulses.
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Figure 27 Mean bioactive LH (LH-BIO), immunoreactive LH (LH-RIA) 
and LH B: I ratios of burned patients and normal controls 
synchronised with time point zero given to the pulse 
peak.
mean LH BIO, LH-RIA and B:I ratios through the pulses were synchronised 
with time point zero given to the pulse peak and are shown graphically in 
Figure 27. In normal men LH-BIO increased from 11.5 ± 2.3 U/l at -40
minutes to 18.7 ± 1.6 U/l at zero minutes; LH-RIA increased from 4.9 ± 1.0 
U/l to 6.6 ± 0.5 U/l; and B:I ratios increased from 2.4 ± 0.1 to 2.9 ±0.2 . 
In burned men LH-BIO increased from 12.1 ± 1.1 U/l to 17.0 ± 1.8 U/l; LH-
RIA increased from 6.3 ± 0.8 U/l to 9.7 ± 0.9 U/l; and B:I ratios
decreased from 2.0 ± 0.1. to 1.8 ± 0.1
Testosterone pulses were seen in all normal subjects studied (range 
2-3/6 hours). All but three were associated with an LH-BIO peak (mean 
time lag 40 minutes). The mean incremental amplitude was 6.1 nmol/1 
(range 3.1-9.3 nmol). Only two testosterone peaks were detected in the
six burned men (incremental amplitude 4.3, 4.9 nmol/1) both being
associated with an LH peak (time lag 40, 70 minutes). The relationship 
between LH and testosterone in normal men and in burned men is 
illustrated in Figures 22-26.
Discussion
This study is unprecedented in the literature as it has examined 
both LH-BIO and LH-RIA through pulse series in burned men. Previous 
authors have only studied LH-RIA in patients with either chronic renal 
failure (Rodger et al., 1985; Wheatley et al., 1987) or liver disease 
(Bannister et al., 1986). The low B:I ratio described in burned men in the 
previous chapter has been confirmed but has been shown not to be due to 
a reduction in LH pulse frequency.
The method for pulse analysis used in this study improves on that 
used in Chapters 12 and 13 in which an increment of 20% between the 
nadir and peak was required before assigning a pulse. This took no 
account of the precision of the assay used in each sampling series. The 
intra-assay coefficient of variation mentioned in Chapter 2 is given as
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3.1% but this takes no account of changes in precision on a day to day 
basis. Measuring all samples in duplicate allowed an intra-assay
coefficient of variation to be calculated for each sampling series. Three 
times the intra-assay coefficient of variation was used to signify a 
peak; this is a widely used parameter and should mean that the chances of 
detecting a true peak do not vary from day to day and assay to assay.
It was felt necessary to require an increment of >2 nmol/1 in serum 
testosterone concentration in addition to the standard definition of three 
times the intra-assay CV before assigning a peak. This is rather
arbitrary but was considered necessary because of the low serum
testosterone levels in burned men. The mean CV of serum testosterone
concentrations for all pulse series was 4.9% (range 3.6%-7.3%). Using the 
standard pulse definition without the )2 nmol/1 stipulation would have 
resulted in an increase of serum testosterone concentration of (0.3 nmol/1 
being labelled a peak in one patient. The testosterone peaks detected in
normal men all had an increment )2nmol/l (range 3.1-9.3 nmol/1) using the
standard pulse definition.
In contrast to the study in Chapter 13 there was no significant 
difference in LH pulsatility between burned patients and normals. In both 
studies there was a heterogeneous pattern in burned patients with one or 
two patients in each group having absent pulsatility a finding not found 
in normal subjects. The study described in this chapter was carried out 
rather later (mean 19, range 10-25 days) after burn injury than the study 
in Chapter 13 (mean 10, range 7-14 days). The timing of LH pulsatility
investigations had not appeared critical as the initial studies on burned
patients in Chapter 6 had demonstrated suppression of serum testosterone 
concentrations for at least five weeks after burns injury.
Different patterns of LH and testosterone pulsatility were found in 
burned patients. A single patient showed no peaks of LH or testosterone 
(Figure 24). Three patients showed LH but not testosterone peaks (eg
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Figure 25). Two patients showed LH peaks with a single testosterone peak 
(eg Figure 26). It is possible that there is a more consistent depression 
of LH pulsatility in the early days after injury with recovery occurring 
in a variable manner. This could only be clarified by sequential 
pulsatility studies which would not be compatible with patient care. More 
consistent findings might have been obtained if patients had been sampled 
within one week of injury but again considerations of patient care often 
require these studies to be delayed.
LH-BIO levels were consistently higher than LH-RIA levels in all 
subjects a finding in common with other authors (Dufau et al., 1983; 
Warner et al., 1985). The value for the LH B:I ratio in plasma has been
found to vary from 0.7 to 7.0 depending on which reference preparation is
employed as standard in the bioassay (Lichtenberg et al., 1983). The
absolute value of LH B:I ratio is by itself of little significance but a 
change gives useful information if the same standard is employed
throughout a study (Robertson et al., 1987) as was the case in this study 
and in those described in Chapters 12 and 13.
Pulse profiles of burned men differed from normal in two ways. The
biological activity as expressed as the B:I ratio was lower at the pulse
peak than at the nadir. The reverse was true in normals, in agreement 
with Dufau et al. (1983) and Veldhuis et al. (1983). LH pulses were 
usually followed by surges of testosterone in normal men but this only 
happened twice in burned men. These differences suggest that either the 
testes of burned men are refractory to stimulation by an LH secretory
episode or that the LH secreted at the pulse peak is qualitatively
abnormal and is unable to stimulate testosterone secretion. The fact that 
most burned men seem to respond normally to HCG might suggest that the 
testes are not refractory to stimulation. However this test uses 
pharmacological doses of HCG and and may not reflect normal physiology.
This study has confirmed the low B:I ratio of LH following burns 
injury. This is not due to reduced LH pulse frequency. LH secreted in a 
pulse in burned men has a lower B:I ratio than that secreted during an 
inter-pulse interval, a finding that contrasts with normal men. The LH 
thus secreted seems to be unable to promote testosterone secretion.
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CHAPTER 15
COHCLUSIONS
This thesis has demonstrated that low serum levels of androgens of 
both testicular and adrenocortical origin are commonly found during 
illness. These changes seem to be specific to illness and cannot be 
attributed to associated psychological disturbance. Indeed the androgenic 
milieu associated with exercise and psychological stress showed few 
similarities to that associated with illness. It may be that tissue injury 
is a prerequisite for the profound changes in serum androgen levels 
described in various clinical situations in this thesis. Although Hans 
Selye (1946) considered the anterior pituitary gland to be central to "the 
general adaptation syndrome", many endocrine changes with illness are not 
readily explained by altered secretion of known pituitary hormones.
Hypothalamic-pituitary-testicular axis
While investigating this endocrine system abnormalities of 
hypothalamic-pituitary function were identified as possible important 
factors leading to low testosterone levels. What factors specific to 
illness might result in hypothalamic-pituitary dysfunction?
Hyperprolactinaemia may abolish the pulsatility of LH secretion 
(Winters & Troen, 1984) and cause male hypogonadism but the prolactin 
levels required are much higher (Carter et al., 1978) than those found in 
either ill patients or athletes.
Cortisol excess is known to have an adverse effect on this axis. 
Patients with Cushing's syndrome often have low testosterone 
concentrations but in association with low gonadotrophin levels (Luton et 
al., 1977). Acute administration of exogenous corticosteroid leads to a 
fall in serum testosterone levels without any change in serum LH levels
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(Cumraing et al., 1983). However long term administration of corticosteroid 
only depresses testosterone levels by around 40 percent (Reid et al., 
1985). An adverse effect of raised corticosteroid activity on this axis is
unlikely to account for the often prolonged and profound depression of
serum testosterone concentrations in ill patients but may be responsible 
for the small reduction found in association with very high serum 
cortisol levels at the end of a marathon run.
Administration of an opiate antagonist such as naloxone to normal 
men results in enhanced LH pulsatility (Grossman et al., 1981) implying 
that endogenous opioid tone in normal man suppresses LH pulsatility. 
Increased levels of endogenous opioid peptides which have been reported 
with exercise (Colt et al., 1981; Farrell et al., 1982) might lead to 
reduced LH pulsatility thus contributing to the low serum testosterone 
levels found following prolonged exertion. However the available evidence 
suggests that LH pulsatility is normal in this situation (McColl et al., 
1989) and indeed there is some doubt whether endogenous opioids are
indeed increased (Elias et al., 1986). Preliminary data suggest that 
elevated levels of endogenous opiates are found following burns injury 
only when complicated by septicaemia (Elliot et al., 1985) whereas very 
low serum testosterone concentrations and disordered LH pulsatility are 
found in uncomplicated burned patients. The techniques required to
measure these peptides are complex and still evolving and it is possible 
that additional endogenous opiates not measurable by current techniques 
might be increased in this situation. Moreover normal levels in the 
circulation do not exclude the possibility of raised levels in the 
environment of the hypothalamus and pituitary.
Raised plasma catecholamine concentrations following head injury 
were found to be inversely related to low serum testosterone 
concentrations (Woolf et al., 1986) but such association does not 
necessarily imply causality. An adrenaline infusion has been shown to
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lower testosterone production rates in man although the mechanism for 
this was not explored (Levin et al., 1967). The catecholamine dopamine 
reduces LH levels when infused intravenously into volunteers (Leblanc et 
al., 1976) but when this experiment was repeated using physiological 
rather than pharmacological doses of dopamine no effect was found 
(Connell et al., 1984). It is possible that raised catecholamine levels 
alter the pulsatile nature of LH secretion and might exert a testosterone 
lowering effect but there is no evidence in the literature to support 
this.
Definite evidence of reduced LH pulsatility was found in uraemic men 
and in some men following burns injury. The heterogeneity of response in 
burned men suggests that some patients might have been sampled while 
their LH pulse generator was recovering but before their hypothalamic- 
pituitary-testicular axis had returned completely to normal.
My finding of low LH B: I ratios in burned men with low serum 
testosterone concentrations has since been confirmed (Plymate et al., 
1987). The study described in Chapter 13 had suggested that this might 
merely reflect reduced LH pulsatility as biologically rich LH is secreted 
preferentially in LH peaks (Dufau et al., 1983; Veldhuis et al., 1983). 
However my later pulsatility study demonstrated that LH pulses are 
heterogeneous rather than uniformly diminished and it was not possible to 
attribute the low LH B:I ratios to reduced LH pulsatility. It is possible 
that the low LH B:I ratios might be a consequence of low serum 
testosterone levels rather than a cause but men with primary testicular 
failure seem to have high LH B: I ratios returning to normal with 
testosterone replacement therapy suggesting that this is unlikely to be 
the case (Tsatsoulis et al., 1990).
What mechanisms might exist to account for the alteration in 
biological activity of LH? This glycoprotein in man is synthesised and 
secreted in several distinct forms each with different biological activity
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(Strollo et al., 1981; Reader, et al., 1983; Lichtenberg et al., 1984; 
Snyder et al., 1989). This heterogeneity is not caused by changes in the 
amino acid sequence of the a or J3 chains but to variations in the nature 
of the carbohydrate moieties of the hormone (Green & Baenziger, 1988). 
The presence of these sugars may be important for activity of polypeptide 
hormones. Deglycosylation of a subunits prior to recombination of the a 
and subunits resulted in a glycoprotein with increased receptor binding 
but with no response from the target cell (Sairam & Bhargavl, 1985). 
Matzuk et al. (1989) using mutant cell lines secreting HCG dimers with 
different oligosaccharides attached found that dimers lacking 
oligosaccharides on the a chain had reduced biological activity and 
indeed some forms of HCG acted as a competitive inhibitor binding to the 
HCG receptor but blocking production of cyclic AMP by native HCG.
LH of increased biological activity is secreted at a pulse peak in 
normal men and in men with hypogonadotrophic hypogonadism whose LH 
pulsatility is restored by LHRH therapy (Dufau et al., 1983; Tsatsoulis et 
al., 1989). Low but not pharmacological doses of exogenously administered 
LHRH stimulate release of biologically rich LH (Veldhuis, Johnson & Dufau, 
1987). In vitro LHRH stimulates subunit glycosylation in pituitary cells 
from castrated rats (Krummen & Baldwin, 1988). LHRH increases the 
glycosylation of LH released from quartered rat anterior pituitary glands; 
moreover the carbohydrate content of LH released in response to LHRH 
differs from that released in its absence (Liu & Jackson, 1978). Thus in 
vivo and in vitro evidence exists to suggest that LHRH may alter 
glycosylation of LH; release of LH of high biological activity may thus 
depend on normal LHRH pulse generator activity.
A passible course of events might be as follows:- soon after burns 
injury the LH pulse generator is switched off; intermittent LHRH release 
is mandatory for release of biologically active LH and possibly also for 
its synthesis; the LH secreted whilst capable of detection by radio­
immunoassay may have altered glycosylation and is not able to stimulate 
testosterone secretion; when the pulse generator begins to recover, 
release of LH of lower biological activity may continue until biologically 
richer LH becomes available.
How might burns injury and other illnesses have such an effect on 
the LH pulse generator? Several possibilities exist. The possible 
influence of endogenous opioid peptides and catecholamines has been 
discussed.'Oestrogen levels are raised in uraemic, burned and septicaemic 
patients to an extent related to severity of illness (Rodger et al., 1985; 
Plymate et al., 1987; Christeff et al., 1988). An oestradiol infusion in 
healthy men reduces LH pulse frequency and LH biological activity with 
the oestrogen antagonist tamoxifen having the opposite effect suggesting 
that oestrogens in health may have an inhibitory effect on the LH pulse 
generator (Veldhuis & Dufau, 1987).
Endotoxin induced shock in male rats is accompanied by a fall in 
testosterone and an increase in oestrogen levels, these endocrine changes 
being prevented by either adrenalectomy or orchidectomy (Christeff et 
al., 1987). This animal experimentation led Christeff et al. (1988) to 
propose that the raised oestrogen levels in ill men resulted from 
testicular conversion of adrenal androgen to oestrogen. There is some 
evidence to suggest that such an interaction between the adrenal cortex 
and the testes may occur in rats (Feek, Tuzi & Edwards, 1989) but no such 
evidence exisis as yet in the human. Oestradiol in man is secreted by the 
testes (Longcope, Widrich & Sawin, 1972) but is also derived from 
aromitisation from testosterone (Longcope, Kato & Horton, 1969). Ho 
information is available in the literature concerning the source of the 
increased oestrogen levels in ill men. Whatever the mechanism leading to 
raised oestrogen levels in ill men, they may have an adverse effect on 
the LH pulse generator similar to an oestradiol infusion thus adversely 
affecting hypothalmic-pituitary-testicular function.
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Severe illness is accompanied by release of a large number of 
locally acting inflammatory mediators and in vitro research has shown 
that some of these may affect endocrine systems. For example fibroblast 
growth factor and interleukin-1 inhibit LH or HCG stimulated testosterone 
secretion in cultured rat Leydig cells (Fauser, Baird & Hsueh, 1988; 
Calkins et al., 1988). Platelet activating factor inhibited LHRH release 
from the rat median eminence in vitro (Junier et al., 1988). There is some 
evidence to suggest that such effects may be of relevance in vivo. Rivier 
& Vale (1989) found that interleukin-la injected into the lateral 
ventricle of castrated rats led to a dose dependent decrease of LH 
secretion whilst having no effect on LHRH stimulated LH release, implying 
an effect on endogenous LHRH release. There is no evidence in humans that 
these substances mediate the endocrine consequences of illness but they 
remain plausible candidates.
HypQthalaaiczpitultary.-a.di:enpsQrti£al-axls.
Although this thesis has demonstrated that DHAS levels often fall 
with longstanding illness I was unable to provide evidence to explain 
this finding. Several possibilities exist:- There may be decreased 
adrenocortical production of DHA and DHAS, reduced sulphation of DHA or 
reduced excretion or altered metabolism of DHAS.
Early investigators found unchanged urinary 17-ketosteroid excretion 
with increased excretion of glucocorticoid following trauma (Forbes et 
al., 1947; Moore et al., 1955). Lephart et al. (1987) obtained similar 
results in burned men with high serum cortisol but depressed serum DHAS 
concentrations. Urinary DHA excretion was reduced in ill men with low 
serum DHA and DHAS concentrations (Parker et al., 1985). Zumoff et al. 
(1971) administered isotopically labelled DHA to ill men and controls and 
found a smaller amount of the radioactivity in the urine of the ill than 
in that of the healthy. Increased urinary excretion of DHAS or its
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metabolites would appear improbable. Serum DHA concentrations of burned 
men are depressed to a similar degree to those of DHAS suggesting that 
reduced sulphation of DHA is not an explanation for the low DHAS levels 
(Parker et al., 1985; Lephart et al., 1987). In addition Lephart et al. 
(1987) found reduced levels of androstenediol and androstenediol sulphate, 
important metabolites of DHA and DHAS respectively. The evidence 
therefore points to inhibition of adrenocortical secretion of DHAS being 
the main mechanism leading to low serum concentrations in ill men.
If ACTH were the only factor regulating cortisol and adrenal
androgen secretion one might expect levels of cortisol and DHAS to change 
in parallel in ill men. The divergence between cortisol and DHAS in
illness and other situations has led to continuing controversy relating 
to control of adrenal androgen secretion discussed in Chapter 1. A 
reduction in the level of the putative pituitary hormone, adrenal androgen 
stimulating hormone, with illness is one possible explanation but as 
there is as yet no firm evidence for its existence it is necessary to
seek alternative mechanisms.
Recent in vitro studies using human adrenocortical tissue have shown 
that intra-adrenal enzyme systems are affected in differing ways by build 
up of substrate (Couch et al., 1986). These authors found that 17,20 
desmolase the enzyme crucial to adrenal androgen synthesis (Figure 28) is 
inhibited in a more sensitive fashion than 17-hydroxylase by the 
accumulation of endogenous steroids; indeed the known intra-adrenal
concentrations in man are sufficient to exert an inhibitory effect on 
17,20 desmolase with relative sparing of 17-hydroxylase (Dickerman et 
al., 1984). Prolonged adrenocortical stimulation, as might be found after 
several days of illness, may lead to increased adrenal blood flow 
promoting passage of increased concentrations of intra-adrenal steroids 
into the inner zone of the gland, the zona reticularis, which is 
responsible for the majority of adrenal androgen production; these
- 129 -
KISERALOQOETI GO ID. GLUmcfWTTqnjp MDRQGM
Cholesterol
DHAS
8
3 4
Pregnenolone 170H-Pregnenolone DHA
Progesterone — 170H-Progesterone A' dione
11-Deoxycorticosterone 11-Deoxycortisol
Corticosterone
t
Aldosterone
V
Cortisol
t
Testosterone
1) Cholesterol desmolase
2) 3£-Hydroxysteroid dehydrogenase (3JJ-HSD)
3) 17a-hydroxylase
4) 17,20-desmolase
5) 21-hydroxylase
6) 17J3-HSD
7) llp-hydroxylase
8) DHA sulphokinase
Figure 28 A simplified representation of the major steroid 
synthetic pathways.
increased steroid concentrations may then inhibit 17,20 desmolase leading 
to a fall in adrenal androgen production.
A reduction in the activity of 17,20 desmolase with relative sparing 
of 17-hydroxylase does not explain the divergence between androstenedione 
and DHAS levels in serum. A further alteration in intra-adrenal enzyme 
systems might account for this. For example, ACTH stimulation seems to 
lead to increased activity of the 3B-HSD enzyme system (Simonian & Gill, 
1981) thus promoting corticosteroid synthesis and also stimulating 
conversion of DHA to androstenedione. Thus although adrenal androgen
synthesis in total may be reduced, there may be a shift from DHA and 
DHAS to androstenedione synthesis. Control of steroid synthesis by local 
intra-adrenal mechanisms does not readily explain the low DHAS levels in 
uraemic patients who probably secrete cortisol normally although may have 
raised circulating levels due to reduced metabolism (Wallace et al., 1980). 
In addition if chronic adrenocortical stimulation secondary to illness 
leads to reduced secretion of adrenal androgen, why do patients with
Cushing's disease have normal or modestly raised DHAS levels rather than 
low levels (Yamaji & Ibayashi, 1969)? Many such questions will remain
unanswered until a fuller understanding of the mechanisms controlling
adrenocortical secretion is reached.
The possibility that factors produced at the site of tissue damage 
might affect hypothalmic-pituitary-testicular function has been discussed. 
There is some evidence that thay might also influence adrenocortical 
function. Interleukin—1 seems to activate the hypothalamic-pituitary— 
adrenocortical axis of rats (Besedovsky & del Rey, 1987) and epidermal 
growth factor has a similar effect in rhesus monkeys (Luger et al., 1988) 
both effects mediated by increased corticotrophin releasing hormone 
release. Insulin-like growth factor I increases cortisol secretion by 
cultured bovine cells by increasing the activity of several enzyme 
systems (Penhoat et al., 1988) whereas Type B transforming growth factor
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seems to depress cortisol secretion (Feige, Cochet & Chambaz, 1986). It is 
likely that many such factors are released from injured or diseased 
tissues. Whether they influence hypothalamic-pituitary-adrenocortical 
function in man and are released in sufficient quantities to have such a 
systemic effect remains to be established.
Implications for survival of changes in androgen levels with illness
The situation with regard to the low T4 syndrome is of interest; 
there is no evidence to suggest that replacement therapy with thyroid 
hormone is beneficial. Burned patients with low levels of T4 and T3 
showed no change in metabolic rate or mortality when treated with T3 
(Becker et al., 1982). Septicaemic rats with low thyroid hormone levels 
showed increased mortality and decreased time to death when treated with 
T4 (Little, 1985). Medically ill patients with the low T4 syndrome have 
not been improved by T4 replacement therapy (Brent & Hershman, 1986). 
Changes in thyroid hormone levels with illness may have a protective
effect possibly by reducing protein catabolism (Gardner et al., 1979).
It is relatively straightforward to find evidence of biochemical 
hypogonadism in ill men as reflected by low serum testosterone
concentrations. It is difficult if not impossible to discover whether 
patients are biologically hypogonadal as suggested by decreased libido 
and frequency of sexual activity. No attempt to research this was 
attempted as the problems involved in attempting to disentangle the 
effects of low serum testosterone concentrations from the general malaise 
induced by illness and hospitalisation presented insurmountable
difficulties. A low serum hormone level does not necessarily equate with 
a deficiency state. In the case of thyroid hormone there are several
intracellular mechanisms which may compensate for low levels of hormone 
reaching the cell (Koenig et al., 1984; Williams et al., 1989). Similar
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mechanisms may exist in the case of androgens but no evidence for this 
exists at present.
It is tempting to speculate that depressed serum testosterone levels 
with illness may be a teleological mechanism promoting decreased libido 
and fertility when the reserves of the patient would be more suitably 
expended on recovery from illness rather than on sexual activity and 
prospective parenthood. A short-term reduction in serum testosterone 
concentrations is unlikely to be harmful as many patients, such as those 
with prostatic carcinoma treated by surgical castration, experience low 
serum testosterone levels in the long-term without ill effects.
Although DHA and DHAS are the most abundant circulating adrenal 
steroids, they are only weak androgens with little virilising or anabolic 
properties. There is limited evidence from animal experimentation to 
suggest that adrenal androgens may have a beneficial effect on the immune 
system. Loria et al. (1989) showed that DHA but not aetiocholanolone had 
a protective effective against a potentially lethal viral infection in 
mice. The hypothesis that low adrenal androgen levels in ill subjects has 
an immunologically deleterious effect remains to be tested.
It seems more likely that adrenal androgens provide a reservoir of 
adrenocortical activity which can be "tapped" in times of chronic illness. 
Thus steroid synthesis in times of chronic illness may be diverted from 
adrenal androgen to corticosteroid pathways ensuring maintained secretion 
of cortisol which is essential for the recovery of ill patients. Other 
factors may also favour corticosteroid production at the expense of other 
adrenocortical products. Thus aldosterone levels may be inappropriately 
low in some chronically and severely ill patients (Zipser et al., 1981; 
Luger et al., 1984; Findling et al., 1987) suggesting that mineralo- 
corticoid as well as adrenal androgen synthetic pathways may be 
inhibited in this situation. Not only does the environment of ill patients 
favour increased cortisol secretion but it also leads to reduced
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elimination (Sandberg et al., 1956). The metabolism of cortisol to 
cortisone accounts for a major proportion of the elimination of cortisol 
(Fukushima et al., 1960) and this process may be inhibited in the 
severely ill (Gold et al., 1958). Thus reduced adrenal androgen secretion 
in the ill may in combination with other mechanisms promote a sustained 
and pronounced increase in cortisol levels which are crucial for recovery.
The work described in this thesis has in great measure occupied the 
author over the last few years always helped by various willing
colleagues. Profound changes in the hormonal milieu of ill patients have
been documented and some pathophysiological mechanisms have been 
explored. The abnormalities found have been difficult to explain in terms 
of classical endocrine control systems. Further research is warranted to 
to investigate the mechanisms leading to the observed changes.
For example a more detailed study of the structure of LH secreted in 
a pulse peak as compared to that present during a nadir with comparisons 
between normal and burned patients would allow confirmation of the
hypothesis that variation in glycosylation is the cause of altered LH 
biological activity. The effect of giving ill patients replacement therapy 
with adrenal androgen would be of interest but not ethically justifiable 
at present. A similar experiment using an animal model might suggest 
whether such treatment was likely to be of value and would be necessary 
before embarking on a trial in humans. Studies using radiolabelled 
steroids administered to ill men could be performed in order to 
investigate the hypothesis that 17,20 desmolase is inhibited with
relative sparing 17-hydroxylase and might also be able to shed light on 
the source of the increased oestrogen levels. It may be possible to 
determine whether the increased oestrogens in the circulation of ill men 
are implicated in the abnormality of hypothalamic pituitary testicular
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function by studying the biological activity of LH through a pulse series 
in burned men treated with either the oestrogen antagonist tamoxifen or 
placebo.
Further investigation of these situations may lead to a better 
understanding of the mechanisms controlling hypothalmic-pituitary- 
testicular and hypothalamic-pituitary-adrenocortical function in health 
and disease.
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